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Abstract and Scope of The Work 
As a consequence of several draw backs encountered by viral technology in achieving efficient and 
safe gene therapy in clinical trials, non-viral gene delivery vectors are considered to date as a valuable 
alternative and to hold promise for future therapeutic applications. 
Nevertheless, the transfection efficiency mediated by these non-viral gene delivery vectors has to 
be improved to benefit fully from their advantages. Cationic transfection compounds/nucleic acid 
complexes have been the subject of intensive investigations in recent years to understand the 
parameters governing the efficiency of transfection. Specifically, the understanding of such 
mechanisms, from the formation of the complexes to their intracellular delivery, will lead to the design 
of better adapted non-viral vectors for gene therapy applications.  
The aim of the study described in this thesis was to investigate the detergent dialysis-based 
approach to form lipoplexes and polyplexes which has been previously applied to prepare non-viral 
lipid-based vectors for delivery of nucleic acids. This was first introduced by Reimer et al., (1995) 
who has demonstrated that addition of mono-cationic lipids to plasmid DNA results in the formation 
of a hydrophobic complex in the presence of non-ionic detergent.  
This technique is based on interacting the cationic lipid and pDNA in presence of the non ionic 
detergent N-octyl β-D-glucopyranoside (OGP). Upon extensive detergent withdrawal by dialysis, the 
cationic compound /pDNA assembly is formed. It is anticipated that excess detergent removal may 
promote DNA condensation and aggregation which could be facilitated through intramolecular acyl 
chain interactions. The primary driving force for association of cationic lipid with pDNA is 
electrostatic; nevertheless, the hydrophobic interactions and hydration forces are still also involved in 
the structural rearrangements to spontaneously form lipid/pDNA complexes. It is proposed that careful 
control of the DNA condensation reaction is crucial in obtaining a suitable lipid or polymer-based 
pDNA particles for efficient delivery of genes into cells in vitro and in vivo. 
Among various cationic lipids, 1,2-dioleoyl-sn-glycero-3-phosphocholine, 1,2-dioleoyl-3-
trimethylammonium propane (DOTAP) and cholesteryl 3β-N-(dimethylaminoethyl) carbamate 
hydrochloride (DC-cholesterol) have become standard for cationic lipid-mediated nucleic acid 
delivery. In addition, a polymer based non-viral delivery system, polyethylenimine (PEI) was selected 
since it is the most successful polymeric gene delivery system at the moment. 
In Chapter 3 we focussed on the establishment of the preparation of lipid based pDNA systems 
which form as a consequence of a self assembly process dependent on the formation of a hydrophobic 
cationic lipid/pDNA complex in presence of non-ionic detergent OGP. The influence of detergent on 
lipoplex assembly with regard to physicochemical characteristics of the produced lipoplexes was 
investigated. Additionally, we estimated the pDNA release from different cationic lipid based systems 
prepared by detergent dialysis technique compared to lipoplexes formed by direct simple mixing. For 
initiation of pDNA release, different negatively charged liposomes as model membranes were used.  
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Furthermore, Chapter 4, aimed to characterize the influence of OGP on the morphological 
characteristics of DOTAP/pDNA lipoplexes. The morphological features of the lipoplexes prepared by 
dialysis technique were visualized using cryo-TEM compared to mixed lipoplexes. Furthermore, the 
mechanisms of pDNA release from DOTAP/pDNA lipoplexes by different negatively charged 
liposomes were visualized. 
In Chapter 5 we have utilized assays including: 1) octadecyl-rhodamine (R18) de-quenching assay 
and 2) fluorescence resonance energy transfer (FRET) assay to assess the membrane destabilization of 
dialysed cationic lipid/pDNA lipoplexes in terms of lipid mixing during pDNA release by negatively 
charged liposomes. The membrane destabilization of lipoplexes was correlated with their pDNA 
release.  
Finally in Chapter 6, the formation of pDNA/25 kDa branched PEI polyplexes in the presence of 
the non-ionic detergent N-octyl-beta-D-glucopyranosid (OGP) at different N/P ratios followed by 
dialysis was investigated. The polyplexes were characterized by laser light scattering to determine the 
influence of OGP on the hydrodynamic diameter and the surface charge of the particles. In addition, 
pDNA condensation was determined using PicoGreen® nucleic dye assay. Gene expression of the 
polyplexes was characterized in HEK 293 cells using flow cytometry analysis. 
 
Reference: 
Reimer D. L., Zhang Y., Kong S., Wheeler J. J., Graham R. W., and Bally M. B., Formation of novel 
hydrophobic complexes between cationic lipids and plasmid DNA, Biochemistry  34 (1995) 12877-12883. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract and Scope of The Work 
 
 3
Zusammenfassung 
Aufgrund diverser Probleme, die die Verwendung viraler Genvektoren hinsichtlich Effizienz und 
Sicherheit aufwirft, sind nicht-virale Genvektoren derzeit als wertvolle und vielversprechende 
Alternativen für die Entwicklung zukünftiger therapeutischer Applikationen einzustufen. 
Um von den Vorteilen nicht-viraler Genvektoren in vollem Umfang profitieren zu können, ist es 
jedoch notwendig, deren Transfektionseffizienz zu steigern. In den letzen Jahren waren kationische 
Transfektionsagens-Nukleinsäure-Komplexe Gegenstand intensiver Untersuchungen, die darauf 
abzielten, die die Transfektionseffizienz steuernden Parameter, zu verstehen. Vor allem das 
grundlegende Verständnis der hierfür relevanten Mechanismen, angefangen von der Bildung der 
Komplexe bis hin zu deren intrazellulärem Transportweg, schafft die Basis für die Entwicklung 
optimal angepasster nicht-viraler Genvektoren für gentherapeutische Anwendungen.  
Das Ziel der vorliegenden Arbeit war die Untersuchung eines Dialyse-basierten Verfahrens zur 
Herstellung von Lipoplexen und Polyplexen, das bereits eingesetzt wurde, um nicht-virale Vektoren 
auf Lipidbasis für den Transport von Nukleinsäuren zu formulieren. Dieses Verfahren geht zurück auf 
Reimer et al. (1995), der gezeigt hatte, dass die Zugabe monovalenter kationischer Lipide zu Plasmid-
DNA in Gegenwart nicht-ionischer Tenside zur Bildung  hydrophober Komplexe führt.  
Diese Technik basiert auf der Interaktion kationischer Lipide und pDNA in Anwesenheit des nicht-
ionischen Tensids n-Octyl-β-D-glucopyranosid (OGP). Während der Elimination des Tensids durch 
Dialyse bildet sich der Komplex aus kationischem Agens und pDNA. Es wird vorausgesetzt, dass das 
Entziehen des Tensids die Kondensation und Aggregation der DNA fördert. Möglicherweise wird dies 
durch die intramolekulare Interaktion der Acylketten erleichtert. Als treibende Kraft für die 
Assoziation von kationischen Lipiden mit DNA sind jedoch elektrostatische Kräfte anzusehen, auch 
wenn hydrophobe Interaktionen und Hydratationskräfte ihren Anteil zur strukturellen Neuorganisation 
von spontan gebildeten Lipid-pDNA-Komplexen beitragen. Es ist anzunehmen, dass die genaue 
Steuerung  der DNA-Kondensationsreaktion ausschlaggebend für die Gewinnung geeigneter Lipid- 
oder Polymer-basierter DNA-Partikel zur effizienten Transfektion von Zellen in vitro und in vivo ist.  
Aus der Vielzahl der üblicherweise verwendeten kationischen Lipide, wurden 1,2-Dioleoyl-sn-
glycero-3-phosphocholin, 1,2-Dioleoyl-3-trimethylammoniumpropan (DOTAP) und Cholesteryl-3β-
N-(dimethylaminoethyl)carbamat-Hydrochlorid (DC-cholesterol) als die wichtigsten Standards für 
kationische lipidbasierte Genvektoren ausgewählt und untersucht. Zusätzlich wurden 
Polyethylenimin(PEI)-basierte DNA-Partikel untersucht, da sie derzeit das erfolgreichste 
Genvektorsystem auf Polymerbasis darstellen. 
In Kapitel 3 wird auf die Entwicklung der Herstellungsmethodik für lipidbasierte DNA-Systeme, 
die sich in Folge eines Selbstassoziationsprozesses bilden eingegangen. Diese Systeme bilden sich in 
Anwesenheit des nichtionischen Tensids OGP in Folge eines Assoziationsprozesses, der abhängig von 
der Bildung des initial gebildeten Komplexes bestehend aus einem hydrophoben kationischen Lipid 
und DNA ist. Zur Herstellung der lipidbasierten DNA-Lipoplexe durch Dialyse wurde OGP 
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verwendet. Der Einfluss des nichtionischen Tensids OGP auf die Bildung der Lipoplexe, der sich in 
den physikochemischen Eigenschaften der Endprodukte wiederspiegelt, wurde untersucht. Zusätzlich 
wurde die pDNA-Freisetzung aus zwei kationischen lipidbasierten Systemen, die durch 
Dialysetechnik im Vergleich zur Mischungstechnik hergestellt wurden, bestimmt. Zur Aktivierung der 
pDNA-Freisetzung wurden die Interaktion der Lipoplexe mit negativ geladenen Liposomen als 
Modellmembranen genutzt. 
Kapitel 4 zielt auf die Charakterisierung des Einflusses von OGP auf die morphologischen 
Eigenschaften von DOTAP-pDNA-Komplexen ab. Die Morphologie von Lipoplexen, die durch 
Dialyse im Vergleich zur Mischungstechnik gewonnen wurden, wurden anhand von cryo-TEM-
Aufnahmen visualisiert. Weiterführend wurde mit dieser Technik die Interaktion von DOTAP-pDNA 
Lipoplexen mit verschiedenen negativ geladenen Liposomen untersucht. 
Kapitel 5 fasst die Ergebnisse der Untersuchungen zur Abschätzung der Membrandestabilisierung 
von Lipid-pDNA-Lipoplexen während der pDNA-Freisetzung zusammen. Die Lipoplexe wurden 
durch Dialyse hergestellt und mittels 1) Octadecyl-Rhodamine (R18) Deuterium- Quenching und 2) 
Fluoreszenz Resonanz Energie Transfer (FRET) untersucht. Die Membrandestabilisierung der 
Komplexe wurde mit der pDNA-Freisetzung, die mittels PicoGreen®-Assay ermittelt wurde, korreliert. 
Abschließend beleuchtet Kapitel 6 die Bildung von Polyplexen aus pDNA und 25 kDA PEI 
(verzweigt) mit unterschiedlichen Verhältnissen von Stickstoff zu Phosphor. Die Polyplexe wurden 
durch Dialyse unter Zusatz des Tensids OGP hergestellt. Der Einfluss von OGP auf den 
hydrodynamischen Durchmesser und die Oberflächenladung der Partikel wurde mittels 
Photonenkorrelationsspektroskopie und der Bestimmung des Zetapotentials abgeschätzt. Zusätzlich 
wurde die pDNA-Kondensation mittels PicoGreen®-Assay gemessen. Die Genexpression der 
Polyplexe in HEK 293-Zellen wurde mittels Durchflusscytometrie bestimmt.  
 
 
Referenz: 
Reimer D. L., Zhang Y., Kong S., Wheeler J. J., Graham R. W., and Bally M. B., Formation of novel 
hydrophobic complexes between cationic lipids and plasmid DNA, Biochemistry  34 (1995) 12877-12883.
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1. Introduction 
1.1. Gene Therapy 
1.1.1. The Principle of Gene Therapy 
Gene therapy provides a unique approach to medicine as it can be adapted towards the treatment of 
both inherited and acquired diseases such as cancer, cardiovascular diseases, AIDS, neurodegenerative 
(Lasic 1997) and recently urological diseases (Goins et al., 2009). Gene delivery relies upon the 
encapsulation of a gene of interest, which is then ideally delivered to target cells. After uptake by 
endocytosis, the DNA has to be released into the cell so that transcription and translation may occur to 
produce the protein of interest. To achieve successful gene delivery, several barriers must be overcome 
at each step of this process in order to optimize gene activity (Figure 1.1).  
Although the objectives and principles of gene therapy have been well-defined over the last 
decades, its application as a versatile, therapeutically successful approach has not yet met 
expectations.  
Today it is clear that gene therapy not only may lead to its primary goal of replacing a deficient 
gene, but it could also lead to a modulation of the expression of genes acting on the physiology of 
malignant cells. Furthermore, by means of gene therapy, functions might be integrated into cells that 
are not originally present and that could serve a therapeutic purpose. Thus in a modern concept and 
broader sense, gene therapy refers to the potential use of nucleic acids, irrespective of whether it 
concerns e.g. plasmid DNA, antisense oligonucleotides or siRNA, to modulate in any kind of way the 
expression of genes in cells for therapeutic purposes (Cornford et al., 2009). 
The number of clinical trials in gene therapy is steadily increasing, exceeding 1405 by March 2009 
(data Wiley 2009, www.wiley.co.uk/genmed). “Naked” plasmid DNA is unstable under in vivo 
conditions due to rapid degradation by serum nucleases. Therefore, the development of gene delivery 
vectors play a predominate role in gene therapy. Carriers or “vectors” are necessary to provide 
effective DNA condensation and to protect DNA or RNA from degradation, to facilitate uptake into 
specific cells and finally to release DNA and to transfer the DNA or RNA into the nucleus or 
cytoplasm, respectively (Luo and Saltzman, 2000; Lechardeur et al., 2005). 
The primary challenge for gene therapy is to develop a method that delivers a therapeutic gene 
(transgene) efficient to target cells where gene expression can be achieved. Depending on the vectors 
used for nucleic acid transfer, gene delivery is divided into two main categories: viral and non-viral 
gene delivery. 
An ideal gene delivery method needs to meet three major criteria: (i) it should protect the transgene 
against degradation by nucleases in the blood circulation and intercellular matrices, (ii) it should 
transfer the transgene across the plasma membrane and into the nucleus of target cells, and (iii) it 
should have no detrimental effects. 
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1.1.2. Viral Gene Delivery Carriers 
Viruses are the most efficient gene vectors known today due to their inherent capacity to carry and 
protect foreign genes, cross the cellular membrane, escape endosomes, and to achieve efficient gene 
expression (Walther and Stein, 2000)..  
Due to their natural ability to infect cells efficiently in terms of the number of transfected cells, several 
viruses, such as retrovirus, adenovirus, adeno-associated virus and herpes virus, have been 
investigated for in-vivo viral-mediated gene. For example, retroviral vectors can introduce genes 
permanently into somatic cells by integration into cell's chromosomal DNA. Retroviruses only infect 
replicating cells, though the resultant permanent integration of therapeutic genes minimizes the ability 
to modify or to terminate therapy in response to any adverse side-effects or cure of the disease. In 
addition, the permanent integration of genes into host chromosomes may result in activation of 
oncogenes or inactivation of tumor suppressor genes.  
In contrast, adenoviruses efficiently infect non-dividing cells and do not integrate genes into the host 
genome (Mulligan, 1993; Tomlinson and Rolland, 1996; Young et al., 2006). 
Different mechanisms were described for interactions of viruses with cells depending on the type of 
virus. The protein capsid of a virus is able to bind to proteins in the cellular membrane, gain entry as 
the cell internalizes, and recycles its membrane proteins. Other viruses have a protein-lipid capsid that 
can fuse and pass through the cell membrane (Subramanian et al., 2002). Viruses have inherent 
mechanisms to avoid lysosomal trafficking by promoting the fusion of the viral envelope with the 
endosomal membrane and therefore, causing the release of the virus into the cytoplasm (Akinc et al., 
2004). These unique abilities of viruses led to the first clinical trial in gene therapy in 1990, where 
retroviral vectors were used to introduce the adenosine deaminase gene into the white blood cells of 
patients suffering from severe combined immunodeficiency (SCID) (Tomlinson and Rolland, 1996; 
Haider et al., 2005). 
Viral vectors are able to mediate gene transfer with high efficiency up to 90 % and the possibility 
of long term as well as stable gene expression, and satisfy 2 out of 3 criteria described above. 
However, acute immune response, immunogenicity, and insertion mutagenesis especially after 
repeated applications in clinical trials have raised serious safety concerns about some commonly used 
viral vectors. 
 
1.1.3. Non-viral Gene Delivery Carriers 
The aforementioned drawbacks of viral vectors have impeded the progress of gene therapy. 
Avoiding these drawbacks with the use of non-viral vectors can lead to major advances in gene 
therapeutics. Methods of non-viral gene delivery have also been explored using i) physical (carrier-
free gene delivery) and ii) chemical approaches (synthetic vector-based gene delivery).  
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Figure 1.1: Obstacles in Gene Delivery Following In-Vitro Administration. The carrier system, 
here a transfection compound, should efficiently condense pDNA into complexes. Complexes have to 
attach to the cell surface, be internalized (e.g. by endocytosis) (1), escape from endolysosomes (2), 
move through the cytoplasm to the nucleus and cross the nuclear membrane (5) and be transcribed 
(gene expression) (6). In addition, the complex must dissociate and pDNA must be released (4). 
Alternative pathways exist for several of these steps, such as endolysosomal complex degradation (3).
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1.1.3.1. Physical Gene Delivery Systems 
Physical approaches include needle injection (Wolff et al., 1990), electroporation (Neumann et al., 
1982; Heller et al., 2005), gene gun (Yang et al., 1990; Yang and Sun, 1995), ultrasound (Lawrie et 
al., 2000) and hydrodynamic delivery (Liu et al., 1999; Zhang et al., 1999) employing a physical force 
that permeates the cell membrane and facilitates intracellular gene transfer. Since the present work is 
focussed on the delivery of chemical gene delivery systems, the physical approaches will not be 
discussed more detailed. 
 
1.1.3.2. Chemical Gene Delivery Carriers 
Cationic lipids and polymers can electrostatically bind DNA or RNA, condense the genetic 
material into particles of a few tens to several hundred nanometres in diameter, protect the genes 
against degradation and mediate cellular entry. Such complexes of plasmid DNA with cationic lipids 
and polymers are known as lipoplexes or polyplexes, respectively.  As opposed to the viral vectors, 
these systems are collectively known as non-viral gene delivery systems.  
Although being less efficient, particularly in vivo (Dass, 2004), both lipoplexes and polyplexes are 
thought to be immunologically inert, and potentially safer than viral vectors for in vivo use. Since they 
are also easy to produce and to modify chemically for improvement of transfection efficiency, research 
efforts in this particular area have drastically increased in recent years (Li and Huang, 2000; Wang et 
al., 2006). Thus, numerous cationic carriers have been synthesized and for rational development 
structurally modified in a systematic manner in order to correlate structure with transfection activity, 
i.e. the identification of the molecular features associated with high transfection efficiency and low 
cytotoxicity. For example, several possibilities to reduce the toxicity of cationic amphiphiles have 
been discovered, among which the use of a biodegradable ester linkage between the headgroup and the 
alkyl tails (Aberle et al., 1998: Pijper et al., 2003).  
The chemical approaches (Huang et al., 1999; Mahato and Kim, 2002; Liu et al., 2003; Neu et al., 
2005) use synthetic or naturally occurring compounds such as chitosan (Masotti et al., 2008) and 
protamine sulphate (Biegeleisen, 2006) as carriers to deliver the transgene into cells. Although 
significant progress has been made in the basic science and applications of various non-viral gene 
delivery systems, the majority of non-viral approaches are still less efficient than viral vectors, 
especially for in vivo gene delivery.  
Non-viral gene delivery systems provide opportunities for improved safety, greater flexibility and 
easier manufacturing. In contrast to viral particles, they are not limited to the delivery of coding 
nucleic acids but can accommodate a greater variety of cargo of different sizes, including antisense 
ODNs, ribozymes, siRNAs, or genes. Finally, non-viral vectors are easier and safer to produce and 
better amenable to chemical modifications for the purpose of effectuating therapeutic applications. 
However the major drawback of non-viral vectors is their low transfection efficiency compared to 
viral systems which especially hinders their use in vivo therapeutic applications. A better knowledge 
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of the mechanism of transfection mediated by non-viral vectors in correlation to their structure will 
allow the development of more efficient non-viral vectors for gene therapy applications. 
 
1.2. Molecular Shape and Aggregation Behaviour of Amphiphilic Compounds: The Packing 
Parameter  
Cationic lipids are amphiphilic molecules, implying that they consist of a hydrophilic and a 
hydrophobic region, i.e. a charged cationic amine headgroup attached via a linker, for example 
glycerol, to a usually double hydrocarbon chain or a cholesterol derivative. 
An important property of the amphiphile, with regard to its application as a vector, is its geometry. 
Like any amphiphile, when suspended in an aqueous environment cationic lipids can adopt various 
structural phases, including the micellar, lamellar, cubic and inverted hexagonal phase. The type of 
structure can be predicted by a factor known as the packing parameter, P. This packing parameter, P = 
V/ a0 * lc , is defined as the ratio of the hydrocarbon volume, v, and the product of the effective head 
group area, a0, and the critical length of the lipid tail, lc (Crystal, 1995; Hsu et al., 2005). In short, the 
correlation emphasizes the relevance of the ratio of the area occupied by the hydrophobic region 
versus that of the hydrophilic region.  
The number of charges on the head group determines whether the cationic lipid will be monovalent 
or multivalent. In monovalent lipids, the head group consists of either tertiary or quaternary 
ammonium groups.  
The positively charged cholesterol derivative DC-cholesterol (Fig. 1.2) was initially designed for 
DNA transfection (Gao and Huang, 1991) and had been used in human gene therapy trials with a good 
safety profile (Stewart et al., 1992; San et al., 1993; Nabel et al., 1993; Middleton et al., 1994). When 
used as a transfection compound, DC-cholesterol is usually combined with the helper lipid DOPE that 
facilitates membrane fusions and intracytoplasmic delivery of the DNA (Gao and Huang, 1991; Li et 
al., 1996). 
It has been shown that DC-cholesterol molecules self-assemble into wormlike micelles in aqueous 
media (Wu et al., 2004). For gene therapy application, this lipid was usually mixed with a zwitterionic 
lipid to form liposomes prior to DNA complexation (Gao and Huang, 1991; Chesnoy and Huang, 
2000). Despite the absence of bilayer entities for DC-cholesterol, the subsequent complexation with 
DNA induces formation and ordering of bilayers, where the DC-cholesterol micelles transform into a 
multilamellar structure after the complexation. This transformation is due to the effective dehydration 
of the DC-cholesterol head groups induced by the electrostatic interaction with DNA. The high 
packing density of DNA stiffened the membrane, thereby resulting in a topological structure of flat 
lamellae. When the lipid is in excess, the hydrophilic layers excluding the lipid head groups contained 
domains of closely packed DNA and water domains. The interhelical distance between the DNA 
chains confined between the fully cationic bilayers and the topological structures of the multilamellar 
phase were observed by transmission electron microscopy (Wu et al., 2004). 
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The cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) (Figure 1.2) consists of 
two unsaturated diacyl side chains (oleoyl), ester linker and trimethylammonium moiety in the polar 
head group (Lasic, 1997). Smyth Templeton et al (1997) and Liu et al (1997) reported good protection 
and effective delivery of DNA mixed with DOTAP: cholesterol liposome to tissue, after systemic 
administration into mice. DOTAP was developed through taking into account that had biodegradable 
ester bonds which showed lower toxicity compared to the activities of 1,2- dioleyloxypropyl-3-
trimethyl ammonium bromide (DOTMA). In the meantime, Liu et al (1997) concluded that stable 
ether bonds may be more beneficial than the less stable ester bonds. 
However, some multivalent lipids, such as lipopolyamines, have intrinsic transfection activity, and 
a helper lipid does not have a major impact on overall transfection activity, indicating that multivalent 
cationic lipids work on a different mechanism (Behr et al., 1989; El Ouahabi et al., 1997). Often, these 
cationic lipopolyamines have protonable amine groups that apparently intercept the endosome 
maturation by absorbing protons to slow down the acidification process inside the endosomes, 
preventing the endosome-lysosome transition.  
Double-chain hydrocarbons represent the majority of cationic lipids synthesized so far. Oleoyl 
chain (C18:1) is the most frequently used unsaturated acyl chain, whereas C14, C16, and C18 are the 
commonly used saturated hydrocarbon chains. The importance of the alkyl chain length in transfection 
activity in vitro was studied by Felgner et al (1994), who varied the alkyl chain length in a 
homologous series of hydroxyethyl quaternary ammonium derivatives. They observed that the alkyl 
chain length can influence the transfection activity (C14:0 > C18:1 > C16:0 > C18:0). Usually, 
double-chain hydrocarbons are capable of forming liposomes by themselves, but they are often used in 
combination with a helper phospholipid in cationic lipid transfection formulations. Derivatives 
containing non-degradable ether bonds were found to be more toxic than those containing 
biodegradable linker bonds such as ester, amide, and carbamoyl bonds (Farhood et al., 1995). 
 
 1.3. Polyethylenimine as a Non viral Vector System 
Among cationic polymers, PEI emerged as a very interesting candidate (Bossif et al., 1995) 
reaching transfection efficiencies similar to viral vectors (Abdallah et al., 1996) (Figure 1.2). The 
recent years have witnessed rapid development of non-viral vectors based on PEI and derivatives 
which possess properties addressing delivery problems associated with gene therapy. 
The most prominent feature of PEI is its high cationic charge density. Condensation of the anionic 
DNA with the cationic PEI based on electrostatic interactions leads to the formation of compact 
particles of approximately 100 nm in diameter depending upon the PEI modification (Kircheis et al., 
2001). Every third atom in the polymer polyethylenimine is a nitrogen atom in an amino group that 
can be protonated, which results in a high positive charge (Park et al., 2000; Choosakoonkriang et al., 
2003). Since PEI does not contain quarternary amines, cationic charges are generated by protonation 
of the amine groups by the biological environment, thus leading to a correlation between 
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environmental pH and cationic charge density. PEI showed a level of protonation at pH 7.4 of 20 % 
compared to about 45 % for a pH at 5 (Suh et al., 1994; Neu et al., 2005). The wide range of apparent 
pKa values leads to a system with effective buffer capacity.  
Polyethlyenimines (PEI) have been suggested to trigger endosomal escape of polyplexes according 
to the “proton sponge hypothesis”. The inherent ability of PEI to facilitate DNA release into the cell is 
a major advantage, since release into the cytoplasm is one of the main crucial processes encountered in 
gene delivery. Release of transfection complexes from endosomes is critical, and delayed release of 
nucleic acids into the cytosol appears to result in substantial degradation (Wattiaux et al., 2000). One 
hypothesis, first reported by Behr in 1997, was called the “proton sponge” hypothesis. This theory 
postulates that a DNA delivery vector that buffers the endosomal or lysosomal compartments can 
propagate the rupture of these vesicles by creating an osmotic gradient between the vesicle interior and 
the cytoplasm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NH CH2 CH2 
 X 
NH CH2 CH2 
 Y
CH2CH2NH2
(C) 
Figure 1.2: Chemical Structures of some Cationic Transfection Compounds. DC-
Cholesterol (A), DOTAP (B) and branched polyethylenimine (C). DC- Cholesterol is 
typified by a tertiary amine head group attached to cholesterol as hydrophobic tail. 
DOTAP contains a quaternary ammonium head group, a glycerol linker, and two oleoyl 
chains as hydrocarbon tail. Polyethylenimine (PEI) shows protonatable amino nitrogens 
indicated by ovals. 
 
(B) 
(A) 
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Upon a decrease of the endosomal pH value from 7 to about 5 the charge of the PEI increases, 
invoking a corresponding influx of protons, negatively charged Cl− ions and water to maintain overall 
electroneutrality (Fig. 1.3). Both influx ions and swelling induce an increased osmotic pressure and a 
destabilization of the endosomal compartment which allows release of the pDNA into the cytoplasm 
(Haensler and Szoka, 1993; Boussif et al., 1995; Kircheis et al., 2001; Forrest and Pack, 2002; Bieber 
et al., 2002; Akinc et al., 2004). In addition to direct membrane interaction, the release of polyplexes 
may also be attributed to the extension of the polymer network as a result of the increasing 
electrostatic repulsion of charged groups during acidification (Merdan et al., 2002).  
Since the process of condensation is entropically driven (Bloomfield, 1997), and polyplexes form 
spontaneously upon mixing of cationic polymers with plasmid DNA, the degree of DNA 
condensation, and thus the net charge of the resulting particle, is strongly dependent on the cation to 
anion ratio, or more precisely the PEI nitrogen to DNA phosphate ratio (N/P ratio). Complete 
condensation of DNA, which means fully exploit cation/anion interactions, seems to occur at N/P 
ratios of 3-5 depending upon the PEI modification (Kleemann et al., 2004). However, a maximum of 
DNA condensation is obtained only with a high PEI extend at N/P ratios > 6, resulting in small 
polyplexes that exhibit a strong positive net charge.  
Choosakoonkriang et al (2003) reported an optimal transfection at N/P 6-10, where small ca. 100 
nm, positively charged polyplexes were formed. At N/P 6-10 it was found that 86 % of the PEI 
molecules were in a free un-complexed form. The DNA density inside the polyplex was found to be 
smaller than that in toroidal condensates induced by e.g. multivalent ions (Clamme et al., 2003). That 
means, only 10 % of the polyplex volume is occupied by DNA in contrast to 72 % within toroidal 
aggregates formed by multivalent cations (Bloomfield 1997). The net cationic charge induces the 
polyplexes to bind to the negatively charged glycosaminoglycans, which are present on cell 
membranes, and leads to the subsequent polyplex internalization by endocytosis (Ruponen et al., 
2003). 
PEI exists as a branched polymer (BPEI), commercially available in a broad range of molecular 
weights (MWs), as well as in its linear form (LPEI). The transfection efficiency and cytotoxicity 
(Moghimi et al., 2005) of PEI-based transfection systems depends on the MW, the degree of 
branching, the cationic charge density and buffer capacity of the polymer (Godbey et al., 1999b; von 
Harpe et al., 2000; Kunath et al., 2003). High MW BPEI has been shown to have a superior 
transfection efficiency compared to BPEIs with lower MW (Godbey et al., 1999b), but unfortunately, 
the higher transfection efficiency was accompanied by a decrease in the cell viability. Therefore, 
among BPEIs, a MW of 25 kDa is commonly believed to be most suitable for gene transfer. 
Polyplexes containing LPEIs have recently been shown to have improved transfection efficiency and 
cell viability compared to BPEI based transfection systems (Ferrari et al., 1997; Goula et al., 1998; 
Bragonzi et al., 1999; Goula et al., 2000). 
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1.4. Lipoplex Formation 
 1.4.1. The Simple Mixing Approach 
Lipoplexes are self assembling structures and their formation entails a multistep mechanism as 
revealed by detailed studies employing atomic force microscopy and cryo electron microscopy 
(Huebner et al., 1999; Oberle et al., 2000; Kennedy et al., 2000). In milliseconds electrostatic 
interactions between DNA phosphate and the positively charged amine head group of the cationic lipid 
occur, the one-sided DNA/liposome surface interaction presumably gives rise to packing constraints in 
the bilayer. The defects triggering extensive interactions between adjacent bilayers as reflected by 
extensive lipid mixing (Oberle et al., 2000; Kennedy et al., 2000; Caracciolo et al., 2005) and 
concomitant release of vesicle contents indicates the rupture of the membrane structure (Huebner et 
al., 1999; Oberle et al., 2000; Kennedy et al., 2000; Simberg et al., 2004). Rupture presumably causes 
exposure of hydrophobic edges of cationic membranes that may serve as nucleation sites for 
interaction with similar adjacent structures leading to further membrane merging, lipid mixing and 
aggregate growth. Compared to addition of DNA to vesicles, the reverse slows down the complex 
assembly process, indicating that DNA mediated vesicle-vesicle interaction is influential in 
destabilization rather than DNA-vesicle interaction per se (Oberle et al., 2000; Kennedy et al., 2000; 
Caracciolo et al., 2006). It was suggested, the cationic lipids are wrapped entirely around the plasmids. 
Figure 1.3: Scheme of the proton-sponge mechanism of polyethylenimine according to Sonawane 
et al., 2003. Polyethylenimine (PEI), which contains a large number of primary, secondary and tertiary 
amines, exhibit pKa values between physiological and lysosomal pH (A). Endolysosomes are acidified 
by the action of ATPases that actively transports protons from the cytosol into the vesicle. PEI polymer, 
therefore, undergoes large changes in protonation during endocytic process (B). It has been proposed 
that proton-sponge polymers prevent acidification of endocytic vesicles, causing the ATPase to 
transport more protons to reach the desired pH. The accumulation of protons into vesicle must be 
balanced by an influx of counter ions (Cl-) and water into endocytic vesicles. The increased ion 
concentration ultimately causes osmotic swelling and rupture of the endosome membrane, which 
releases the polyplexes into the cytocol (C). 
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The surfaces of the assembled complex show a smooth appearance implying proper DNA packaging. 
At that stage, the tendency of adjacent complexes to further undergo extensive lipid mixing decreases 
(Huebner et al., 1999; Oberle et al., 2000), since potential interaction sites are blocked. 
Obviously, effective DNA compaction is important. In fact, the amphiphiles that are easily 
hydrated, form fluid aggregates, and undergo a transition to the inverted hexagonal phase in the 
presence of plasmid DNA at physiological ionic strength are often more favourable for effective 
transfection. In this so called simple direct mixing approach, kinetic control is achieved by adjusting 
the concentration of DNA, charge ratio, ionic strength of the solution and rate of mixing of the 
cationic lipid and nucleic acid. This approach relies on kinetic control to permit small particles that 
consist of cationic lipids and nucleic acid. 
 
1.4.2. The Detergent Substitution Approach 
In more sophisticated methods, cationic lipid and nucleic acid are inhibited from aggregation using 
a detergent to disrupt the bilayer structure. The addition of detergents to a bilayer forming lipid 
induces the formation of a number of intermediate mixed vesicles (MVs) and various types of mixed 
micelles (MMs) depending on detergent/lipid ratio. Afterwards, the detergent is removed by dialysis 
or filtration. As the concentration of the detergent/solvent decreases, the self-assembly of the lipids 
with the nucleic acid into lipoplexes takes place (Reimer et al., 1995; Zhang et al., 1997). 
This approach was initially used for preparing stable cationic lipid/DNA particles by dissolving 
DNA and the cationic lipid mixture in a detergent solution followed by detergent removal (Wang and 
Huang, 1987; Hofland et al., 1996). The resulting particles were stable for a longer period and were 
more active in the presence of serum containing medium than lipoplexes prepared by the simple 
mixing technique (Guo et al., 2000; Xu et al., 2001). However, this method did not improve the in-
vivo performance. Nevertheless, this approach showed that (i) a detergent solution can be used as a 
medium for the particle formulation because both DNA and lipids are soluble and (ii) N-octyl β-D-
glucopyranoside (OGP) is a good choice as detergent since it has high critical micelle concentration 
(CMC) and is a non-ionic detergent which would not interfere with the charges of either DNA or 
cationic lipid. 
The incubation of plasmid DNA with cationic lipids in presence of a detergent could result in a 
hydrophobic particle which is soluble in organic solvents (Reimer et al., 1995). The authors suggested 
the possibility that such a hydrophobic particle could be surrounded by an outer coating of lipid, which 
would then result in small plasmid containing particles stabilized in an aqueous medium. When the 
cationic lipid was added to plasmid in distilled water, the formation of large (> 1000 nm diameter) 
precipitates was observed. However, the subsequent addition of OGP (200 mM) resulted in 
solubilization of the precipitate, forming an optically clear suspension consistent with entrapment of 
hydrophobic plasmid DNA/cationic lipid particles within detergent micelles. However, when dialysis 
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was attempted to facilitate removal of the detergent, lipid based DNA particles were formed (Reimer 
et al., 1995; Zhang et al., 1997). 
Wheeler et al. (1999) established “stabilized plasmid-lipid particles” (SPLP), produced by 
detergent dialysis employing a POPC/DODAC/PEG-CerC20 lipid mixture. The features of SPLP are 
the extended circulation lifetime of systemically administered gene therapy vectors and their 
accumulation at a distal tumor site. A detailed protocol for producing SPLP is provided in Phillips 
(2002). 
 
1.5. DNA Condensation  
DNA condensation is the collapse of extended DNA chains into compact in presence of multivalent 
cations, orderly particles containing only one or a few molecules of DNA. The decrease in size of the 
DNA domain is striking, as is the characteristic toroidal morphology of the condensed particle, so the 
phenomenon of DNA condensation has drawn considerable attention. 
When a DNA molecule is tightly packed, almost all of the negative charges should be neutralized, 
accompanied by the enhancement of counter-ion condensation release. More precisely, the volume 
part of the compact DNA is fully neutralized whereas negative charge remains on the surface 
(Yamasaki et al., 2001). It is obvious that an abrupt change in the degree of association of counter-ions 
is caused by the discrete transition between the elongated coil and folded compact states. In other 
words, the charge neutralization by cationic species has a significant contribution to the free energy 
change of the folding transition. 
There are essentially two challenges for the dominant attractive force in condensation: hydration 
forces and correlated counter-ion fluctuations (Bloomfield, 1997). Condensing agents generally act 
either by decreasing repulsions between DNA segments e.g. neutralizing of phosphate charge, 
reorienting water dipoles near DNA surfaces, by multivalent cations, or by making DNA-solvent 
interactions less favourable, for example by adding ethanol, which is a poorer solvent than water for 
DNA, or by adding another polymer, such as polyethylene glycol (PEG), which excludes volume to 
the DNA.  
When the alcohol concentration increases, discrete toroids and rods are replaced by more 
extensively aggregated structures. With sufficient alcohol able to reduce the dielectric constant below 
65 as well as in the presence of Co (NH3)63+, DNA collapses into a network of multistranded fibers 
(Arscott et al., 1995). Using circular dichroism spectroscopy, a study indicates that the DNA has 
undergone a B-A transition, although at concentrations at which neither ethanol nor Co (NH3)63+ could 
induce the transition alone. The A-DNA then apparently strongly self-adheres and rapidly aggregates 
into fibrous networks, not allowing more compact and ordered condensates to form. Multivalent 
cations may also cause localized bending or distortion of the DNA, which can also facilitate 
condensation.  
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DNA condensation is a readily reversible process, which depends on the association of sufficient 
condensing compound with the DNA (Bloomfield, 1997). DNA condensation by hexaamine cobalt 
(III) (Widom and Baldwin, 1980; Conwell and Hud, 2004) has been studied using light scattering 
kinetic of in dilute DNA solutions (1–5 µg/ml). These experiments typically show an initial rapid 
increase in scattering intensity over the first few minutes followed by a slower increase to a plateau 
after 30-120 minutes. The increase in intensity is attributed to a collapse of individual or association of 
several DNA molecules resulting in a larger particle structures. Further moderate increase in intensity 
after several hours may be due to secondary aggregation of toroids or rods.  
Much attention has been paid recently to the condensation of DNA with cationic liposomes, since 
the lipoplex can be an efficient agent for transfection of eukaryotic cells. This is presumably because 
the condensed state of the DNA protects it from nucleases (Van der Woude et al., 1995; Xu and 
Szoka, 1996) and allows better binding to the negatively charged cellular membrane and hence lipid 
coating increases the permeability of DNA through cell membranes.  
 
1.6. Morphology of Cationic Lipid/pDNA Assembly 
Addition of DNA to the lipid dispersion leads to a spontaneous formation of discrete complexes. 
The structures formed between cationic vesicles and DNA are called lipoplexes. Such structures have 
attracted large interest due to their potential application in gene therapy (Audouy and Hoekstra, 2001; 
Dass, 2002; Simberg et. al., 2004). DNA condensation and lipid restructuring are known to occur 
during lipoplex formation. Lipid restructuring involves both liposome fusion (Gershon et al., 1993; 
Mok and Cullis, 1997) and release of the vesicles’ aqueous content (Kikuchi and Carmona-Ribeiro, 
2000; Kennedy et al., 2000). 
For characterization of parameters such as the effect of homogeneity in size and morphology, 
microscopic techniques of sufficient resolution were highly useful, because they may provide further 
insight into the mechanism of lipoplex assembly (Simberg et al., 2001). Freeze–fracture electron 
micrographs of DNA mixed with cationic liposomes led to the hypothesis that intact liposomes bind to 
DNA at low concentration and fuse to encapsulate the DNA at higher concentrations (Sternberg et al., 
1994). The authors postulated that during the cationic lipid/DNA assembly at low DNA/lipid ratios 
aggregated globular lipid structures known as “meatballs“ covered by DNA tubules known as 
“spaghetti” like structures were formed, DNA tubules were found to be connected to the liposome 
complexes as well as occurred free in suspension (Fig. 1.4 ). Cyro-TEM studies showed further 
evidence for liposome restructuring like elongated rod-like structures (Gershon et al., 1993) and 
aggregates of globular particles (Sternberg et al., 1994; Mok and Cullis, 1997; Eastman et al., 1997).  
Gershon et al (1993) have proposed another model for cationic lipid/DNA complexation. At low 
ratios of liposomes to DNA, positively charged lipid vesicles are adsorbed to nucleic acids to form 
aggregates that gradually surround larger segments of the DNA. When the amount of liposomes is 
increased, the aggregated liposomes along the DNA reach critical concentrations and charge densities 
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at which membrane fusion and cooperative DNA collapse processes are initiated. After increase of the 
liposome concentration, the collapsed DNA structures are covered completely by the lipid bilayers. 
The size of the final product is dependent on the size of the initial lipid vesicles (Goncxalves et al., 
2004), the positive-to negative charge ratio and the ionic strength of the medium. The proposed 
appearance of the complexes showed clusters of aggregated dense particles.  
Cryoelectron microscopy (Gustafsson et al., 1995; Lasic et al., 1997; Huebner et al., 1999; Schmutz 
et al., 1999) and small angle x-ray scattering studies of such aggregates (Lasic et al., 1997; Rädler et 
al., 1997; Boukhnikachvili et al., 1997) reveal an internal multilamellar structure where lipid bilayers 
alternate with hydrated DNA monolayers. This lamellar structure coexists with an inverted hexagonal 
structure when the cationic liposomes contain dioleoylphosphatidylethanolamine (DOPE) at molar 
ratios greater than 0.41 (Koltover et al., 1998; Lin et al., 2000). 
A similar study was performed by Gustafsson et al (1995) using cryo transmission electron 
microscopy of cationic liposomes composed of DOTAP or dimethyl dioctadecylammonium bromide 
(DDAB) and DOPE mixed with plasmid DNA revealed entrapment of DNA into aggregated 
multilamellar structures at low lipid-DNA ratios. When the amount of DNA was increased, plasmid 
DNA was found to be associated on the surface of the complexes. 
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Figure 1.4: Scheme showing lipoplex assembly as proposed by Sternberg et al., (1994), 
based on freeze-fracture electron micrographs. Negatively charged DNA with the 
cationic DC-cholesterol liposomes formed cationic lipid/DNA aggregates without spaghetti-
like structures “meat ball like aggregates” occurring at short incubation times and low 
DNA/lipid ratios, and spaghetti-like structures, at longer incubation times and higher 
DNA/lipid ratios. 
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   1.7. Gene Delivery Associated Barriers 
The cationic compounds interact spontaneously with the negatively charged DNA. The mechanism 
of non-viral gene transfer is thought to follow an endocytotic process. In order to lead to successfully 
high transgene expression, various biological barriers must be crossed: (i) interaction with the plasma 
membrane and uptake by endosomes, (ii) escape from the endosome into the cytoplasm, (iii) 
trafficking from the cytoplasm into the nucleus and (iv) nucleus entry (Fig. 1.1). 
 
1.7.1. Cellular Uptake and Intracellular Distribution of DNA complexes 
Both, cationic polymers and lipids have shown promise as gene delivery agents since their 
polycationic nature produces particles that pass one or more of these barriers. For example, by 
collapsing DNA into particles of reduced negative or increased positive charge binding to the cell 
surface by electrostatic interaction and enhanced endocytosis may be promoted (Boussif et al., 1995; 
Haensler and Szoka, 1993). In many cases, cationic polymers seem to produce more stable complexes, 
thus offering more protection during cellular trafficking than cationic lipids (Zabner et al., 1995; 
Pollard et al., 1998; Hwang and Davis, 2001). 
DNA by itself associates very poorly with the negatively charged cell membrane because of charge 
repulsion. Positively charged complexes interact by electrostatic interaction with negatively charged 
cell surface domains. Therefore, a high positive zeta potential of transfection complexes is an 
important step to accomplish cellular interaction and uptake. Complexes composed of polycations 
with molecular weights of several thousands exhibit comparably higher zeta potentials (Ruponen et 
al., 1999; Jeong et al., 2001; Ahn et al., 2002) irrespective of the polycations used. 
Internalization events seem to be affected not only by charge, but also by the size of complexes 
used for transfection. Given the heterogeneity of cationic compound/DNA complexes, it has been 
difficult to define precisely the effect of complex size on transfection and at what levels in the overall 
transfection process size might be relevant. In recent study, Rejman et al (2004) have shown that 
particle size as such can strongly affect the efficiency of cellular uptake, the mode of endocytosis and 
the subsequent efficiency of particle processing along the endocytic pathway. They demonstrated that 
particles of about 500 nm could be internalized by non-phagocytic cells by a clathrin-independent 
pathway. Particles with diameters less than 200 nm, and approx. 80 % of the 200 nm particles as such, 
are internalized via clathrin-coated pits. The upper limit is about 1 µm since these particles were not 
internalized by the non-phagocytic B16 cells investigated in this study. 
A previous study showed that complex properties of linear poly-L-lysine, intact polyamidoamine 
(PAMAM) dendrimers, fractured dendrimers, and branched PEI with DNA were similar in terms of 
size and zeta potential. Nevertheless, high levels of gene expression could only be achieved by 
fractured dendrimers and branched PEI presumably due to the stability of the complexes and absence 
of aggregation (Tang and Szoka, 1997).   
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 1.7.2. Endosomal Escape  
During the cellular process of endocytosis, early endosomal vesicles become acidified by the 
vacuolar-ATPase proton pump (Figure 1.3), producing a large vesicular proton gradient versus 
cytosolic pH (Tycko and Maxfield, 1982). The pH inside endosomal compartments could become as 
low as pH 5.5-4.5. It has been demonstrated that escape of DNA from the endocytic compartments is 
one of the major barriers to efficient gene delivery (Amiji, 2005).  
A key question in terms of the trafficking of complex along the endocytic pathway is the 
mechanism by which material moves through the endosomal compartments. Regarding this issue two 
different hypothesis were proposed (Helenius et al., 1983; van Deurs et al., 1989); i) the vesicle shuttle 
model and ii) The maturation model. 
The vesicle shuttle model proposed that early endosomes represent stable, long-lived organelles, 
and complex destined for the lysosomes would be packed into vesicles that bud from one endosomal 
membrane compartment and fuse with the next. 
The maturation model predicts that the complex taken up by endocytosis is contained within an 
organelle composed initially of internalized plasma membrane and that with time this organelle 
develops into a secondary endosome and then a late endosome (Lloyd and Mason, 1996). It is 
generally believed that failure of DNA to escape to a significant extent from the endosomal 
compartment constitutes a major barrier to efficient DNA complex mediated transfection. If a non 
viral vector has the ability to disrupt or fuse with the endosomal membranes, the released gene can 
escape from the endosome into the cytosol, and effective transgene expression should occur.  
Endolysosomal escape may also be exemplified by endosomolytic polycationic polymers such as 
PEI. Behr (1997) postultated the so-called ‘proton sponge hypothesis’, which relates the intrinsic 
endosomolytic activity of PEI to its capacity to buffer the endosomal environment, prompting the 
osmotic swelling of the vesicle and finally its rupture, which leads to the liberation of the DNA/PEI 
complexes (polyplexes) into the cytoplasm (for details see section 1.3). Another mechanism for 
endolysosomal escape of polyplexes was suggested by Bieber et al. (2002). Using  electron 
microscopy , endosomal membrane holes have been observed and were related to the direct interaction 
of high molecular weight (MW) branched PEI (BPEI) (800 kDa) with the endosomal membrane in a 
non-acidic environment. The authors suggested that low molecular weight (MW) PEIs (25 kDa) also 
induce minor membrane damages, but that those holes may be quickly resealed. In addition to direct 
membrane interaction, the release of polyplexes may also be attributed to the extension of the polymer 
network as a result of the increasing electrostatic repulsion of charged groups during acidification 
(Merdan et al., 2002). 
An alternative pathway for endosomal escape is considered to be fusion of the cationic lipid/pDNA 
complex with endosomal membranes (or membrane destabilization). This appears to be necessary for 
the effective delivery of the nucleic acids from the lipoplex to the cell (Düzgüneş, 2004). Different 
mechanisms have been proposed for DNA release from lipoplexes. For lipoplexes, endosomal 
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membrane destabilization is thought to result from the intermingling of lamellar phase perturbing 
lipids, including inverted hexagonal phase HII preferring cationic lipids, with the endosomal 
membrane. Zelphati and Szoka (1996) have proposed a model that describes nucleic acids release from 
the endosome. After internalization of the DNA complexes by endocytosis, the endosomal membrane 
is destabilized, which causes a flip-flop of anionic lipids from the cytoplasmic face of the endosome 
into the internal face. The anionic lipids interact with the cationic lipids, displacing the nucleic acid 
from the cationic lipid and allowing the release of the anionic nucleic acid from the lipoplex into the 
cytoplasm of the cell. The presence of negatively charged lipids DOPS may amplify this destabilizing 
non-bilayer membrane organization upon its interaction with the cationic lipid and simultaneously 
cause the competitive dissociation of the DNA from the lipoplex. 
Another strategy to avoid the endolysosomal pathway is the extra-cellular release and subsequent 
diffusion of the transfection complex over the plasma membrane. This may provide an effective way 
to achieve cytosolic delivery. The so-called cell-penetrating peptides (CPP) have been reported to 
accomplish direct cytosolic delivery when attached to various carriers including liposomes (Torchilin 
et al., 2001; Tseng et al., 2002). This could be achieved by co-encapsulation of fusogenic peptide, 
surface coupling of CPP to liposomes surface and photochemical internalization.  
Co-encapsulation of fusogenic peptides such as N-terminal domain of viral protein hemagglutinin 
subunit HA2 induces membrane destabilization in the lysosomes. Upon acidification, this peptide 
domain becomes protonated, causing a conformational change from random coil to alpha helix (Skehel 
et al., 1982; Doms et al., 1985). Due to this conformational change, the fusion peptide is inserted into 
the endosomal membrane and destabilizes it (Harter et al., 1989; Stegmann et al., 1991). 
Mastrobattista et al. (2002) studied the co-encapsulation of the influenza virus-derived synthetic 
diINF-7 whether it could enhance the cytosolic delivery of liposome entrapped proteins. They showed 
that the alpha helical content increased from 15% to 31% when the pH was lowered from 7.4 to 5.2. 
The coupling of TAT-peptide to liposomes surface also greatly enhanced the cellular binding and 
subsequent uptake of the liposomes (Fretz et al., 2004).   
A novel photochemical technique, named photochemical internalization (PCI), was developed for 
inducing release of molecules from endocytic vesicles (Hogset et al., 2004). The photosensitizer can 
preferentially localize in endosomal membranes. Upon illumination of the photosensitizers, highly 
reactive oxygen species are formed and the endosomal membrane is damaged and the carriers will be 
released into the cytosol. 
 
    1.7. 3. Entry of DNA into the Nucleus  
Entry of DNA into the nucleus after its release into the cytosol is necessary for gene expression 
(Chesnoy and Huang, 2000). The mechanism of the nuclear delivery of the lipid-DNA complex is 
believed to be an inefficient process (Fig. 1.1). The aqueous channels of the nuclear pore complex 
allow the free diffusion of small macromolecules (<70 kDa), but the transport of larger 
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macromolecules requires an active process (Dowty et al., 1995). Remy et al. (1995) formulated a 
virus-like particle containing lipospermine as cationic lipid and a lipid bearing a head group of a 
nuclear localizing signal peptide (NLS). They did not notice any improvement in transfection. Zabner 
et al. (1995) showed that intact lipid-DNA complexes microinjected into the cytoplasm of Xenopus 
oocytes had only low transfection activity. Thus it can be concluded that DNA has to be released from 
lipids to enter the nucleus. The efficiency of entry of lipoplexes into the nucleus is very low. This was 
observed in the case of lipoplexes, where fluorescent labelled DNA and lipids were used. Labelled 
DNA appeared in the nucleus whereas the cationic lipids did not. This suggests that lipoplex 
disassembly takes place before the DNA reaches the nucleus (Marcusson et al, 1998). However, in the 
case of polyplexes composed from PEI and pDNA, PEI not only accompanied the nucleic acid to the 
nucleus but moreover targeted into the nucleus (Boussif et al, 1995; Pollard et al, 1998; Godbey et al, 
1999a; Wightman et al, 2001). 
Another drawback of the nuclear transport of DNA is its instability in the cytoplasm. However, 
Zanta et al (1999) reported that a single nuclear-localization signal peptide linked to one end of a gene 
is sufficient to promote up to 1000-fold higher transfection levels compared with naked plasmid DNA 
lacking the single nuclear localization signal peptide. 
 
1.8. Conclusive Remarks 
Significant effort in research has been dedicated to the development of lipidic and/or polymeric 
nanoparticular nonviral gene carriers in the past 10 years, but there are still obstacles that have to be 
overcome. Likewise, since the uptake of non-viral carries occurs mainly via endocytosis, in order to 
exert its activity, the pDNA must be released from the endo- and lysosomes. Additionally, it must be 
transported to the assigned organelle. It is important to note that strong binding and efficient DNA 
condensation do not correlate directly with gene delivery efficiency, probably because tight binding 
prevents transcription. One important step involved in the process leading to transfection is the release 
of the DNA from the complex. Only free DNA would be able to interact with target structures in the 
cells and can be transcribed and translated into the protein structures.  
Therefore, disassembly of the complexes must occur before mRNA transcription can proceed. Both 
the stability of complexation and the rate of dissociation influence transfection efficiency. In other 
words, the disassembly of DNA complexes diametrically opposes the previous stages of gene delivery; 
premature dissociation could lead to DNA degradation and low efficacy of gene delivery, while 
delayed or incomplete dissociation would interfere with efficient gene expression (Schaffer et al., 
2000). 
A transfection compound must therefore balance sufficient binding strength to initially protect the 
plasmid with the ability to release the plasmid, perhaps by competitive binding of genomic DNA, 
cytosolic proteins or anionic membrane lipids (Zelphati and Szoka; 1996; Schaffer et al., 2000).
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2.1. Materials 
PicoGreen® was obtained from Molecular Probes (Invitrogen, Eugene, OR, USA) and N-octyl β-
D-glucopyranoside (OGP) was purchased from Carl-Roth GmbH, Karlsruhe, Germany. Trizma® pre-
set crystals pH 7.4 (Sigma, St. Louis, MO, USA), HEPES, 4-(2-hydroxyethyl)-1-
piperazinethanesulfonic acid (Carl-Roth GmbH, Karlsruhe, Germany) and sodium chloride (NaCl) 
(Fluka, Deisenhofen, Germany) were used for buffer solutions. 
 
2.1.1 Lipids 
The phospholipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1,2 dioleoyl-sn-glycero-3-phospho-l-serine (DOPS), the cationic 
lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine, 1,2-dioleoyl-3-trimethylammonium-propane 
(DOTAP), 3β-N-(dimethylaminoethane) carbamoyl cholesterol, oleic acid and the fluorescent lipids 
1,2-dioleoyl-sn-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)-ammonium salt (NBD-
PE), N-1,2-dioleoyl-sn-Glycero-3 Phosphoethanolamine-N- (lissamine Rhodamine B sulfonyl) 
(Rhodamine DOPE) and octadecyl rhodamine B chloride (R18) were purchased from Avanti Polar 
Lipids Inc., Alabaster, USA. All lipids were used without further purification as stock solutions in 
chloroform and were stored at –20 °C.  
 
 2.1.2. Polymers 
The polyethylenimine (PEI) used in this work was Lupasol® WF (BASF, Ludwigshafen, 
Germany). It is a technical grade 25 kDa, branched polyethylenimine in a 50 % watery solution and 
was a kind gift from BASF. Before being used for complexation experiments, PEI was diluted to 0.9 
mg/ml in 10 mM TRIS buffer, and pH was adjusted to 7.4. The solution was sterile filtered using 
Sterifix 0.2 µm filter (Braun Melsungen AG, Melsungen, Germany), aliquoted and stored at 8 ºC.  
 
2.2. Methods 
2.2.1. pDNA 
The plasmid deoxyribonucleic acid (pDNA) used in this study was the plasmid EGFP-C3 
(Clontech Laboratories, Mountain View, CA, USA) coding for enhanced green fluorescence protein. 
The plasmid was amplified in the Escherichia coli strain (E. coli) XL-Blue MRF supercompetent cells 
(Stratagene, La Jolla, CA, USA). This seed was used to inoculate 150 ml Luria Bertani medium (Carl-
Roth GmbH, Karlsruhe, Germany) containing 30 µg of the selective aminoglycoside antibiotic 
kanamycin (Carl-Roth GmbH, Karlsruhe, Germany). Plasmid was extracted from E. coli cells using 
the GenElute Endotoxin-free Plasmid Maxiprep Kit (Sigma, Deisenhofen, Germany) following 
manufacturer’s instruction. UV-spectroscopy showed no presence of protein contamination in all 
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pDNA batches: the ratio of absorbance of 260 nm and 280 nm was about 1.8–1.9. Calf thymus DNA 
(Fluka, Deisenhofen, Germany) was used for pDNA condensation assays.  
 
2.2.2. Lipoplex Preparation 
 
2.2.2.1. Mixed Lipoplexes 
Lipoplexes were prepared by two strategies. In strategy I, lipoplexes were formed by conventional 
mixing of cationic lipid and pDNA.  
The thin-film hydration method was used to prepare the cationic lipid films as described before 
(Wang et al., 2006). The cationic liposomes were prepared by mixing chloroform or chloroform 
methanol (3:1, v/v) solutions of the lipids in round bottom glasses followed by removal of the 
chloroform by a stream of nitrogen gas to produce dried lipid films. Residual solvent was removed by 
exposing the dry film to high vacuum for at least 2 h. The lipid film was re-suspended in 20 mM 
HEPES containing 145 mM NaCl (pH 7.4). Cationic lipoplex compositions included DOTAP and DC-
cholesterol. The cationic lipid/pDNA complexes in most of the experiments were prepared by mixing 
equal volumes of liposomes and 0.1mg /ml pDNA at N/P ratios 4 and 5. Afterwards lipoplexes were 
ultra-sonicated in an ultrasonic bath (Bender Hobein, Zürich, Switzerland) for a few seconds and 
allowed to incubate for 30 min at room temperature before use. 
 
2.2.2.2. Dialysed Lipoplexes 
Alternatively in strategy II, lipoplexes were prepared by detergent dialysis as described previously 
(Wheeler et al., 1999; Hafez et al., 2000). Lipoplexes were prepared in the presence of the non-ionic 
detergent OGP followed by detergent dialysis. Plasmid DNA was diluted to 0.1 mg/ml pDNA in 20 
mM HEPES, 145 mM NaCl buffer containing 200 mM detergent OGP at pH 7.4. This solution was 
used to reconstitute the cationic lipid films prepared as described in section 2.2.2.1. After 20 min 
incubation at room temperature, the mixture was subjected to dialysis against 2 L of the same buffer 
for 48 h at room temperature with changing the buffer twice. Under the chosen conditions pDNA and 
cationic lipids were prepared with the following cationic lipid/pDNA molar ratio, (ρ) = LC/D = (moles 
of cationic lipid)/ (moles of pDNA bases) of 4 and 5. According to previous studies (Gershon et al., 
1993) this would be a condition in which the majority of pDNA molecules should be complexed. 
 
2.2.3. Polyplex Preparation 
Polyplexes composed of polyethylenimine and the plasmid EGFP-C3 were prepared by diluting 
plasmid and the appropriate amount of polymer separately with 10 mM Tris buffer, pH 7.4, to equal 
volumes according to the protocol of Boussif et al., (1995).  
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Calculation of Nitrogen to Phosphate (N/P) Ratio  
The required amounts of polymer and plasmid were calculated according to the desired N/P ratio 
based on previous results (Fischer et al., 1999). The N/P ratio is the ionic balance of the PEI/pDNA 
polyplexes. The positive charge of PEI is originated from the nitrogen (N) of the repeat unit of PEI, 
NHCH2CH2, which has a molecular weight of 43 g/mol. The negative charge in the plasmid DNA 
backbone arises from the phosphate group (P) of the deoxyribonucleotides. The average molecular 
weight of a nucleotide is assumed to be 330 g/mol.  
 
Two strategies were used for preparation of the polyplexes. Mixed polyplexes of plasmid DNA and 
PEI were prepared by mixing of both components leading to complex formation based on electrostatic 
interactions. Additionally, dialysed polyplexes were performed by an alternative technique 
complexing pDNA and PEI in the presence of the nonionic detergent OGP followed by dialysis. 
Plasmid DNA was complexed with polyethylenimine at different nitrogen/phosphate (N/P) ratios. 
 
2.2.3.1. Mixed Polyplexes 
Mixed polyplexes at nitrogen/phosphate ratios 5 and 10 were formed as follows: The polymer 
solution was added to pDNA in 10 mM Tris buffer at pH 7.4. The mixture was sonicated in an 
ultrasonic bath (Bender Hobein, Zürich, Switzerland) for few seconds and allowed to incubate at room 
temperature for 30 min before use. All samples were prepared in triplicates.  
 
2.2.3.2. Dialysed Polyplex 
For dialysed polyplex formation, polyplexes were formed by mixing plasmid DNA and PEI in the 
presence of the non-ionic detergent OGP as described previously (Wheeler et al., 1999; Hafez et al., 
2000). The required amount of plasmid DNA was diluted in 10 mM Tris, pH 7.4 containing 50, 100 or 
200 mM nonionic detergent OGP. The solutions containing pDNA and OGP were allowed to stand at 
room temperature for 30 min before addition of PEI solution. After PEI addition, incubation in 10 mM 
Tris buffer at pH 7.4 for 30 min was completed before the plasmid DNA/PEI mixture was dialysed 
against 2 L 10 mM Tris, pH 7.4 for 48 h with 2 buffer changes.  
 
2.2.4. Photon Correlation Spectroscopy 
The hydrodynamic diameter of complexes was determined by photon correlation spectroscopy. 
Measurements were performed using a Zetasizer Nano ZS (Malvern Instruments, Herrenberg, 
Germany) with laser beam of 633 nm. The scattered light was detected at 173° angle. The viscosity 
(0.88 mP) and the refractive index (1.33) of distilled water were used for data analysis. Thirty minutes 
before measurement, the pDNA complexes were diluted 1:50 in 10 mM Tris buffer, pH 7.4. Sampling 
time was set to 5 min, and three measurements with 4 sub-runs were performed for each sample. The 
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samples were thermostated to 25 °C. Data were evaluated with the Dispersion Technology Software 
version 5.10 (Malvern Instruments). 
 
2.2.5. Zeta Potential Measurement 
pEGFP-control plasmid was complexed by simple mixing or dialysis techniques with the 
appropriate amount of polymer or lipid in 1 ml water as described above. Zeta potential measurements 
were carried out in the standard capillary electrophoresis cell in position 2 mm using a Zetasizer Nano 
ZS (Malvern Instruments, Herrenberg, Germany) at 25 °C. The measurements were performed in 
filtered (0.2 µm) de-ionized water. The sampling time was set to automatic. Average values were 
calculated with the data from 20 runs. Zeta potential was calculated according to the Smoluchowski 
model equation using the Dispersion Technology Software version 5.10 (Malvern Instruments). 
 
2.2.6. pDNA Condensation of Polyplexes 
pDNA condensation was examined by determining pDNA accessibility to the nucleic acid 
intercalating dye PicoGreen®. pDNA unpacking was measured by dequenching of PicoGreen® 
fluorescence at different pHs as described previously (Moret et al., 2001). Briefly, triplicates of 100 µg 
calf thymus DNA were complexed with polymer at nitrogen/phosphate ratios of 5 and 10 in 10 mM 
Tris buffer, pH 7.4. The pH was adjusted to 7.3, 8 and 11.6. Plasmid DNA was used in a concentration 
of 2 µg/ml for each polyplex. Fifty microlitres polyplex solution were added to each well of a 96-well 
plate. 50 µl PicoGreen® (1:200) were added per well. The plate was gently shaken on a plate shaker 
(Titramax 100, Heidolph Instruments GmbH & Co. KG, Schwabach, Germany) at 125 rpm. 
Fluorescence was subsequently recorded at excitation wavelength λex 485 nm and emission 
wavelength λem 520 nm (Jeffs et al., 2005) using a plate reader (Fluostar optima, BMG 
Labtechnologies, Offenburg, Germany).  
Plasmid concentration in polyplexes was determined by measuring fluorescence upon addition of 
PicoGreen® dsDNA Quantitation probe (Molecular probe) to the polyplexes (Fi) and comparing this 
value to that obtained upon increasing pH to 8 or 11.6 (FpH). Each well was measured three times with 
an average of 9 samples, and the mean was calculated. Naked pDNA as control was also processed at 
different pHs in the same way as indicated for the polyplexes. Results were transformed into relative 
fluorescence values as described in the literature (Moret et al., 2001). A value of 1 is attributed to the 
fluorescence of PicoGreen® with naked pDNA. A value of 0 is assigned to the residual fluorescence of 
PicoGreen® without pDNA. 
 
2.2.7. Cell Culture 
The transfection efficiency of pDNA delivered by PEI was examined by green fluorescence protein 
(GFP) expression as a gene reporter using Fluorescence Activated Cell Sorting Technique (FACS). 
HEK 293 (human embryonic kidney) cell line was obtained from the Institute of Cell Biology and 
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Immunology, University of Stuttgart as a gift. Cells were cultured in Earle’s minimal essential 
medium (MEM) supplemented with 10% fetal calf serum (FCS) and 2 mM L-glutamine (PAA 
Laboratories, Linz, Austria) at 37 ºC, 5 % CO2 and 95 % relative humidity.  
 
2.2.8. Transfection Experiment 
Transfection experiments were performed in quadruplicate. Briefly, HEK 293 cells were seeded in 
12 well-plates at a density of 50,000 cells/well 24 h before transfection. Afterwards, medium was 
replaced by fresh MEM (400 µl) without FCS containing polyplexes of pEGFP and 25 kDa PEI (N/P 
5, 10, 15 and 20) at final concentrations of 2 and 3 µg pDNA per well. After the volume was 
completed to 1 ml medium without FCS in each well, cells were incubated for transfection. Five hours 
later, the medium was discarded and replaced by the full growth medium at 37 °C in 5 % CO2. Cells 
were harvested after 24 and 48 h. Cells were washed twice with Phosphate Buffered Saline (PBS), 
detached by gentle pipetting and checked by microscopy to ensure at least 85 % of the cells were 
detached. The cell suspension was then transferred to FACS polystyrene test tubes (12×75 mm, 
Falcon). Cell sample treated with free pDNA were used as control. 
For assessment of gene expression, flow cytometric analysis was carried out by using a flow 
cytometer (Epics XL MCL, Beckman Coulter GmbH, D-Krefeld, Germany) equipped with an air-
cooled argon laser (wavelength: 488 nm). The emitted fluorescence of green fluorescence protein was 
detected at the corresponding photomultiplier tube (PMT) at the FL1 channel (515–545 nm). Forward 
laser light scattering (FSC) is useful in estimating the size and shape of cells, while side scattering 
(SSC) at 90° to the laser beam indicates cell granularity or internal complexity of various cell 
populations. The corresponding discrimination window (gate) is set in the cytogram in which the main 
cell pool is selected to avoid small (debris) and big (aggregates) particles, based on the forward and 
side scattering data.  
The fluorescence intensity is given by the X-axis of the histogram, while the number of events 
(number of cells) is given by the Y-axis. Ten thousand events were accumulated for every sample, and 
the fluorescence intensity range (M1) was set as a threshold throughout the experiments. For EGFP 
detection, the percentage of fluorescent cell sorting events in the established threshold (M1) was 
reported with correction for the background fluorescence of the control sample with λex 495 nm and 
λem 518 nm. Measurements were carried out with a flow speed counting until 250 events per second. 
The percentage of transfected cells was counted based on the two peaks in the FL1 channel, which 
reflects: (1) the presence of transfected cells in the population that have synthesized green fluorescent 
protein (GFP) and (2) non-transfected cells with autofluorescence only. 
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2.2.9. Preparation of Anionic Liposomes (AL) 
Liposomes containing anionic lipids were prepared as described previously (Tarahovsky et al., 
2004). Lipid films were prepared from chloroform solutions containing appropriate amounts of lipids, 
as shown in Table 2.1. The solvent was evaporated under a stream of nitrogen to obtain a thin lipid 
film which was hydrated in 20 mM HEPES buffer containing 145 mM NaCl at pH 7.4 to form 
multilamellar vesicles (MLVs) at 10 mM lipid concentration. Unilamellar vesicles with a size of about 
100 nm were then prepared by extrusion through polycarbonate membranes with different pore sizes 
(400 nm, 200 nm, 100 nm, 50 nm, Armatis, Mannheim, Germany) with the help of a Liposofast-
Miniextruder (Avestin, Ottawa, Canada, MacDonald et al., 1991). The lipid mixture was subjected to 
extrusion decreasing pore sizes from 400 to 50 nm 21 times for each membrane at room temperature. 
Liposomes were evaluated by photon correlation spectroscopy. 
 
 
 Table 2.1:  Composition of Negatively Charged Liposomes  
 
2.2.10. pDNA Release  
Lipoplexes were prepared at (ρ) of 4 and 5 according to the approaches described (Tarahovsky et 
al., 2004; Wang et al., 2006; Koynova and MacDonald, 2007) Lipoplexes were then diluted to an 
amount of 2 µg pDNA/ml followed by addition of PicoGreen® solution 1:200 dilution (Molecular 
Probe). Anionic liposomes (AL)/lipoplex mixed dispersions were prepared by mixing solutions of AL 
and preformed lipoplexes at different charge ratios R=A/Lc (moles of anionic lipid/moles of cationic 
lipid). Volumes containing 4 fold more negative charges than positive charges were added to 
accomplish pDNA release. Fifty microlitres of each solution were added to each well of a 96-well 
plate. The change of fluorescence was subsequently monitored using three different kinetic windows 
as shown in Table 2.2, at excitation wavelength λex 485 nm and emission wavelength λem 520 nm using 
a plate reader (Fluostar optima, BMG Labtechnologies, Offenburg, Germany). Data of release were 
calculated from the fluorescence level obtained at certain time points, corrected for the background 
value obtained prior to addition of anionic vesicles, relative to the fluorescence obtained upon total 
Anionic liposomes  Composition Molar ratio 
I DOPS/DOPE/DOPC 2.5:2.5:5 
II OA/DOPE/DOPC 2.5:2.5:5 
III DOPS:DOPC 3 :7 
IV OA: DOPC 3 :7 
V OA/DOPE 3 :7 
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release. Measurement start time was chosen at 0 s and the number of flashes were 10 flashes per well 
and cycle. 
 
 
 
 
 
 
 
Table 2.2: Kinetic window protocol for pDNA release experiments 
 
 2.2.11. Vesicle-Vesicle Interaction: Membrane Lipid Mixing Assays 
 
2.2.11.1. Octadecyl Rhodamine B (R18) Dequenching 
To investigate the fusion between the intact anionic liposomes used previously to trigger pDNA 
release from lipoplexes, a method has been developed based on the relief of fluorescence self 
quenching. In this assay, a fluorescent lipid like probe octadecyl rhodamine B chloride (R18), is 
inserted into the lipoplexes. The fluorescently labelled lipoplexes were prepared by conventional 
mixing or detergent dialysis techniques by addition of (OD R18) ethanolic solution of to the cationic 
lipid organic solution. At a sufficiently high concentration of 5 mol% with respect to the total lipid 
content, an efficient self-quenching of the fluorescence occurs. Fusion of labelled lipoplexes with 
anionic liposomes membranes will result in dilution of the probe and concomitant relief of the self-
quenching. The increase in the fluorescence observed is taken as a measure of fusion. Once inserted in 
the lipidic membrane, the probe does not dissociate from the membranes by either spontaneous 
transfer of the free monomer through the aqueous phase or by collional transfer.  
Lipoplexes were prepared with 1.5 µmole of cationic lipid DOTAP or Dc-cholesterol, mixed with 
100 µg plasmid DNA at (ρ) of 5 and diluted in 20 mM HEPES, 145 mM NaCl buffer at pH 7.4. 
Labelled cationic lipoplexes were pipetted into a 96 well plate, and treated with unlabeled negatively 
charged lipids at 2 and 4 fold molar excess of negative charges at 25 °C. Fluorescence increase 
occurred upon relief of self-quenching, was monitored for approx. 7000 s using a microplate reader 
(Fluostar optima, BMG Labtechnologies, D-Offenburg, Germany). Fluorescence intensity was 
monitored as a function of time with an excitation wavelength λex 544 nm and an emission wavelength 
λem 590 nm at 25 °C. Measurements were taken according to kinetic window as stated in Table 2.2, 
yielding fluorescence values at the onset (F0) and during the reaction (Ft). Parallel measurements of 
samples containing 200 mM OGP were averaged and used as a value for the fluorescence after infinite 
dilution (FOGP). The relative total fluorescence change was calculated using the following equation 
(Jun and Wickner, 2007): 
Kinetic window 1 2 3 
Number of cycles 3 3 5 
Cycle time (s) 120 600 1200 
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∆Ft /FOGP = (Ft- F0)/FOGP 
Where Ft is the fluorescence intensity at a certain time point, F0 the residual fluorescence before 
addition of anionic liposomes, and FOGP the maximum fluorescence obtained after complete lipid 
mixing.  
Fusion dependent change of fluorescence was calculated by subtracting fusion independent 
fluorescence change values represented by a sample containing only labelled donor lipoplexes from 
total fluorescence change values. 
 
2.2.11.2. Fluorescence Resonance Energy Transfer (FRET) 
FRET was used to assess lipid mixing after the addition of anionic liposomes to lipoplexes 
according to a well established fluorescence resonance energy transfer assay (Struck et al., 1981) using 
the probe dilution method. Briefly, cationic lipoplexes were prepared by mixing and detergent dialysis 
methods. They were labelled with 0.5% NBD-PE and 0.5% rhodamine-PE (Rh-PE). Negatively 
charged liposomes were prepared at 10 mM lipid concentration without fluorescent probes. Labelled 
cationic lipoplexes were placed in a 96 well plate, and were treated with unlabeled negatively charged 
lipids at 25 °C at a 2 fold excess of negative charges. Fluorescence intensity was monitored as a 
function of time with λex 460 nm, λem 530 nm at 25 °C. Fluorescence was also measured for samples 
with negatively charged liposomes which were mixed the presence of 200 mM OGP. This intensity 
was then used for normalization of measurements. In the probe dilution method, the residual 
fluorescence of the labelled vesicles containing 0.5 mol % each of NBD-PE and Rh-PE was taken as 
0% of maximum fluorescence. Samples used for the calibration of the fluorescence to 100% maximum 
fluorescence (Fmax) were taken for those treated with 200 mM OGP. Complete intermixing of all 
bilayers upon fusion would be expected to result in a membrane containing 0.3 mol% each of the two 
fluorescent phospholipids, which was taken as the theoretical maximum fluorescence. NBD 
fluorescence measurements were continuously monitored, using an excitation wavelength of λex 460 
nm and an emission wavelength λem 530 nm.  
The transfer efficiency (E) can be determined by steady state measurements of the extent of donor 
(D) NBD fluorescence de-quenching due to the acceptor (Struck et al., 1981).  
 
E =1- [FDA / FD ] 
 
Where, F is the fluorescence intensity in the absence (FD) and presence (FDA) of the acceptor. 
 
2.2.12. Cryo-Transmission Electron Microscopy (Cryo-TEM) 
The morphology of lipoplexes as well as the structures during pDNA release was determined by 
transmission cryo-TEM. For cyro-TEM experiments, DOTAP lipoplexes were mixed with different 
anionic liposomes at 4 fold molar excess of negatively charged lipids. One minute and 1 h after 
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mixing, samples were prepared for visualization as previously adapted (Bunjes et al., 2007): A 3 µl 
droplet of the lipoplex/anionic liposome suspension is deposited on an electron microscopy copper 
grid with perforated carbon film (Quantifoil R 1.2/1.3) (Quantifoil micro tools, Jena, Germany). After 
removing the excess solution with a filter paper, the thin layer of water is plunged rapidly into liquid 
ethane at -178 °C in a cryobox (Zeiss, Oberkochen). Excess ethane was removed with a piece of filter 
paper. The grid, kept under liquid nitrogen, is then transferred into a cryo-holder (Gatan 626, 
Pleasanton, CA and München, Germany) maintained at -170 °C, which, in turn, is introduced into the 
TEM for observation at -170 °C. To limit beam damage, the specimens are observed with a limited 
amount of electrons using the low-dose technique. Images were obtained under cryogenic conditions 
and investigated at 120 kV in a Philips CM 120 electron microscope. The micrographs were generated 
by a Tietz-Fast Scan CCD camera. 
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    Abstract 
The preparation of lipoplexes consisting of cationic lipid/plasmid DNA (pDNA) which form as a 
result of a self assembly process in the presence of the non-ionic detergent N-octyl-beta-D-
glucopyranosid (OGP) has been investigated (Reimer et al., 1995; Bally et al., 1997; Zhang et al., 
1997). This assembly is dependent on the formation of a hydrophobic cationic lipid/pDNA complex 
intermediate. It was assumed that the interaction between cationic lipid/pDNA assemblies is mediated 
by hydrophobic interactions rather than charge-charge interactions (Zhang et al., 1997). 
The detergent dialysis technique used in the present work is based on the preparation of mixed 
micelles containing the non-ionic detergent N-octyl-beta-D-glucopyranosid OGP and cationic lipids. 
When these micelles were mixed with plasmid, defined particles formed spontaneously. Consecutive 
detergent removal leads to the formation of lipid/plasmid DNA lipoplexes. This technique was shown 
to produce highly stable lipoplexes against nucleases compared to those produced by mixing technique 
(Guo et al., 2000; Xu et al., 2001). 
In this chapter, lipoplexes were prepared using DOTAP and DC-cholesterol cationic lipids at N/P 
ratios 4 and 5 in the presence of 200 mM OGP based on earlier investigations.  
The physicochemical properties of the dialysed lipoplexes were investigated and correlated to that 
of mixed lipoplexes. The mixed and dialysed lipoplexes were characterized by laser light scattering to 
determine the influence of OGP on the hydrodynamic diameter and the surface charge of the 
lipoplexes. Additionally, to characterize these lipid/based pDNA formulations, we have used an 
approach similar to that described by Xu and Szoka (1996), in which anionic liposomes containing 
composition that mimic the cytoplasmic facing monolayer of the plasma membrane (e.g. 
phosphatidylserine) rapidly release pDNA from the complex. The lipoplexes destabilize by a flip flop 
process of the anionic lipids from the cytoplasmic facing monolayer of the endosomal membrane into 
the inner monolayer, which laterally diffuse into the complex and form a charge neutral ion-pair with 
the cationic lipids. In other report, minor cellular lipids like oleic acid (OA) possessed strong pDNA 
releasing activity (Tarahovsky et al., 2004). In this study, the PicoGreen® assay, as pDNA marker, was 
used to assess pDNA condensation state.  
Lipoplexes prepared by detergent dialysis technique showed a pronounced increase in 
hydrodynamic diameters compared to mixed lipoplexes. The increase in particle size was better 
observable in DOTAP/pDNA than DC-cholesterol/pDNA lipoplexes. The increase in hydrodynamic 
diameter was accompanied by remarkable decrease in the zeta potentials. This was obvious in both 
lipoplexes at N/P ratios examined.  
Corresponding to the physicochemical characteristics, this was supplemented by pDNA 
condensation as measured using PicoGreen® assay. The strong pDNA compaction of dialysed 
lipoplexes showed lower pDNA de-condensation capability compared to the mixed lipoplexes when 
anionic lipids were applied.  
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In conclusion, the preparation technique influenced the physicochemical characteristics of 
produced lipoplexes in terms of hydrodynamic diameter, zeta potential as well as pDNA compaction. 
The effect of OGP on pDNA compaction was well characterized by a significantly lower pDNA 
release from dialysed lipoplexes compared to mixed lipoplexes regardless to the cationic lipid used to 
condense pDNA and the N/P ratios used.  
 
3.1. Size of Lipoplexes  
The hydrodynamic diameters of mixed and dialysed lipoplexes of DOTAP and DC-cholesterol 
were measured in order to compare the effect of OGP on various mixing ratios between pDNA and 
cationic lipids. 
The hydrodynamic diameter of the lipoplexes was determined by photon correlation spectroscopy. 
For these measurements, mixed DOTAP/pDNA and DC-cholesterol/pDNA lipoplexes were prepared 
with plasmid DNA at different N/P ratios at 4 and 5 in 20 mM HEPES/145 mM NaCl buffer solution 
at pH 7.4. Mixing of pDNA and cationic lipids leads to complex formation based on electrostatic 
interactions. Dialyzed lipoplexes were formed by an alternative technique complexing pDNA and 
cationic lipids in the presence of 200 mM non-ionic detergent OGP followed by dialysis. For details of 
preparation see chapter 2 Materials and Methods section 2.2.2.  
The optimal ratio found for in-vitro transfection is in the range of 3.6 to 9 (cationic lipid: pDNA, 
nmol: µg) depending on the types of cationic liposomes, and cell types used (Liu and Song, 1998). 
Under the chosen conditions pDNA and cationic lipids were prepared with the following cationic 
lipid/pDNA molar ratio, (ρ) = LC/D = (moles of cationic lipid)/ (moles of pDNA bases) of 4 and 5. 
According to previous studies, this could be a condition in which the majority of pDNA molecules 
should be complexed (Gershon et al., 1993; Lee et al., 2004). 
Hydrodynamic diameter was found to be dependent on preparation technique of lipoplexes, 
cationic lipid used to condense pDNA and the N/P ratio.  
Dialysed DOTAP/pDNA lipoplexes had larger diameters than mixed lipoplexes. More specifically, 
the DOTAP/pDNA lipoplexes formed by the mixing technique without OGP showed comparable 
hydrodynamic diameters of 218.2 ± 8 nm and 297.5 ± 20.2 nm at N/P 4 and 5, respectively (Figure 3.1 
A). Formation of DOTAP/pDNA lipoplexes in the presence of 200 mM OGP resulted in an increase in 
size to 1176 ± 471.09 nm and 601.3 ± 311.1 nm at N/P 4 and 5, respectively. Additionally, the 
polydispersity indices (PDI) of the size measurements as a marker for particle size distribution width 
were diverse. PDI showed a wide size distribution width for both mixed and dialysed lipoplexes 
demonstrating a heterogeneous size distribution. Increasing the N/P ratio from 4 to 5 improved the 
polydispersity (PDI) of produced DOTAP/pDNA lipoplexes prepared by mixing technique. 
 
 
 
3. Physicochemical Characterization of The Lipoplexes 
 47
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In contrast, the effect of OGP (200 mM) on hydrodynamic diameter of DC-cholesterol/pDNA at 
N/P 4 and 5 was not observed compared to the same mixed lipoplexes (Fig. 3.1 B). DC-
cholesterol/pDNA lipoplexes showed comparable hydrodynamic diameters of 424.5 ± 96.5 nm 
(mixed) and 418.9 ± 25.8 nm (dialysed) at N/P 4, while a slight increase in the hydrodynamic 
diameters observed for dialysed (311 ± 312.8 nm) compared to mixed (224.4 ± 196.2 nm) DC-
cholesterol/pDNA lipoplexes at N/P 5 (Fig. 3.1 B).  
The PDI of mixed and dialysed lipoplexes exhibited high values of 0.89 ± 0.14 (mixed) and 0.96 ± 
0.08 (dialysed) at N/P 4 the condition which indicates heterogeneity of the lipoplexes. The increase in 
PDI of DC-cholesterol/pDNA lipoplexes was accompanied by a bimodal peak profile suggesting 
aggregation of the lipoplexes, both in case of mixed and dialysed lipoplexes. 
Based on the structures of cationic headgroups, DC-cholesterol contains a tertiary amine while 
DOTAP cationic lipid contains quaternary amine. The tertiary amine of DC-cholesterol is non-ionized 
at neutral to alkaline pH shows a pKa of 8 (Zuidam and Barenholz, 1997) compared to the quaternary 
amine of DOTAP that is ionized at all pH ranges (Ajmani and Hughes, 1999). It was assumed that 
interaction of cationic DC-cholesterol vesicles with negatively charged plasmid DNA will lead to 
further protonation of the DC-cholesterol tertiary amine, due to lowering of the pH of the surface 
membrane by the charged phosphates (Zuidam and Barenholz, 1998). Consequently, this leads to more 
free cationic interaction with the pDNA wrapped DC-cholesterol vesicles by attraction forces. This 
interaction may produce large aggregates with a high zeta potential value as shown below for mixed 
DC-cholesterol/pDNA lipoplexes.  
Figure 3.1: Influence of OGP on the hydrodynamic diameter of lipoplexes at different N/P ratios. 
The effect of OGP concentrations (200 mM) on the hydrodynamic diameter at N/P ratio 4 and 5 of mixed 
(striated bars) and dialysed (solid bars) DOTAP (A) and DC-cholesterol (B) was measured by photon 
correlation spectroscopy in three independent experiments. Results are given as mean +/- standard 
deviation.  
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The heterogeneous size distribution was previously reported for lipoplexes prepared by mixing 
technique (Ciani et al., 2004). This might be due to the aggregation of the intact cationic liposomes 
wrapped by pDNA by electrostatic attraction forces. It has been also demonstrated, for example, that 
pDNA binding to liposomes can provoke significant disruption in liposome structure (Sternberg et al., 
1994; Rädler et al., 1997; Wasan et al., 1999). 
Conclusively, in the case of DOTAP/pDNA lipoplexes, detergent dialysis technique showed an 
increase in size of the lipoplexes presumably by aggregation enhancement. The effect was pronounced 
at N/P 4 than at N/P 5. In case of DC-cholesterol/pDNA lipoplexes, OGP had a lower influence on the 
resulting lipoplex size.  
 
3.2. Zeta Potential of Lipoplexes 
Formation of lipoplex is mediated through simple electrostatic interactions, typically between 
positively charged cationic liposomes and the phosphate groups of pDNA (Zuidam and Barenholz, 
1998; Ciani et al., 2004). The ratio of cationic lipid to pDNA has been shown to be one of the most 
important factors affecting the transfection efficiency.  
These systems are formulated in a manner whereby the resulting cationic lipid/pDNA lipoplexes 
exhibit a positive charge that facilitates association with the negatively charged cell surface domains 
(Stamatatos et al., 1988; Wong et al., 1999; Liang and Chou, 2009). Zeta potential is an indirect 
measurement of the lipoplex surface charge, and it can be used to evaluate the extent of interaction of 
the cationic lipid surface charges with the anionic charges of pDNA (Eastman et al., 1997; Perrie and 
Gregoriadis, 2000; Perrie et al., 2001; Ma et al., 2007).  
Figure 3.2 shows the zeta potential values of mixed and dialysed lipoplexes, as measured by LDA, 
as a function of: (i) the method of preparation, (ii) the type of cationic lipid used to condense pDNA 
and (iii) the mixing N/P ratios. Mixed DOTAP/pDNA lipoplexes showed zeta potentials of 48.6 ± 4 
mV (N/P 4) and 44.64 ± 6.3 mV (N/P 5). The presence of the OGP detergent during lipoplexes 
assembly caused a reduction in zeta potential upon detergent withdrawal (Fig. 3.2 A). Zeta potentials 
of 30.2 ± 3.1 mV (N/P 4) and 36.65 ± 4.8 mV (5 N/P) were recorded for dialysed DOPAP/pDNA 
lipoplexes. The reduction in zeta potential at N/P 4 than at N/P 5 the condition indicates higher 
cationic DOTAP lipids are involved in pDNA neutralization.  
A similar pattern in the zeta potential values as a function of preparation technique and mixing 
ratios was also observed for DC-cholesterol/pDNA lipoplexes prepared by detergent dialysis 
technique at the same N/P ratios (Fig. 3.2 B). In general, the mixing technique resulted in the 
formation of positively charged lipoplexes. Nevertheless, the zeta potentials of DC-cholesterol/pDNA 
lipoplexes were lower than the values of DOTAP/pDNA lipoplexes prepared by mixing technique. 
The increase in the N/P ratio from 4 to 5 barely changed the zeta potential of mixed lipoplexes. Mixed 
DC-cholesterol/pDNA lipoplexes exhibited zeta potential values of 36.02 ± 2.1 mV and 36.76 ± 3.5 
mV at N/P ratio 4 and 5, respectively. In contrast, the presence of OGP during lipoplex preparation 
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produced lipoplexes with reduced zeta potentials. These values were 26.1 ± 3.6 mV and 25.32 ± 0.95 
mV for N/P ratio 4 and 5, respectively.  
In accordance to previous studies, DOTAP/pDNA and DC-cholesterol/pDNA lipoplexes prepared 
by conventional mixing technique showed zeta potential of + 48 mV and +39 mV, respectively (Ciani 
et al., 2004). This was in the line to our zeta potential values for mixed lipoplexes. 
The increase in DOTAP/pDNA lipoplexes size due to OGP effect was correlated with lower zeta 
potentials. 
 Conclusively, the detergent dialysis may influence the interactions between pDNA and 
transfection compounds. The presence of non-ionic detergent during cationic lipid/pDNA assembly 
generally affects the particle size and the zeta potentials of the produced lipoplexes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Effect of OGP (200 mM) on the zeta potential of different lipoplexes at different N/P 
ratios. The zeta potential of mixed (striated bars) and dialysed (solid bars) DOTAP/pDNA (A) and DC-
cholesterol/pDNA (B) lipoplexes at two different N/P ratios 4 and 5 was measured by laser Doppler 
anemometry in three independent experiments. Results are shown as mean +/- standard deviation. 
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3. 3. pDNA Release 
Szoka and co-workers reported that different types of anionic lipids were equally effective in 
pDNA release. In the meantime, twofold excess of anionic lipid was sufficient to release 80-90 % of 
the lipoplex pDNA (Xu and Szoka, 1996; Zelphati and Szoka, 1996). A similar process of lipid 
exchange between lipoplexes and cytoplasmic membranes resulting in pDNA release into the 
cytoplasm was later observed in cultured cells (Wrobel and Collins, 1995; Noguchi et al., 1998; 
Nakanishi and Noguchi, 2001). Furthermore, intermixing of endosomal membrane lipids with lipoplex 
lipids seems to be an important step in the transfection process.  
We applied the PicoGreen® assay as pDNA fluorescent probe to examine the pDNA condensation 
state in the mixed and dialysed lipoplexes as a function of time. This was taken as a measure of pDNA 
release. The pDNA release was induced by addition of different negatively charged liposomes.  
The results are presented as plots of the percentage of pDNA released from cationic 
DOTAP/pDNA and DC-cholesterol/pDNA lipoplexes after incubation with negatively charged DOPS 
or oleic acid containing liposomes. Several negatively charged liposomes were used for the 
experiments: (i) DOPS/DOPC (3:7), (ii) DOPS: DOPE: DOPC (2.5:2.5:5), (iii) oleic acid (OA)/DOPE 
(3:7), (iv) OA/DOPC (3:7) and (v) OA/DOPE/DOPC (2.5:2.5:5). 
The cationic lipid/pDNA ratio influenced both lipoplex formation and pDNA release after addition 
of negatively charged lipid (Pantazatos and MacDonald, 2003; Tarahovsky et al., 2004; Koynova and 
MacDonald, 2007). Therefore, the lipoplexes were prepared at N/P ratios 4 and 5. Lipoplexes were 
equilibrated for 30 min before addition of the negatively charged liposomes in case of mixed 
lipoplexes and equilibrated in 200 mM OGP followed by detergent dialysis in case of dialysed 
lipoplexes.  
The negatively charged liposomes were added to the cationic lipoplexes at R = 4 where R = A/Lc 
(moles of anionic lipid/moles of cationic lipid). pDNA release was estimated by an increase of 
PicoGreen® fluorescence after pDNA displacement from lipoplexes by negatively charged liposomes. 
pDNA release was  expressed as percentage of pDNA released as previously described in chapter 2 
Materials and Methods section 2.2.10. 
 
   3.3.1. pDNA Release from DOTAP/pDNA and DC-cholesterol/pDNA Lipoplexes by DOPS 
Containing Liposomes 
3.3.1.1. DOTAP/pDNA Lipoplexes  
For DOTAP/pDNA lipoplexes, the mixing technique always demonstrated a higher pDNA release 
by anionic DOPS/DOPE/DOPC and DOPS/DOPC liposomes compared to dialysed lipoplexes. Even 
after more than 2 h, only a part of the pDNA was released from dialysed lipoplexes. Experiments 
using liposomes with and without DOPE resulted in different release profiles for the DOTAP/pDNA 
lipoplexes tested. Furthermore a higher N/P ratio of 5 resulted in a higher pDNA release compared to 
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N/P 4 in case of DOPS/DOPC liposomes while DOPS/DOPE/DOPC liposomes were efficient to 
displace pDNA from DOTAP/pDNA lipoplexes at N/P 4 than N/P 5. 
Following addition of DOPS/DOPC containing liposomes to mixed DOTAP/pDNA lipoplexes at 
N/P 5 (Fig. 3.3 A), pDNA release was not considerably different as compared to the pDNA release by 
DOPS/DOPE/DOPC liposomes (Fig.3.3 B).  
DOPS/DOPE/DOPC liposomes induced a maximum of 40.5 ± 0.7 % pDNA release compared to 
38.65 ± 1.1 % for DOPS/DOPC liposomes. A slight difference in the initial release rate could be 
detected which is more steep in case of DOPE containing liposomes than in case of only DOPS/DOPC 
liposomes indicating higher initial pDNA release rate in the first phase (Fig. 3.3).  
In contrast, the maximum pDNA release from dialysed DOTAP/pDNA lipoplexes exhibited only 
6.1 ± 0.2 and 4.0 ± 0.4 % for DOPS/DOPC and DOPS/DOPE/DOPC, respectively (Fig. 3.3). A small 
amount of pDNA from dialysed lipoplexes could be detected immediately after the addition of 
negatively charged liposomes. We assume that this small amount of uncondensed pDNA was attached 
to lipoplex surface and hence was available to PicoGreen® dye intercalation, but the mean pDNA is 
still retarded by cationic lipid aggregate. 
A considerable difference in pDNA displacement was shown at N/P ratio 4 than 5. This was 
observed for both mixed and dialysed DOTAP/pDNA lipoplexes treated with DOPS/DOPE/DOPC 
liposomes (Fig. 3.3).  
DOPS/DOPC liposomes exhibited greater pDNA release efficiency at N/P 5 ratio than observed at 
N/P 4. At N/P 4, mixed DOTAP/pDNA lipoplexes showed 26.9 ± 1.1 % pDNA released while at N/P 
5 pDNA release was 38.65 ± 1.1 % (Fig. 3.3 A). 
A difference in the pDNA release efficiency from DOTAP/pDNA lipoplexes was observed when 
DOPS/DOPE/DOPC liposomes were used compared to DOPS/DOPC liposomes. As seen in Figure 
3.3 B, mixed DOTAP/pDNA lipoplexes showed complete pDNA release at N/P 4, while exhibited 
only 40.5 ± 0.7 % at N/P 5. 
The effect of DOPE to induce more pDNA release at N/P 4 than N/P 5 could be referred to its 
ability to form fusion with DOTAP lipid in the lipoplex. 
A similar effect of DOPS/DOPE/DOPC liposomes to displace pDNA release was also observed in 
case of dialysed DOTAP/pDNA lipoplexes at N/P 4 than N/P 5. Dialysed DOTAP/pDNA lipoplexes 
showed 21.2 ± 2.65 % (N/P 4) and 4.0± 0.4 % (N/P 5) pDNA released (Fig. 3.3 B). 
 
3.3.1.2.. DC-cholesterol/pDNA Lipoplexes  
Dialysed DC-cholesterol/pDNA lipoplexes demonstrated in all cases a lower pDNA release 
compared to mixed lipoplexes. This corresponds to the results for the DOTAP/pDNA lipoplexes 
described in the last section. In contrast, the effect of DOPE on pDNA release from DC-
cholesterol/pDNA lipoplexes was lower than observed for DOTAP/pDNA lipoplexes. Furthermore, 
higher N/P ratios showed higher pDNA release. 
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 Mixed DC-cholesterol/pDNA lipoplexes showed 23.5  ± 0.18 and 29 ± 1.1% pDNA released at 
N/P of 4 and 5, respectively when DOPS/DOPC liposomes were used (Fig. 3.4 A). A similar final 
extent of pDNA released was observed when these lipoplexes were treated with DOPS/DOPE/DOPC 
liposomes at N/P 4 (24.5 ± 1.3%) and (32.6 ± 0.75 %) at N/P 5 (Fig. 3.4 B).  
Like dialysed DOTAP/pDNA lipoplexes, dialysed DC-cholesterol/pDNA lipoplexes exhibited also 
a low pDNA release pattern. DOPS/DOPC liposomes exerted a slight increase in the extent of pDNA 
released at N/P 5 (7.5 ± 0.1%) than at N/P 4 (3 ± 0.03 %). While, dialysed DC-cholesterol showed 
only 3.1 ± 0.1 % (N/P 4) and 3.7 ± 0.2 % (N/P 5) pDNA released when DOPS/DOPE/DOPC 
liposomes were applied (Fig. 3.4). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Time-dependent effect of N/P ratio and preparation technique on the pDNA release 
from DOTAP/pDNA lipoplexes using DOPS/DOPC (3:7) (A) and DOPS/DOPE/DOPC (1:1:2) 
(B) liposomes. DOTAP/pDNA lipoplexes prepared at N/P 4 (dialysed (●); mixed (○)) and N/P 5 
(mixed (●) and mixed (○)) were treated with DOPS at R=4. PicoGreen® solution was added to 
2µg/ml pDNA/ DOTAP lipoplexes, and the increase of PicoGreen® fluorescence was monitored over 
time at pH 7.4 as described in the Materials and Methods section 2.2.10. Data were shown as mean 
+/- standard deviation of three independent experiments.  
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3.3.2. pDNA Release from DOTAP/pDNA and DC-cholesterol/pDNA Lipoplexes by oleic acid 
(OA) Containing Liposomes  
Oleic acid is considered as a minor cellular lipid component of the biological membranes (Epand et 
al., 1991; Tarahovsky et al., 2004). In previous work, oleic acid was a strong pDNA releaser from o-
ethyl-dioleoylphosphatidylcholinium (EDOPC) lipoplexes (Tarahovsky et al., 2004). In this study, 
negatively charged oleic acid was used in combination with different phospholipids to exert pDNA 
release from DOTAP/pDNA and DC-cholesterol/pDNA lipoplexes (Fig. 3.5 and Fig. 3.6). 
 
3.3.2.1. DOTAP/pDNA Lipoplexes  
Changing the type of the anionic lipid did affect the extent of pDNA release from DOTAP/pDNA 
lipoplexes. Mixed DOTAP/pDNA lipoplexes were characterized by a higher pDNA release in the 
presence of oleic acid (OA) compared to dialysed lipoplexes. Lipoplexes prepared at N/P ratio 5 
always were found to release more pDNA than lipoplexes at N/P 4. Additionally, the oleic acid 
Figure 3.4: Time-dependent effect of N/P ratio and preparation technique on the pDNA release 
from DC-cholesterol/pDNA lipoplexes using DOPS/DOPC (A) and DOPS/DOPE/DOPC (B) 
liposomes. DC-cholesterol/pDNA lipoplexes were treated with DOPS/DOPC (3:7) and with 
DOPS/DOPE/DOPC (1:1:2) at N/P 4 (dialysed (▲); mixed (∆)) and N/P 5 (dialysed (●) and mixed 
(○)) at R=4. PicoGreen® solution was added to 2µg/ml pDNA/ of DC-cholesterol lipoplexes, and the 
increase of PicoGreen® fluorescence was monitored over time at pH 7.4 as described in the Materials 
and Methods section 2.2.10. Data were shown as mean +/- standard deviation of three independent 
experiments. 
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capability to release pDNA from DOTAP/pDNA lipoplexes increased in the range from DOPE < 
DOPC < DOPE/DOPC. 
As shown in Figure 3.5 A and Fig. 3.5 B, the efficiency of oleic acid to exert pDNA release from 
DOTAP/pDNA lipoplexes was varied depending on the phospholipid compositions. When OA/DOPC 
liposomes were used, oleic acid exhibited an ability to release pDNA to about 36 ± 0.4 % (mixed 
lipoplexes) and a lower pDNA release (22.1 ± 0.7 %) could be detected at N/P 5 when OA/DOPE 
liposomes was used. 
OA/DOPE/DOPC liposomes showed stronger pDNA release in terms of the percent (45.8 ± 1.3 %) 
and the release rate, Figure 3.5 C, compared to the pDNA released by DOPS/DOPE/DOPC liposomes 
(40.5 ± 0.7 %). 
The initial rate and extent of the pDNA release were depended on composition of the phospholipids 
used to initiate pDNA release. The highest pDNA release could be found for OA/DOPE/DOPC 
liposomes (45.8 ± 1.3 %) for DOTAP/pDNA lipoplexes at N/P 5 (Fig. 3.5 C). 
 For dialysed DOTAP/pDNA lipoplexes, the rate of pDNA release was low for all oleic acid lipids 
combinations tested.  
Figure 3.5 shows the effect of OA/DOPC liposomes (4.8 ± 0.1%); OA/DOPE (3 ± 0.3 %) and 
OA/DOPC/DOPE (4.8 ± 0.4 %) to release pDNA from dialysed DOTAP/pDNA lipoplexes at N/P 5 
was observed.  
The OA capability to release pDNA in presence of DOPE was lower than OA/DOPC liposomes. In 
contrast, OA ability to release pDNA from DOTAP/pDNA lipoplexes in presence of DOPE and 
DOPC improved the OA pDNA release capability.  
The neutral lipid DOPE adopts non-bilayer inverted hexagonal (HII) phase in isolation. To stabilize 
the Lα phase of DOPE, anionic lipids such as oleic acid was previously used in its ionized state 
(Düzgüneş, 2004). The lower capability of oleic acid/DOPE to release pDNA from DOTAP/pDNA 
lipoplexes may be due its stabilizing effect to DOPE into Lα phase bilayer. As a consequence, its 
partition from the OA/DOPE vesicles to form DOTAP/OA ion pair is not enhanced. 
The N/P ratio influenced the maximum extent of pDNA release after addition of negatively charged 
liposomes. In all cases, the rate of pDNA release estimated from DOTAP/pDNA lipoplexes at N/P 4 
was lower than that at N/P 5(Fig. 3.5 A, B and C).  
The free cationic lipids around the formed lipoplexes are considered to be necessary to initiate 
pDNA release through the ion-pair formation with anionic lipids. At lower N/P ratio, the excess 
cationic lipid is low; therefore, the lipids bound to pDNA are not able to form neutralized ion-pair with 
anionic lipid which is a prerequisite to initiate pDNA release from lipoplexes (Pantazatos and 
MacDonald, 2003; Koynova and MacDonald, 2007). 
In the line with our data, pDNA release from DOTAP/ODNs previously showed that the pDNA 
release was highest at excess positive charge of the complexes (Jääskeläinen et al., 1998).   
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From a previous report, the pDNA release from EDOPC lipoplexes was investigated (Koynova and 
MacDonald, 2007). They showed that lipoplexes with excess cationic lipids rapidly released their 
pDNA content upon addition of anionic liposomes. While, in the case of the lipoplexes with excess 
pDNA, the release of pDNA was quite inefficient even after 1 h of incubation with the same anionic 
lipids. 
 
3.3.2.2. DC-cholesterol/pDNA Lipoplexes           
As observed in the experiments described above, mixed DC-cholesterol based lipoplexes 
demonstrated higher pDNA release than dialysed lipoplexes in the presence of OA containing 
liposomes. Again, N/P ratio of 5 resulted in a higher pDNA release than at N/P ratio 4. Independent 
from the composition of the anionic liposomes (OA/DOPC, OA/DOPE and OA/DOPE/DOPC), the 
pDNA release from mixed DC-cholesterol lipoplexes was comparable for each liposomes composition 
(Fig. 3.6). 
Mixed DC-cholesterol/pDNA lipoplexes treated with oleic acid containing liposomes exhibited a 
considerable pDNA released compared to DOTAP lipoplexes. 
A percentage of 43 ± 0.7 % pDNA was released from mixed DC-cholesterol/pDNA lipoplexes at 
N/P 5 when a mixture of OA/DOPC was used (Fig. 3.6 A). In contrast, mixed DOTAP/pDNA 
lipoplexes showed only 36 ± 0.4 % pDNA released for the same negatively charged lipid composition 
(Fig. 3.5 A).  
 Unlike the effect on DOTAP/pDNA lipoplexes, OA/DOPE liposomes showed pDNA release from 
mixed DC-cholesterol/pDNA lipoplexes as twice as that observed in case DOTAP/pDNA lipoplexes at 
N/P 5 (Fig. 3.5 B and Fig. 3.6 B). 
OA/DOPE/DOPC liposomes showed the highest capability to exert pDNA release in both 
lipoplexes (Fig. 3.5 C and Fig. 3.6 C). The effect of OA/DOPE to exert pDNA release from DC-
cholesterol/pDNA lipoplexes was as equal as the effect of other lipid combinations (Fig. 3.6 A-C)  
Like the other dialysed lipoplexes, the rate of pDNA release from dialysed DC-cholesterol/pDNA 
lipoplexes was considerably low. pDNA release in terms of method of preparation and N/P ratios, OA 
exhibited pDNA percentages of 6.5 ± 0.48, 5.3 ± 0.19 and 7.7 ± 1.16 % pDNA released for DOPC; 
DOPC/DOPE and DOPE containing oleic acid at N/P 5  respectively(Fig. 3.6).  
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Figure 3.5: Time-dependent effect of N/P ratio and preparation technique on the pDNA release 
DOTAP/pDNA lipoplexes using various oleic acid (OA) liposomes. DOTAP/pDNA lipoplexes were 
treated OA/DOPC (3:7) (A); OA/DOPE (3:7) (B) and OA/DOPE/DOPC (1:1:2) (C) at N/P 4 (dialysed (▲); 
mixed (∆)) and N/P 5 (dialysed (●) and mixed (○)) at R=4. PicoGreen® solution was added to 2µg/ml 
pDNA/ of DOTAP lipoplexes, and the increase of PicoGreen® fluorescence was monitored over time at pH 
7.4 as described in the Materials and Methods section 2.2.10. Data were shown as mean +/- standard 
deviation of three independent experiments.  
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Figure 3.6: Time-dependent effect of N/P ratio and preparation technique on the pDNA release DC-
cholesterol/pDNA lipoplexes using various oleic acid (OA) liposomes. DC-cholesterol/pDNA lipoplexes 
were treated OA/DOPC (3:7) (A), OA/DOPE (3:7) (B) and OA/DOPE/DOPC (1:1:2) (C) at N/P 4 (dialysed 
(▲); mixed (∆)) and N/P 5 (dialysed (●) and mixed (○)) at R=4. PicoGreen® solution was added to 2µg/ml 
pDNA/ of DC-cholesterol lipoplexes, and the increase of PicoGreen® fluorescence was monitored over time at 
pH 7.4 as described in the Materials and Methods section 2.2.10. Data were shown as mean +/- standard 
deviation of three independent experiments.  
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 From these data it can be concluded that the releasing activity of a given anionic lipid depends on 
the nature of cationic component of the lipoplexes and might be the mesomorphic phases of the 
anionic lipid used to trigger pDNA release. This will be discussed in detail in chapter 4 in combination 
with the cryo-TEM experiments. 
In accordance to our data, similar studies showed that oleic acid was a very potent pDNA releaser 
in the case of EDOPC lipoplex, while DOPS showed a lesser efficiency (Tarahovsky et al., 2004). In 
comparison, pDNA release data from DOTAP/pDNA and DC-cholesterol/pDNA lipoplexes revealed a 
considerable difference in pDNA releasing capabilities of DOPS and OA containing liposomes. The 
effect was better observable in DC-cholesterol/pDNA lipoplexes when OA was used. A possible 
explanation is that the efficiency of anionic lipids to release pDNA could be observed only in terms of 
the stability of the formed ion-pair between anionic and cationic lipids. This could be partly dependent 
on the mesomorphic phases and the negative to positive ratio which could form ion-pair at 
electroneutrality (Tarahovsky et al., 2004; Koynova and MacDonald, 2007).  
The dialysed lipoplexes showed low pDNA release under all conditions tested. This was prominent 
in all dialysed lipoplexes regardless to the type of cationic lipid and N/P ratios used to condense 
pDNA. The effect of OGP dialysis technique would be suggested to modify the pDNA binding to the 
cationic lipids.  
Based on literature, we assume that the presence of OGP might correlate with the enhancement of 
charge neutralization of the pDNA phosphate groups. The strong compaction effect of cationic lipid 
on the pDNA in presence of OGP could be explained by the following expectation:  
The non-ionic OGP detergent forms mixed micelles with cationic lipids (Reimer et al., 1995; 
Gregoriadis 2007). The formed OGP/cationic lipid mixed micelles might have an effect on the 
distribution of the condensed counter ions surrounding the pDNA (Manning, 1978; Taira et al., 2005) 
as well as on the water hydration shell (Hackl and Blagoi, 2004). Under these conditions, the 
interaction between pDNA and cationic lipids is more cooperative (Fig. 3.7). Upon detergent removal, 
pDNA condensation is promoted which could be facilitated through intra-molecular acyl chain 
interactions (Reimer et al., 1995). 
In addition, it was suggested that the interaction between pDNA and cationic lipids in the presence 
of OGP is a consequence of electrostatic and hydrophobic interactions (Wong et al., 1996; Zhang et 
al., 1997; Wasan et al., 1999). 
This correlated with our LDA measurements showing a marked reduction in the zeta potential of 
dialysed lipoplexes compared to mixed lipoplexes. It could be suggested that excess cationic lipids are 
involved in neutralization of pDNA.  
In addition, the effect of OGP concentration on the zeta potential values of pDNA was recorded. 
Interestingly, the zeta potential values of pDNA were observed to be increased as the OGP 
concentration in solution is increased (Fig. 3.8). This reflects that the electric double layer disturbance 
around pDNA might be accompanied by a reduction in the zeta potential negative value of pDNA. 
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Conclusively, the stronger condensation of pDNA and lower release of pDNA from the lipoplexes 
as observed for dialysed complexes may also contribute to the low transfection efficiency in previous 
work (Wheeler et al., 1999; Tam et al., 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
3. Physicochemical Characterization of The Lipoplexes 
 60
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Figure 3.7: Strategies in Cationic lipid/pDNA Lipoplex Preparation. The Lipoplexes is prepared by 
simple mixing approach (A). An alternative approach, where the pDNA is mixed with cationic liposomes 
in presence of non-ionic OGP detergent (B).  Here a cationic lipid/OGP mixed micelles are formed and 
should efficiently condense DNA into lipoplexes upon detergent substitution using dialysis technique. 
This forms aggregated lipoplexes characterised by lower zeta potentials. 
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Figure 3.8: Effect of OGP concentration (0-200 mM) on the zeta potential of pDNA. The zeta 
potential of pDNA was measured by laser Doppler anemometry in three independent experiments in 10 
mM Tris, pH 7.4. Results are shown as mean +/- standard deviation. 
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3.5. pDNA Release from DOTAP/pDNA and DC-cholesterol/pDNA Lipoplexes by DOPS and 
Oleic Acid (OA) Containing Liposomes at Acidic pH 
Rapid release of lipoplexes from the endosomal compartment is supposed to constitute one of the 
critical steps in determining the efficiency of transfection (Elouahabi and Ruysschaert, 2005; Hoekstra 
et al., 2007; Caracciolo et al., 2009).  
Therefore, we studied the effect of the acidic endosomal pH on the pDNA release from different 
lipoplexes. 
3.5.1. DOTAP/pDNA Lipoplexes  
The effect of the acidic pH on the pDNA release from DOTAP/pDNA as well as DC-
cholesterol/pDNA lipoplexes at N/P ratio 4 and 5 was examined. Negatively charged liposomes 
DOPS/DOPE/DOPC (1:1:2) and OA/DOPE/DOPC (1:1:2) were used to initiate pDNA release at R= 
4.  
In this experiment we observed that DOTAP/pDNA lipoplexes dissociation measured in terms of 
pDNA release was increased markedly at acidic pH after addition of DOPS/DOPE/DOPC liposomes. 
As seen in Figure 3.9, a high pDNA release from mixed DOTAP/pDNA lipoplexes at pH 5.3 
exhibiting 80 ± 0.46 % at N/P 5 compared to pDNA released at pH 7.4 (40.5 ± 0.7 %). DOTAP/pDNA 
lipoplexes at N/P 4 revealed a complete DNA release (Fig. 3.10). 
We assume that the effect of high H+ concentration was accompanied by lipoplexes/DOPS 
liposomes aggregation which induced lipoplexes destabilization and hence, higher pDNA release.  
A previous report showed that DOPS containing liposomes exhibited massive non leaky vesicle 
aggregations in presence of Ca+2. These vesicle aggregations showed a faster overall fusion reaction at 
high H+ concentration which is therefore due to the higher aggregation rate rather than the fusion rate 
per se (Nir et al., 1982). 
In contrast, dialysed DOTAP/pDNA lipoplexes showed 3.5 ± 0.5 % and 13.6 ± 0.7 % at N/P 5 and 
4 using the same negatively charged liposomes (Fig. 3.9 and Fig. 3.10), respectively. Dialysed 
DOTAP/pDNA lipoplexes release data confirm highly bound pDNA as reflected by the low DNA 
release at different pHs.  
In contrast, oleic acid efficiency to exert pDNA release from DOTAP/pDNA lipoplexes was not 
affected by pH change at N/P 5. 
OA/DOPE/DOPC liposomes showed  42.3 ± 0.4 % and 46.2 ± 2.9 % pDNA release at N/P 4 and 5, 
respectively (Fig 3.10 and Fig 3.11 A) when pH decreased to an acidic value.  
 
3.5.2. DC-cholesterol/pDNA Lipoplexes  
DC-cholesterol/pDNA lipoplexes treated with DOPS/DOPE/DOPC liposomes showed, in contrast 
to DOTAP/pDNA lipoplexes, no marked increase in pDNA release (Fig. 3.9 A) compared to pDNA 
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released at pH 7.4 (Fig. 3.9 B). The protonation state of tertiary amine group of DC-cholesterol lipid at 
low pH might minimize the ion-pair formation with anionic DOPS lipid. 
At N/P 5, mixed DC-cholesterol/pDNA lipoplexes showed  33.7 ± 2.3 % pDNA release which, in 
contrast to N/P 4 showed only 18.4 ± 0.8 % pDNA release (Fig. 3.9 A and Fig 3.12).  
The pDNA release from the DC-cholesterol lipoplexes revealed no correlation between the extent 
of pDNA release and H+ concentration after addition of oleic acid containing liposomes. This marked 
reduction of pDNA release from DC-cholesterol/pDNA lipoplexes at lower N/P ratio verifies that the 
amount of free tertiary amine group is protonated the condition suggests higher stability of DC-
cholesterol/pDNA lipoplexes at acidic pH. From another point of view, the observed reduction in 
pDNA release might result from the binding capability of pDNA to tertiary DC-cholesterol when pH 
decreased.  
The dialysed DC-cholesterol/pDNA lipoplexes treated with OA/DOPE/DOPC liposomes showed 
similar behaviour in terms of lower pDNA release. 
At pH 5.3, N/P 5 the DC-cholesterol/pDNA lipoplexes exhibited 41.29 ± 0.65 % pDNA release by 
OA/DOPE/DOPC liposomes which was as equal as pDNA released at neutral pH. Nevertheless, the 
rate of pDNA release was considerably different showing slower rate in case of acidic pH (Fig. 3.11 A 
and Fig. 3.11 B). The effect of OA on the mixed DC-cholesterol/pDNA lipoplexes at N/P 4 showed a 
decrease in pDNA release of 8.84 ± 0.81 % (Fig. 3.12). 
Under acidic conditions, DC-cholesterol protonates and the ability to dissociate pDNA both by 
DOPS/DOPE/DOPC and OA/DOPE/DOPC liposomes, especially at low N/P ratio is reduced.  
The inherent buffering capacity of cationic polyamine lipids which have protonizable amines such 
as DC-cholesterol may take advantage of the “proton-sponge” effect. This effect promotes a continual 
influx of ions and water, causing a disruption of the vesicle (Rolland and Sullivan, 2003), for more 
details see page 21.  
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Figure 3.9: pH-dependent effect on the pDNA release from DOTAP/pDNA and DC-
cholesterol/pDNA lipoplexes at N/P 5 using DOPS/DOPE/DOPC (1:1:2) liposomes. 
DOTAP/pDNA (dialysed (●) and mixed (○)) and DC-cholesterol/pDNA (dialysed (▲); mixed (∆)) 
lipoplexes were treated with DOPS/DOPE/DOPC (1:1:2) at pH 5.3 (A), and 7.3 (B) at R=4. 
PicoGreen® solution was added to 2µg/ml pDNA/ of DOTAP or DC-cholesterol lipoplexes, and the 
increase of PicoGreen® fluorescence monitored over time at pH 7.4 as described in the Materials 
and Methods section 2.2.10. Data were shown as mean +/- standard deviation of three independent 
experiments. 
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Figure 3.10: pH-dependent effect on the pDNA release from DOTAP/pDNA lipoplexes at N/P 4
using various anionic liposomes. DOTAP/pDNA lipoplexes were treated with OA/DOPE/DOPC 
(1:1:2) (dialysed (▲); mixed (∆)) and DOPS/DOPE/DOPC (1:1:2) (dialysed (●) and mixed (○)) 
liposomes at pH 5.3 at R=4. PicoGreen® solution was added to 2µg/ml pDNA/ of DOTAP lipoplexes, 
and the increase of PicoGreen® fluorescence monitored over time at pH 7.4 as described in the 
Materials and Methods section 2.2.10. Data were shown as mean +/- standard deviation of three 
independent experiments. 
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Figure 3.11: pH-dependent effect on the pDNA release from DOTAP/pDNA and DC-
cholesterol/pDNA lipoplexes at N/P 5 using OA/DOPE/DOPC (1:1:2) liposomes. 
DOTAP/pDNA (dialysed (●); mixed (○)) and DC-cholesterol/pDNA lipoplexes (dialysed (▲) 
and mixed (∆)) were treated with OA/DOPE/DOPC liposomes at pH 5.3 (A) and pH 7.3 (B) at 
R=4. PicoGreen® solution was added to 2µg/ml pDNA/ of DOTAP or DC-cholesterol 
lipoplexes, and the increase of PicoGreen® fluorescence monitored over time at pH 7.4 as 
described in the Materials and Methods section 2.2.10. Data were shown as mean +/- standard 
deviation of three independent experiments. 
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Figure 3.12: pH-dependent effect on the pDNA release from DC-cholesterol/pDNA lipoplexes 
at N/P 4 using various anionic liposomes. DC-cholesterol /pDNA were treated with 
OA/DOPE/DOPC (1:1:2) (dialysed (▲); mixed (∆)) and DOPS/DOPE/DOPC (1:1:2) (dialysed (●) 
and mixed (○)) liposomes at pH 5.3 and R=4. PicoGreen® solution was added to 2µg/ml pDNA/ of 
DC-cholesterol lipoplexes, and the increase of PicoGreen® fluorescence monitored over time at pH 
7.4 as described in the Materials and Methods section 2.2.10. Data were shown as mean +/-
standard deviation of three independent experiments. 
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    3.6. Conclusion 
Here, we show that the superior stability of dialysed lipoplexes does correlate with their limited 
capability to release DNA by different negatively charged liposomes both at pH 7.4 and 5.3. Our 
results may be potentially important for the development of new strategies toward the rational design 
of lipoplexes by enhancing their destabilization ability. 
The effect of OGP detergent dialysis as an alternative technique to produce lipid-based pDNA 
influenced the physicochemical properties of the produced lipoplexes. This was clearly seen by a 
marked reduction in the zeta potential values upon detergent dialysis. As a consequence, the colloidal 
stability of the lipoplex decreased showed tendency to aggregate. This was observed by large 
hydrodynamic diameter compared to mixed lipoplexes. 
The presence of OGP during cationic lipid/pDNA interaction enables cooperative interaction of the 
cationic lipid with pDNA. We assume that the effect of OGP may alter the counter-ion condensed 
layer which considered as a barrier between cationic compounds to neutralize sufficient negative 
phosphates carried by pDNA.   
Interestingly, in absence of OGP during lipoplex assembly, pDNA release from lipoplexes was 
pronounced when different negatively charged liposomes were applied. 
It seems that the non-ionic detergent can play a strong protective role for the pDNA. We will 
therefore further examine the morphological features of the dialysed lipoplexes to visualize the 
compaction effect of the cationic DOTAP lipid on pDNA in the DOTAP/pDNA lipoplexes. 
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Abstract 
Previously we reported on the pDNA condensation state in DOTAP/pDNA lipoplexes prepared by 
detergent N-octyl-beta-D-glucopyranosid (OGP) dialysis approach compared to mixed lipoplexes. 
pDNA release using PicoGreen® assay as a nucleic acid marker was estimated when anionic lipids 
DOPS and oleic acid (OA) containing liposomes were initiated pDNA release from the lipoplexes. 
pDNA release was considered negligible from dialysed lipoplexes as compared to mixed 
DOTAP/pDNA lipoplexes. Nevertheless, negatively charged liposomes of OA/DOPE/DOPC (1:1:2) 
exhibited more efficient pDNA release capabilities than DOPS/DOPE/DOPC (1:1:2) in terms of rate 
and extent of pDNA release. 
In the present study, DOTAP/pDNA lipoplexes were formed by an alternative technique than 
simple mixing process complexing pDNA and DOTAP in the presence of 200 mM non-ionic detergent 
N-octyl-beta-D-glucopyranosid (OGP) at N/P ratio 5. After 30 min incubation, the detergent 
substitution was performed using membrane dialysis. The mixed and dialysed lipoplexes were 
characterized using cyro-TEM to visualize the influence of OGP on the morphological features of 
assembled DOTAP/pDNA lipoplexes.  
The mechanisms by which pDNA released from DOTAP/pDNA lipoplexes using different anionic 
lipids were visualized.  
The preparation technique using detergent OGP dialysis influenced the morphological 
characteristics of the DOTAP/pDNA lipoplexes. Cryo-TEM revealed that dialysed DOTAP/pDNA 
lipoplexes formed compact aggregated structures of pDNA than that observed in mixed 
DOTAP/pDNA lipoplexes.  
This correlated well with pDNA condensation using PicoGreen® assay characterised by lower 
pDNA de-condensation capability from dialysed lipoplexes.  
The mechanism of pDNA release by DOPS/DOPE/DOPC (1:1:2) liposomes was different than by 
OA/DOPE/DOPC liposomes. This was observed for both mixed and dialysed DOTAP/pDNA 
lipoplexes.  
DOPS/DOPE/DOPC liposomes induced pDNA release by vesicle adhesion characterised by 
massive aggregation between negatively charged liposomes and cationic DOTAP lipoplexes. While, 
OA/DOPE/DOPC liposomes induced pDNA release by “inverted” non-lamellar intermediates 
formation.  
In conclusion, the preparation technique influenced the morphological features of the produced 
lipoplexes. Two different mechanisms were observed to induce pDNA release from DOTAP/pDNA 
lipoplexes. Regardless to the method of preparation, both mechanisms were observed in mixed and 
dialysed lipoplexes. Yet the effect of anionic/ cationic lipid phase formation during pDNA release was 
more pronounced in mixed than dialysed DOTAP/pDNA lipoplexes. 
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4.1. Morphology of DOTAP/pDNA Lipoplexes 
As a first experiment, before the interaction with anionic liposomes was investigated, the 
morphology of pure DOTAP/pDNA lipoplexes was characterized using cryo-TEM. The interaction 
between plasmid DNA and the cationic lipid in bulk phase is a very fast process which is governed by 
electrostatic interactions between the phosphate group of the pDNA and the cationic head groups of 
the cationic amphiphile. 
Gershon et al., (1993) have proposed a model for cationic liposome/pDNA complexation. At low 
ratios of liposomes to pDNA, positive vesicles are adsorbed to pDNA to form aggregates that 
gradually surround larger segments of the pDNA. As the amount of liposomes is increased, the 
aggregated liposomes along the pDNA reach critical concentrations and charge densities at which 
membrane fusion and pDNA collapse processes are initiated. Upon additional increase of the liposome 
concentration, the collapsed pDNA structures are covered completely by the lipid bilayers. The size of 
the final product is dependent on the size of the initial lipid vesicles, the nitrogen/phosphate ratio and 
ionic strength of the medium. pDNA condensation is caused by mechanisms independent of the length 
of the individual pDNA molecules (Reich et al., 1991; Bloomfield, 1991) and the absolute 
concentration of the nucleic acids (Gershon et al., 1993). These complexes form clusters of lipid 
molecules and not a vesicularized membrane bilayer, and therefore lack an internal aqueous space.  
 
4.1.1 Visualization of Mixed DOTAP/pDNA Lipoplexes 
Mixed lipoplexes of DOTAP/pDNA were prepared by mixing technique at N/P ratio 5 as described 
in chapter 2 the Materials and Method section 2.2.2.1. Structural details of the mixed DOTAP/pDNA 
lipoplexes were visualized by cryo-TEM (Fig 4.1).  
The addition of pDNA to preformed cationic liposomes triggers significant structural changes in 
the liposomes as well as the pDNA. Pure cationic DOTAP liposomes were mostly unilamellar vesicles 
in the range between 80 and 100 nm diameters. After pDNA contact with cationic lipid vesicles, a 
marked fusion of the cationic vesicles was observed. This could be explained by wrapping pDNA 
around cationic DOTAP vesicles. More cationic vesicles adhered to the pDNA wrapped vesicle were 
also observed (Fig. 4.1 A and B). Addition of pDNA to lipid caused aggregation of most vesicles into 
larger complexes. The size distribution shown in cyro-TEM pictures indicated vesicles of 
heterogeneous distribution in size of more than 200 nm. This correlated to our PCS measurements 
shown in chapter 3. 
Eventually rupture and collapse of vesicles occurred. These events of adhesion and fusion indicate 
that the vesicles had acquired a coating of pDNA. Otherwise cationic vesicles exhibited no 
interactions with each other. 
Figures 4.1 C and D show DOTAP vesicles wrapped by pDNA where two initially separate 
membranes forced into close contact by bound pDNA showed a thick border compared to pure 
4. Cryo-TEM Studies of DOTAP/pDNA Lipoplexes 
 72
DOTAP vesicles. In some lipoplexes (Figure 4.1 B), the inter bilayer binding is discontinuous and the 
outer membrane exhibits a bulb-like form.  
These consecutive adhesions led to eventual collapse of more than one DOTAP vesicle wrapped 
pDNA aggregates (Fig 4.1 E).  
Different membrane morphology was also observed by Xu et al., (1999) showing that 
DOTAP/pDNA lipoplexes had many spike-like strands similar to our observation in Figure 4.1 E. In 
accordance, Lasic, (1997) observed that DOTAP/pDNA lipoplex form loose aggregations without 
DNA/lipid fibers. 
In conclusion, the mixed lipoplexes were found to show structures according to the proposed model 
of pDNA/cationic lipid complexation (Felgner et al., 1987; Felgner and Ringold, 1989; Gershon et al., 
1993; Lasic and Templeton, 1996; Xu et al., 1999). 
 
4.1.2 Visualization of Dialysed DOTAP /pDNA Lipoplex 
Dialysed lipoplexes of pDNA and DOTAP lipid were prepared by detergent OGP dialysis 
technique. Dialysed lipoplexes were prepared in presence of 200 mM OGP at N/P ratio 5 followed by 
dialysis as described in chapter 2 the Materials and Method section 2.2.2.2.  
Structural details of the dialysed DOTAP/pDNA lipoplexes were visualized by cryo-TEM. 
Dialysed DOTAP/pDNA lipoplexes showed highly condensed particles (Fig 4.2 A). These collapsed 
structures indicate that the compaction effect of DOTAP lipid on pDNA is enhanced during lipoplex 
assembly. For example, a detailed figure (Figure 4.2 B) showed a triplet structure consisting of a dark 
central line surrounded on both sides by a bright band alternating with a dark line, which could be 
explained as two cationic bilayer membranes adsorbed to one other. The contact between the bilayers 
suggested that this higher contrast resulted from the presence of pDNA sandwiched between the 
membranes. Another indication for pDNA location is the fact that the membranes are not 
electrostatically repelled from each other which would be expected to cause large aggregates.  
 
 
 
 
 
 
 
 
 
 
 
 
4. Cryo-TEM Studies of DOTAP/pDNA Lipoplexes 
 73
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 
A B 
C 
E 
Figure 4.1: Cryo-TEM micrographs of mixed DOTAP/pDNA lipoplexes. The mixed 
DOTAP/pDNA lipoplexes at N/P 5 were prepared and visualized by cryo-TEM as described in the 
Materials and Methods section 2.2.12. The figure shows complexes of DOTAP/pDNA prepared by 
mixing technique in 145 mM NaCl/10 mM HEPES, pH 7.4. Bars are 200 nm. 
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The aggregates according to cyro-TEM photographs showed large sized lipoplexes of approx. > 
800 nm. In correlation to PCS measurements, a marked increase in the particle size was clearly 
observed for dialysed DOTAP/pDNA lipoplexes compared to mixed lipoplexes. The hydrodynamic 
diameter measured by PCS showed an increase from 297.5± 20.22 nm (mixed) to 601.3 ± 311.13 nm 
(dialysed). 
In contrast, in the presence of the OGP detergent the driving force for mixed micelles self-assembly 
is not cohesion between the hydrocarbon chains, but the so-called hydrophobic effect (Widom et al., 
2003). The hydrophobic effect responsible for the self assembly is in principle an entropically driven 
effect arising from the hydrogen bonded structures of water. In the pure water phase, strong hydrogen 
bonds between water molecules are formed. When a hydrocarbon molecule is added to the water 
phase, the water/water bonds have to be disrupted. 
In presence of OGP, it was assumed that these water/water bonds could be disrupted as previously 
described (Gregoriadis, 2007). We assume that the effect of detergent could induce cooperative 
contact between cationic lipid and negatively charged phosphates of pDNA which may provoke 
pDNA condensation upon detergent dialysis. 
It was demonstrated that pDNA lipid particles obtained by the detergent dialysis technique is 
protected from the external environment. As marker for protection, pDNA was completely protected 
against nuclease digestion (Hofland et al., 1996; Wheeler et al., 1999). In conclusion, the ultra-
structure of the dialysed lipoplexes showed an ordered and high compaction level of pDNA which 
leads to more stable lipoplexes compared to mixed cationic lipid/pDNA systems.  
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4.2. Visualization of Interaction of DOTAP/ pDNA Lipoplexes with Different Negatively Charged 
Liposomes 
In this study, we performed cryo-TEM experiments and investigated the mesomorphic structures 
developing during the pDNA release when anionic lipids were added. 
DOTAP/pDNA lipoplexes were prepared by mixing and detergent dialysis techniques at N/P 5, and 
the negatively charged DOPS/DOPE/DOPC (1:1:2) and OA/DOPE/DOPC (1:1:2) liposomes at R = 4, 
where R= A/Lc (moles of anionic lipid/moles of cationic lipid) were used.  
Cyro-TEM micrographs immediately and 1 hour after incubation were visualized. The 
morphological changes were visualized as described in chapter 2, the Materials and Method section 
2.2.12.  
 
4.2.1. Visualization of DOTAP/pDNA Lipoplexes after Interaction with DOPS Containing 
Liposomes 
4.2.1.1. Interaction of Mixed DOTAP/pDNA Lipoplexes with DOPS Containing Liposomes 
Cryo-TEM micrographs of pure negatively charged DOPS/DOPE/DOPC (1:1:2) liposomes 
revealed spherical, unilamellar lipid bilayer vesicles (Fig. 4.3). The anionic liposomes were 
monodisperse distributed vesicles and showed diameter of approx. 80 nm.  
Figure 4.2: Cryo-TEM micrographs of dialysed DOTAP/pDNA lipoplexes. The dialysed 
DOTAP/pDNA lipoplexes at N/P 5 were prepared and investigated by cryo-EM as described in the 
Materials and Methods section 2.2.12. In A, complexes consisting of DOTAP/pDNA prepared by detergent 
dialysis technique in 20 mM HEPES/145 mM NaCl, pH 7.4 are shown. In B an enlarged micrograph of A 
showed huge DOTAP/pDNA lipoplexes which appeared as a collapsed structure. Bars are 200 nm. 
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DOPS containing liposomes showed massive aggregations when incubated with mixed 
DOTAP/pDNA lipoplexes governed mainly by electrostatic interactions between DOTAP/pDNA 
lipoplexes and anionic liposomes. Aggregations were accompanied by mutual flattening of the anionic 
liposomes. When compared to the pure anionic liposomes, a marked increase in size of anionic 
liposomes was observed. Furthermore, adhesion was characterized by the formation of thick contact 
layers where the lipoplex adhered to the anionic liposomes indicating direct molecular contact 
between the membranes of the opposite charge (Fig 4.4). The observed thick contact layer is an 
evidence for the collapse of lipoplexes to many adjacent DOPS liposomes, becoming immediately 
apparent as the lipoplex and anionic surfaces came into contact.  
To recapitulate our cryo-TEM observations, several features of mixed DOTAP/pDNA lipoplexes 
and DOPS/DOPE/DOPC liposomes were observed:  
I. Rupture of the anionic vesicle could not be observed.  
II. Adhesion of lipoplexes to DOPS containing liposomes, which showed size expansion 
in all cyro-TEM fields. The increase in size was 5-10 times the size of the original DOPS 
liposomes.  
III. Mixed DOTAP/pDNA lipoplexes remained attached to the anionic vesicle. 
IV. Squeezing of DOTAP/pDNA lipoplexes was seen after adhesion to DOPS liposomes 
leading to a localized collapse. 
A similar observation was done by Berezhna et al., (2005) using laser scanning imaging in 
conjunction with fluorescence cross-correlation analysis. They visualized intermembrane interactions 
between DOTAP lipoplexes and giant uni-lamellar vesicles (GUVs) composed of 
DOPS/DOPE/DOPC. They observed a binding of lipoplex at the surface of the GUV, but no rupture of 
the vesicles was detected. Importantly, this might be indicative of lipid translocation to the outer 
leaflet of the bilayer (Kahya et al., 2002), as has been proposed to occur for DOPS translocation from 
outer to inner leaflet within the endosomal compartment (Xu and Szoka, 1996). During lipoplex/GUV 
interaction, polynucleotides with a length of 66 base pairs were effectively delivered inside the GUV, 
which was enhanced when the GUV contained increasing levels of DOPS and DOPE, by charge 
neutralization of the cationic lipid.  
In this study, the morphological changes of DOPS liposomes and DOTAP/pDNA lipoplexes 
mixture were also monitored after longer incubation time of 1 hour. Subsequent events generally led to 
changes in vesicle membrane integrity (Fig. 4.5) were observed. Lipid tubular like forms was also 
found to observe, as indicated by arrows (Fig. 4.5 B and Fig. 4.5 C).  
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Figure 4.3: Cryo-TEM micrograph of pure negatively charged DOPS/DOPE/DOPC 
(1:1:2). Liposomes were visualized by cryo-EM before addition to lipoplexes. Bar is 500 nm. 
Figure 4.4: Cryo-TEM micrographs of mixed DOTAP/pDNA lipoplexes after interaction with 
DOPS containing liposomes. Interactions between DOTAP/pDNA lipoplexes and anionic 
liposomes were visualized by cryo-EM immediately after mixing. Anionic vesicles adhesion was 
induced by electrostatic attraction forces. The mixed DOTAP lipoplexes/DOPS containing 
liposomes were investigated by cryo-EM as described in the Materials and Methods section 2.2.12. 
Bars are 500 nm.  
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After longer contact, we have observed some vesicles deformation. These morphological changes 
could be due to the increase in the vesicle membrane tension as previously described (Evans and 
Parsegian, 1983; Parsegian and Rand, 1983).  
Seifert and Lipowsky (1990) also observed that strong adhesive forces between vesicles leads to 
surface deformation as a consequence of increased edge stress. We suppose that the edge stress 
eventually induces rupture of the adsorbed vesicles presumably leading to complete pDNA release 
with simultaneous transformation of vesicle bilayer into planar lipid bilayer and/or neutralized ion pair 
of DOTAP/DOPS bilayers. This indicates a lipoplex disassembly (Fig. 4.5).  
Figure 4.5: Cryo-TEM micrographs of mixed DOTAP/pDNA lipoplexes after interaction 
with DOPS containing liposomes. Negatively charged liposomes were visualized by cryo-TEM 
one hour after addition to mixed lipoplexes. The mixed DOTAP lipoplexes/DOPS containing 
liposomes were investigated by cryo-EM as described in the Materials and Methods section 
2.2.12. Bars are 500 nm.  
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In a previous study, using synchrotron small angle x-ray diffraction (SAXD), Caracciolo et al., 
(2006) showed that only lamellar lipoplexes were found to exist when phosphatidylglycerol (DOPG), 
a lamellar bilayer forming lipid, is used to exert pDNA release. In this study, a characteristic structural 
feature of the DOTAP/DOPC/pDNA lipoplexes and DOPG mixture was the extensive swelling of the 
lamellar phase of lipoplexes that accompanied its enrichment with lamellar DOPG. Other studies 
supposed that electrostatic interactions between the cationic lipids of the lipoplex and the anionic 
phospholipids that laterally diffuse within lipoplex result in simultaneous charge neutralization of 
cationic lipids and weakening of the cationic lipid/pDNA interaction(Xu and Szoka 1996; Caracciolo 
et al., 2006).  
 
4.2.1.2. Interaction of Dialysed DOTAP/pDNA Lipoplexes with DOPS Containing Liposomes 
As shown for mixed DOTAP/pDNA lipoplexes, a massive surface expansion of negatively charged 
liposomes upon contact with lipoplexes was a characteristic feature in all cryo-TEM micrographs. The 
vesicle expansion was indicated by an increase of the vesicle diameter immediately after the reaction 
was initiated.  
The strong compaction of pDNA in dialysed lipoplexes observed in cryo-TEM micrographs was 
accompanied by reduction in the zeta potential values, according to PCS measurements. The dialysed 
DOTAP/pDNA lipoplexes showed 18 % reduction in positive zeta potential value at N/P 5 compared 
to mixed DOTAP/pDNA lipoplexes.  
Upon contact of DOPS/DOPE/DOPC liposomes with dialysed DOTAP/pDNA, no thick layer of 
contact compared to mixed DOTAP/pDNA lipoplexes. 
Although a collapse of dialysed lipoplexes was not observed, cryo-TEM micrographs showed 
similarly lamellar structures as observed with mixed lipoplexes (Fig. 4.6).  
In some cyro-TEM fields (Fig. 4.6 A and Fig. 4.6 C), we observed vesicles showing a semifusion 
contact, as indicated by arrows, including only the outer monolayer membranes merging.  
Similar to mixed DOTAP/pDNA lipoplexes after immediate contact with DOPS vesicles, dialysed 
lipoplexes showed similar aggregates after one hour incubation (Fig. 4.7). This could be interpreted by 
the effect of DOPS containing liposomes to partially dissociate DOTAP lipid upon longer contact by 
electrostatic attraction forces. However, after longer incubation, vesicle deformation was not observed 
in case of dialysed DOTAP/pDNA lipoplexes. 
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Figure 4.6:  Cryo-TEM micrographs of dialysed DOTAP/pDNA lipoplexes after interaction 
with DOPS containing liposomes. Anionic liposomes were visualized by cryo-TEM 
immediately after addition to dialysed DOTAP/pDNA lipoplexes. The dialysed DOTAP/pDNA 
lipoplexes/DOPS containing liposomes were investigated by cryo-EM as described in the 
Materials and Methods section 2.2.12. Bars are 200 nm.  
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Figure 4.7: Cryo-TEM micrographs of dialysed DOTAP/pDNA lipoplexes after interaction with 
DOPS containing liposomes Anionic liposomes were visualized by cryo-TEM one hour after addition to 
dialysed DOTAP/pDNA lipoplexes. The dialysed DOTAP/pDNA lipoplexes/DOPS containing liposomes 
were investigated by cryo-EM as described in the Materials and Methods section 2.2.12. Bars are 200 nm.  
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4.2.2. Visualization of DOTAP/ pDNA Lipoplexes upon Interaction with Oleic Acid Containing 
Liposomes 
From our pDNA release data in chapter 3, oleic acid (OA) in combination with DOPE/DOPC 
liposomes was found to be more efficient in terms of the release rate of pDNA from DOTAP/pDNA 
lipoplexes compared to DOPS/DOPE/DOPC liposomes.  
We were particularly interested whether different mesomorphic organizations of the DOTAP/OA 
lipid mixtures might correlate with the pDNA release compared to DOPS containing liposomes 
described above. 
Cryo-TEM study revealed that the structural features of mixed as well as dialysed DOTAP/pDNA 
lipoplexes were accompanied by the appearance of “inverted” non-bilayer lipid structures as fusion 
intermediates when oleic acid was used to exert pDNA release. 
In more detail, as shown in Figure 4.8, cyro-TEM micrographs showed a characteristic of three 
dimensionally organized, striated pattern of lipids which organized in “inverted” non-bilayer phases. 
Previous studies reported that oleic acid undergoes a lamellar to inverted hexagonal phase 
transition (Epand et al., 1991; Tarahovsky et al., 2004). We assume that oleic acid/DOTAP ion pair 
formation is mediated by “inverted” non-bilayer lipid phase separation. 
One hour later, a size increase of the “inverted” non-bilayer phase intermediates was observed only 
in mixed lipoplexes (Fig. 4.9).  
We reasoned that the increase in size of DOTAP/OA lipid intermediates due to excess DOTAP 
lipids disassembled from mixed lipoplexes showed size enlargement of these fusion intermediates in 
presence of excess OA approaching neutrality. 
In line to our observation, Ruthven et al., (2000) showed that the ability to form “inverted” non-
lamellar phases is maximal in mixtures where the mean surface charge of membranes approaches 
neutrality and decreases with the increase in the density of positive or negative charges at the 
membrane surface.  
Vesicle systems that undergo a lamellar to inverted hexagonal Lα-HII phase transition rapidly 
develop so called inverted micellar intermediates (IMI) between the bilayers of the contacted vesicles 
(Figure 4.10). These fusion intermediates are known as lipidic particles (Verkleij et al., 1980; Siegel 
1986 a, b) and can either assemble into vesicles or they may evolve into so called interlamellar 
attachment sites (ILA) formed at the site of the interbilayer contact and this transformation will result 
in mixing of the bilayer lipids. 
The structural organization of dialysed DOTAP lipoplexes was similar to mixed DOTAP 
lipoplexes in presence of oleic acid liposomes. Nevertheless, in case of dialysed lipoplexes, the 
“inverted” non-bilayer phase separation showed smaller size of approx. 200 nm diameters than that 
observed in mixed lipoplexes (Fig. 4.11 A-D).  
Unlike mixed lipoplexes, longer incubation time revealed disappearance of lipidic intermediates in 
case of dialysed lipoplexes (Fig. 4.12 A and Fig. 4.12 B). The transformed intermediate structures 
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found for dialysed lipoplexes (Figure 4.12) suggested complete lipidic particle dissociation into 
vesicles composed presumably of neutralized ion-pair vesicles.  
This process of phase conversion from lamellar to non-lamellar phase, which may include the 
hexagonal HII or HI  as well as the micellar cubic phase, also seems to be  influential in causing 
efficient dissociation of the pDNA from the lipoplex (Zuhorn et al., 2005; Koynova et al., 2005; 
Wasungu et al., 2006;  Ewert et al., 2006).  
The stability of such phases may possibly depend on the nature of the anionic and cationic lipids 
involved (Koynova et al., 2005). This was suggested by revealing a highly stable curved micellar cubic 
phase, induced in lipoplexes consisting of a cationic lipid, upon their interaction with cardiolipin-
containing bilayers. At these conditions, the highest pDNA dissociation was obtained which showed a 
transient formation of the micellar cubic phase.  
A situation can be also obtained in lipid mixtures containing DOPS and phosphatidylethanolamine 
(DOPE), where the presence of Ca2+ can allow the preference of DOPE to form HII phase to express 
(Cullis and Verkleij, 1979; Hope and Cullis, 1979). 
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Figure 4.8: Cryo-TEM micrographs of mixed DOTAP/pDNA lipoplexes after interaction 
with oleic acid (OA)/DOPE/DOPC (1:1:2) liposomes. Negatively charged liposomes were 
visualized by cryo-TEM immediately after addition to mixed lipoplexes. The mixed DOTAP 
lipoplexes/OA liposomes were investigated by cryo-EM as described in the Materials and 
Methods section 2.2.12. Bars are 200 nm.  
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Figure 4.9: Cryo-TEM micrographs of mixed DOTAP/pDNA lipoplexes after interaction 
with oleic acid (OA)/DOPE/DOPC (1:1:2) liposomes. Anionic liposomes were visualized by 
cryo-TEM one hour after addition to mixed DOTAP/pDNA lipoplexes. The mixed DOTAP 
lipoplexes/OA liposomes were investigated by cryo-EM as described in the Materials and 
Methods section 2.2.12. Bars are 500 nm.  
Figure 4.10: Membrane-membrane interactions that can occur via inverted micellar intermediate 
(IMI) in lipid vesicle dispersions. When IMI form between two vesicles, the outer monolayers of the 
membranes become continuous, allowing lipid molecules to diffuse back and forth between the two 
vesicles and formation of Intra-lamellar attachment (ILA) as proposed by (Siegel 1986a). 
      (IMI) formation 
Outer monolayer exchange 
      (ILA) formation 
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Figure 4.11: Cryo-TEM micrographs of dialysed DOTAP/pDNA lipoplexes after interaction 
oleic acid (OA)/DOPE/DOPC (1:1:2) liposomes. Anionic liposomes were visualized by cryo-
TEM immediately after addition to dialysed DOTAP/pDNA lipoplexes. The dialysed DOTAP 
lipoplexes/OA liposomes were investigated by cryo-EM as described in the Materials and Methods 
section 2.2.12. Bar is 200 nm.  
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It is observed that fusion between cationic DOTAP/pDNA lipoplexes and oleic acid liposomes is 
stimulated by the preference for “inverted” non-bilayer lipid phase structures. We assume that 
formation of stable “inverted” non-bilayer phase depends on the surface charge neutrality. That means 
excess free cationic lipids are necessary. It should be noted that at a molar charge ratio of N/P 5, 
DOTAP/pDNA lipoplexes showed an optimal pDNA wrapping efficiency as reported elsewhere 
(Madeira et al., 2008). Evidently, at this charge ratio the lipids are in excess over plasmid DNA and, 
consequently, the phase behaviour described with oleic acid might partly reflect a contribution of free 
lipids that are not bound to pDNA in mixed lipoplexes. In contrast to dialysed DOTAP/pDNA 
lipoplexes, these fusion intermediates were rarely found. 
 However, smaller size of the “inverted” non-bilayer fusion intermediates in comparison to that 
formed in mixed DOTAP/pDNA lipoplexes was shown (Fig. 4.11).  
Some evidences have been reported that the anionic lipids that are more efficient in releasing DNA 
adopt non lamellar phases with high interfacial curvature when mixed with lipoplexes, while the 
anionic lipids that are poorly efficient DNA releasers form mostly lamellar phases (Tarahovsky et al., 
2004; Koynova et al., 2006; Wang et al., 2006). As evident, our combined nucleic acid dye 
fluorescence technique and Cryo-TEM results oppose with that opinion. 
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Figure 4.12: Cryo-TEM micrographs of dialysed DOTAP/pDNA lipoplexes after 
interaction oleic acid (OA)/DOPE/DOPC (1:1:2) liposomes. Anionic liposomes were 
visualized by cryo-TEM one hour after addition to dialysed DOTAP/pDNA lipoplexes. The 
dialysed DOTAP lipoplexes/OA liposomes were investigated by cryo-EM as described in the 
Materials and Methods section 2.2.12. Bars are indicated.  
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4.3. Conclusion 
In conclusion, the detergent dialysis technique utilized to prepare lipid-based/pDNA complexes 
showed morphological features which was not observed in case of same mixed lipoplexes. The 
cationic DOTAP strong compaction effect on pDNA was indicated by the cryo-TEM study. 
Cryo-TEM experiments showed that pDNA release from DOTAP/pDNA lipoplexes was mediated 
by lamellar fusion intermediates formation when DOPS was used, while was mediated by a 
lamellar/non-lamellar phase transition in mixtures with oleic acid. However, nucleic acid dye 
fluorescence technique showed that such different phase behaviour did not result in diverse pDNA 
release efficiency; only the rate of release might be enhanced. 
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Abstract 
Our previous study showed that the non-ionic detergent N-octyl-beta-D-glucopyranosid (OGP) 
dialysis technique utilized to prepare lipoplexes showed neglected pDNA release from DOTAP/pDNA 
and DC-cholesterol/pDNA lipoplexes when treated with different negatively charged liposomes. In 
contrast, the extent of pDNA release from these lipoplexes prepared by mixing technique was found to 
be high. This was accompanied by morphological features, in case of dialysed DOTAP/pDNA 
lipoplexes, different than that observed in mixed DOTAP/pDNA lipoplexes as visualized by cyro-
TEM. These reports were previously described in Chapter 3 and Chapter 4. 
Therefore, we estimated in this study if the pDNA release from these lipoplexes is correlated with 
membrane fusion between lipoplexes and the negatively charged liposomes.  
For efficient transfection plasmid DNA has to be released from the cationic lipids and to be 
translocated into the nucleus. Several investigators have demonstrated that anionic membranes 
promote cationic lipid/pDNA complex dissociation. They postulated that after endocytosis of the 
cationic lipid/DNA complex, anionic lipids can migrate from the endosomal membrane into the 
complex where they displace pDNA from the cationic lipid and promote its release into cytoplasm (Xu 
and Szoka, 1996; Zelphati and Szoka, 1996; Bhattacharya and Mandal, 1998).  
From the literature, it was hypothesised that transfection agents, which are characterized by high 
transfection efficiency, fused more rapidly with endosomal membranes and escape into the cytoplasm. 
One finding supports this explanation that increased transfection efficiencies of cationic lipid mixtures 
correlated well with increased fusion with negatively charged liposomes (Wang and MacDonald, 
2004; Koynova and MacDonald, 2007).  
Other reports suggested that membrane mixing does not necessarily correlate with the extent of 
pDNA release from lipoplexes (Zabner et al., 1995; Friend et al., 1996; Wang et al., 2006).  
To address this issue that high pDNA release is accompanied by membrane fusion between 
lipoplex lipids and negatively charged lipid, the membrane destabilization of lipoplexes as a 
consequence of interaction with negatively charged liposomes was assessed in terms of lipid mixing.  
To estimate membrane fusion, (i) octadecyl-rhodamine OD (R18) de-quenching assay (Hoekstra et 
al., 1984) and (ii) fluorescence resonance energy transfer (FRET) assay (Struck et al., 1981; 
MacDonald et al., 1999) were applied. Two different negatively charged liposomes were used; (i) 
DOPS/DOPE/DOPC (1:1:2) liposomes and (ii) oleic acid (OA)/DOPE/DOPC (1:1:2). The increase in 
the fluorescence of the self quenched fluorophore OD (R18) or of the donor NBD-PE fluorophore thus 
observed is taken as a measure of fusion.  
 
I. Octadecyl-rhodamine OD (R18) De-Quenching Assay 
OD (R 18) labelled lipoplexes with 5 mol % with respect to the total lipid content were prepared by 
both mixing and non-ionic detergent N-octyl-beta-D-glucopyranosid (OGP) dialysis techniques. At 
this sufficiently high concentration (5 mol %), a self-quenching of OD (R 18) fluorescence occurs. 
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Once inserted into the lipid membrane, the fluorescent dye does not dissociate from the membranes by 
either spontaneous transfer of the free monomer into the aqueous phase or by collional transfer 
(Hoekstra et al., 1984). Fusion of labelled lipoplexes with anionic liposomes membranes will results in 
dilution of the probe and concomitant relief of the self-quenching as depicted in Figure 5.1 A.  
 
II. Fluorescence Resonance Energy Transfer (FRET) Assay 
In FRET, the emission band of the energy donor fluorophore (NBD-PE) overlaps with the 
excitation band of the energy acceptor fluorophore (Rh-PE). The excited energy state of the donor 
generated by an absorbed photon is transferred non-radiatively to the acceptor, which in turn starts to 
fluoresce. The overlap of the emission spectrum of the donor and the absorption spectrum of the 
acceptor, as well as the inverse sixth power of the distance between the two fluorophores, determine 
the rate and efficiency of energy transfer. The assay depends on the dilution of a donor-acceptor pair 
from ‘‘labelled’’ liposomes to ‘‘unlabelled’’ liposomes as a result of lipid mixing during membrane 
fusion (Fig. 5.1 B). The efficiency of energy transfer is then decreased. 
Briefly, two fluorescent lipids 0.5 mol % each were incorporated into the cationic lipoplexes, N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)-phosphatidylethanolamine (NBD-PE) and rhodamine phosphatidyl-
ethanolamine (Rhd-PE). At optimal energy transfer, the emission of the donor (NBD-PE) at λem 535 
nm was strongly suppressed when the excitation wavelength was λex 470 nm at 25 °C, which 
corresponds to NBD-PE absorption (Struck et al., 1981). Fusion of labelled lipoplexes with unlabelled 
negatively charged liposomes was indicated by an increase in NBD-PE fluorescence because probe 
dilution and fluorophore separation, and hence, reduced energy transfer efficiency is observed. 
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Figure 5.1: Lipid mixing techniques used to estimate membrane fusion. Octadecyl rhodamine (R18) 
(A) and FRET (B) assays are demonstrated. 
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5.1. Vesicle-Vesicle Interaction: I. Octadecyl rhodamine OD (R18) De-quenching Dilution 
Membrane Mixing Assay 
5.1.1. DOTAP/pDNA Lipoplexes  
Fig. 5.2 shows the lipid mixing of OD (R18) labelled DOTAP/pDNA lipoplexes after addition of 
different negatively charged liposomes.  
The lipid mixing showed 61.82  ± 2.68 % (dialysed) and 59.59 ± 2.75 % (mixed) at R = 2. At R = 
4, the lipid mixing increased to 73 ± 1 % (dialysed) and 71 ± 0 % (mixed). Dialysed DOTAP/pDNA 
lipoplexes showed OD (R18) de-quenching and hence virtually showed the same extent of the lipid 
mixing as observed in case of mixed DOTAP/pDNA lipoplexes when DOPS/DOPE/DOPC liposomes 
were used (Fig.5.2 A).  
According to pDNA release experiments, dialysed technique generally produced tightly bound 
cationic lipid/pDNA lipoplexes, as previously shown, compared to mixed lipoplexes. Unexpectedly, 
dialysed DOTAP/pDNA lipoplexes exhibited an increase in lipid mixing upon addition of 
DOPS/DOPE/DOPC liposomes regardless to the extent of pDNA release.  
In correspondence to membrane fusion assessed by OD (R18) de-quenching assay, the pDNA 
release from dialysed DOTAP/pDNA lipoplexes by negatively charged lipid DOPS was not correlated 
with pDNA release from the same mixed lipoplexes.  
In cryo-TEM studies we observed that dialysed DOTAP/pDNA lipoplexes and DOPS liposomes 
showed vesicle aggregation. We assume that, the aggregation might be accompanied by OD (R18) 
fluorophore dilution. However, the probe dilution between the outer monolayers could also be possible 
indicating that the probe exchange is sensitive to aggregation.  
Conclusively, OD (R18) assay did not indicate full fusion between DOPS/DOPE/DOPC liposomes 
and dialysed DOTAP/pDNA lipoplexes the condition which is necessary for lipoplex disassembly.  
The lack of correlation between lipid mixing and pDNA release from dialysed DOTAP/pDNA 
lipoplexes may be attributed to the fact that membrane contact between lipoplexes and anionic 
membranes is not the absolute limiting step in pDNA release. This is also in the line with Zabner et al., 
(1995), Friend et al., (1996) and Wang et al., (2006) who suggested that membrane mixing does not 
necessarily correlate with the extent of DNA release from lipoplexes. Our observations may also be 
accompanied only by the outer monolayers of the aggregated vesicles showing a semifusion process 
which could also be detected by probe dilution assay. 
As shown here, membrane fusion between DOPS/DOPE/DOPC liposomes and dialysed 
DOTAP/pDNA lipoplexes was as the same extent as mixed DOTAP lipoplexes, although evidently 
was not related to pDNA released in these systems. 
To further confirm the phase dependent destabilization properties of DOTAP/pDNA lipoplexes as 
detected by cryo-TEM using OA/DOPE/DOPC liposomes, we next investigated the effect of 
mesomorphic phase formation on DOTAP/pDNA lipoplex disassembly in terms of lipid mixing. 
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We examined the interaction between the DOTAP lipoplexes and OA/DOPE/DOPC (1:1:2) 
liposomes. As shown in Fig. 5.2 B, when OA containing liposomes were incubated with 
DOTAP/pDNA lipoplexes at R = 2 and 4, an extensive lipid mixing for both dialysed and mixed 
DOTAP/pDNA lipoplexes was also observed. The lipid mixing showed 53.6 ± 0.34 % (dialysed) and 
61.77 ± 0.96 % (mixed) at R = 2 as reflected by almost instantaneous increase in OD (R18) 
fluorescence. R = 4 resulted in similar lipid mixing for both lipoplexes as observed for R = 2. For 
DOTAP/pDNA lipoplexes treated with DOPS containing liposomes, lipid mixing was anionic/cationic 
ratio dependent. This was observed, as shown in Figure 5.2 A, by higher lipid mixing when R 
increased from 2 to 4 than that observed with oleic acid containing liposomes.  
 
5.1.2. DC-cholesterol/pDNA Lipoplexes  
The membrane mixing observed in case of mixed DC-cholesterol/pDNA lipoplexes was different 
from dialysed lipoplexes and correlated well with the pDNA release data. Mixed DC-
cholesterol/pDNA lipoplexes showed a marked increase in the probe dilution and a higher de-
quenching effect compared to dialysed lipoplexes. Dialysed DC-cholesterol/pDNA lipoplexes showed 
slower and lesser degree of lipid mixing (Fig. 5.3). At R = 2, DC-cholesterol/pDNA lipoplexes 
exhibited 12.85 ± 1.23 % (dialysed) and 48.4 ± 1.45 % (mixed) lipid mixing when DOPS containing 
liposomes were used. A marked increase in lipid mixing was observed when R increased from 2 to 4 
showing 19.5 ± 2.95 % (dialysed) and 58.66 ± 2.2 % (mixed) as shown in Figure 5.3 A. These data are 
consistent with pDNA accessibility measured by PicoGreen® fluorescence assay when the same 
lipoplexes were treated with DOPS containing liposomes.  
The effect of oleic acid, an inverted non bilayer forming lipid, on the DC-cholesterol/pDNA 
lipoplexes is illustrated in Figure 5.3 B. Lipid mixing was found to be particularly prominent in case 
of mixed DC-cholesterol/pDNA lipoplex rather than for the dialysed lipoplexes. 
The observed extent of lipid mixing was 9.1 ± 0.85 % (dialysed) and 46.8 ±1.64 % (mixed) at R= 
2, and 12.1± 3.9 % (dialysed) and 41.15 ± 1.71 % (mixed) at R=4. In contrast to pDNA release data, 
the extent of lipid mixing after addition of oleic acid liposomes to DC-cholesterol/pDNA lipoplexes 
was found to be comparable to DOPS/DOPE/DOPC (1:1:2) liposomes.  
In conclusion, although the aggregation was accompanied by probe dilution, the chosen conditions 
were in a range where the DOPS containing liposomes were still not able to destroy the dialysed 
lipoplexes and induce pDNA release as a consequence.  
Taken together, these findings led to the hypothesis that there may be an influence of the detergent 
substitution technique on the produced lipoplexes. This effect is presumably due to the tight 
compaction of pDNA in lipoplexes. This could well correlated with low in-vitro transfection 
efficiency reported else where (Guo et al., 2000; Xu et al., 2001; Heyes et al., 2007). 
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Figure 5.2: Time-dependent effect on lipid mixing between OD (R18) labelled DOTAP/pDNA 
lipoplexes and negatively charged DOPS/DOPE/DOPC (1:1:2) (A); OA/DOPE/DOPC (1:1:2) (B) 
liposomes. DOTAP/pDNA lipoplexes prepared at N/P 5 were treated with anionic lipid at R=2 (dialysed 
(●); mixed (○)) and R=4 (mixed (●) and mixed (○)). Lipid mixing was deduced by OD (R18) de-quenching. 
Fluorescence intensity was monitored as a function of time with an excitation wavelength λex 544 nm and an 
emission wavelength λem590 nm, at pH 7.4. The percentage of membrane fusion was calculated according to 
∆Ft /FOGP = (Ft- F0)/FOGP as described in the Materials and Methods section 2.2.11.1. Data were shown as 
mean +/- standard deviation of three independent experiments.  
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5.2. Vesicle-Vesicle Interaction: II. FRET Membrane Lipid Mixing Assay 
5.2.1. DOTAP/pDNA Lipoplexes  
Although the extent of pDNA release from dialysed lipoplexes was low, our previous lipid mixing 
studies  using OD (R 18) showed a marked lipid mixing extent in dialysed DOTAP/pDNA lipoplexes 
equal to mixed DOTAP/pDNA lipoplexes when negatively charged DOPS containing liposomes were 
used. 
To investigate the lipid mixing characteristics of DOTAP/pDNA lipoplexes in terms of energy 
transfer efficiency, we performed probe dilution FRET assay to assess  the membrane fusion of 
labelled lipoplexes when different negatively charged liposome were applied.  
 Fusion between NBD-PE/Rhd-PE- labelled lipoplexes with unlabelled negatively charged 
liposomes gave rise to a decrease in the surface density of the probes and consequently a relief of 
donor quenching occurred. In Figure 5.4 and Figure 5.5, a series of experiments with the FRET pair 
NBD-PE and Rhd-PE labelled lipoplexes at N/P ratio 5 is shown. For each lipoplex, the FRET 
efficiency decrease as the acceptor concentration decreases, however with various extents.  
The experimental results illustrate the overall decrease in FRET efficiency at R = 2. Figure 5.4 A 
shows extensive FRET efficiency reduction, E = 1- IDA/ID, for NBD-PE/Rhd-PE pairs among 
DOTAP/pDNA lipoplexes when treated with DOPS/DOPE/DOPC (1:1:2) liposomes. The initial 
values of energy transfer efficiency (E○) were 21 ± 0.01 % and 18.5 ± 0.01 % for dialysed and mixed 
Figure 5.3: Time-dependent effect on lipid mixing between OD (R18) labelled DC-cholesterol/pDNA 
lipoplexes, and negatively DOPS/DOPE/DOPC (1:1:2) (A) as well as OA/DOPE/DOPC (1:1:2) (B) 
liposomes. DC-cholesterol/pDNA lipoplexes prepared at N/P 5 treated with anionic lipid at R=2 (dialysed (●); 
mixed (○)) and R=4 (mixed (●) and mixed (○)). Lipid mixing was deduced by OD (R18) de-quenching. 
Fluorescence intensity was monitored as a function of time with an excitation wavelength λex 544 nm and an 
emission wavelength λem590 nm, at pH 7.4. The percentage of membrane fusion was calculated according to 
∆Ft /FOGP = (Ft- F0)/FOGP as described in the Materials and Methods section 2.2.11.1. Data were shown as 
mean +/- standard deviation of three independent experiments.  
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DOTAP/pDNA lipoplexes, respectively, and therefore in a comparable range. This low (E○) values in 
DOTAP/pDNA lipoplexes suggest an instant interaction between DOTAP/pDNA lipoplexes and 
DOPS/DOPE/DOPC (1:1:2) liposomes as observed in OD (R18) lipid mixing assay. This is in the line 
with cyro-TEM observations where vesicles aggregations were involved.  
The release of pDNA and lipid structural reorganisation shown in DOTAP/pDNA lipoplexes, 
treated with OA/DOPE/DOPC (1:1:2) liposomes, are interpreted as energy transfer efficiency (Fig. 5.4 
B). The initial values of energy transfer efficiencies (E○) for oleic acid containing liposomes were 
comparable for the mixed and dialysed DOTAP/pDNA lipoplexes. An initial energy transfer 
efficiency of approx. 29% for both dialysed and mixed DOTAP lipoplexes could be observed and the 
extent of energy transfer efficiencies become distinguished over time showing 11.68 ± 0.01 % for 
mixed and complete loss of energy transfer efficiency for dialysed lipoplexes (Figure 5.4 B).  
In contrast to DOPS, the oleic acid  effect on the DOTAP/pDNA lipoplexes was distinguished 
showed different values by means of initial and extent of energy transfer efficiency (Fig 5.4 A and B). 
 
5.2.2. DC-cholesterol/pDNA Lipoplexes  
The energy transfer efficiency data of DC-cholesterol/pDNA lipoplexes revealed a correlation 
between the extent of membrane fusion of lipoplexes and pDNA release that was induced by 
negatively charged liposomes. 
As shown in Figure 5.5 A, the initial stability of both DC-cholesterol/pDNA lipoplexes in presence 
of DOPS/DOPE/DOPC liposomes was high compared to DOTAP/pDNA lipoplexes 89 ± 0.01 % 
(dialysed) and 84 ± 0.01 % (mixed) energy transfer efficiency. After incubation with 
DOPS/DOPE/DOPC liposomes, a decrease in energy transfer efficiency was observed over time 
showing 70.4 ± 0.01 % for dialysed lipoplexes whereas mixed lipoplexes showed only 50 ± 0.01 % 
energy transfer efficacy (Fig 5.5 A). 
Although the pDNA release from DC-cholesterol/pDNA lipoplexes by oleic acid was more 
efficient than that observed using DOPS/DOPE/DOPC liposomes, the initial values of energy transfer 
efficiency (E○) of these lipoplexes in presence of OA showed higher stability to disassemble.  From 
the figure 5.5 B, energy transfer efficiencies of 76 ± 0.02 % (dialysed) and 60.5 ± 0.01 % (mixed) 
were obtained after incubation with OA/DOPE/DOPC (1:1:2) liposomes. The lipid reorganization 
during lipoplex dissociation might affect the redistribution of the fluorescent probes keeping the 
energy transfer efficiency maintained although their ability to exert pDNA release is still efficient. 
Lipoplex stability in terms of lipid mixing and disassembly, due to the effect of anionic lipids, was 
observed for DC-cholesterol/pDNA lipoplexes than DOTAP/pDNA lipoplexes. This could be 
observed in the initial (E○) efficiencies between the probes. These values decreased overtime showing 
a maximum probe dilution only in case of DOTAP/pDNA lipoplexes where no FRET was found to 
occur (Fig. 5.4).  
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In contrast, DC-cholesterol/pDNA lipoplexes showed high initial (E○) indicating higher stability to 
disassemble by the effect of negatively charged liposomes (Fig. 5.5).  
FRET assay was used previously to assess the stability of pegylated antisense phosphodiester 
oligonucleotides (ONs) lipoplexes in presence of DNase I (Remaut et al., 2005) and also the 
condensed state of pDNA in lipoplexes in presence of serum (Itaka et al., 2002).  
Recent studies showed that DOTAP/DOPC lipoplexes are very unstable against disintegration by 
cellular lipids and rapidly release DNA (Caracciolo et al., 2007a; Caracciolo et al., 2007b; Caracciolo 
and Caminiti, 2009). This binary DOTAP/DOPC lipoplexes showed almost no cytoplasmic plasmid 
DNA released. When DC-cholesterol was added to this binary complex, lipoplexes were mainly 
distributed throughout the cytoplasm and to some extent at the cell periphery (Caracciolo and 
Caminiti, 2009). This reflects a higher stability of DC-cholesterol containing lipoplexes. 
A similar observation reported by Berezhna et al., (2005) who visualized the interaction between 
DOTAP lipoplex and giant uni-lamellar vesicles (GUVs) composed of DOPS/DOPE/DOPC using 
laser scanning imaging. They found aggregations at the surface of the GUV, but no rupture of the 
vesicles was detected. Importantly, this aggregation might be indicative of lipid translocation to the 
outer leaflet of the bilayer as supposed by Kahya et al., (1996).  
Our observations may also be attributed to the mixing of lipids located only in the outer 
monolayers of the aggregated DOTAP/DOPS vesicles (semifusion) showing probe dilution in both 
OD (R18) and FRET assays.  
Previous work showed that lipid mixing does not have to impair bilayer integrity. It could be a lipid 
exchange at points of close contact that the vesicles could then dissociate (Düzgünes et al., 1987). 
However, it is also possible to interpret the results in terms of structural changes in the bilayer 
affecting both the aggregation and fusion steps (Wilschut et al., 1985). 
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Figure 5.5: Time-dependent effect on energy transfer efficiency (E) between NBD-PE/Rhd-PE labelled 
DC-cholesterol/pDNA lipoplexes, and negatively DOPS/DOPE/DOPC (1:1:2) (A); OA/DOPE/DOPC 
(1:1:2) (B) liposomes. DC-cholesterol/pDNA lipoplexes prepared at N/P 5 were treated with anionic lipid at 
R=2 (dialysed (▲); mixed (∆)). FRET was deduced by NBD-PE de-quenching. Fluorescence intensity was 
monitored as a function of time with an excitation wavelength λex 470 nm and an emission wavelength λem535 
nm at 25°C. The Energy transfer efficiency was calculated according to E =1- [FDA / FD] as described in the 
Materials and Methods section 2.2.11.2. Data were shown as mean +/- standard deviation of three independent 
experiments.  
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Figure 5.4: Time-dependent effect on energy transfer efficiency (E) between NBD-PE/Rhd-PE labelled 
DOTAP/pDNA lipoplexes, and negatively DOPS/DOPE/DOPC (1:1:2) (A) as well as OA/DOPE/DOPC 
(1:1:2) (B) liposomes. DOTAP/pDNA lipoplexes prepared at N/P 5 were treated with anionic lipid at R=2 
(dialysed (●); mixed (○)). FRET was detected by NBD-PE de-quenching. Fluorescence intensity was monitored 
as a function of time with an excitation wavelength λex 470 nm and an emission wavelength λem535 nm at 25°C. 
The energy transfer efficiency was calculated according to E =1- [FDA / FD] as described in the Materials and 
Methods section 2.2.11.2. Data were shown as mean +/- standard deviation of three independent experiments.  
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5.3 Conclusion 
In conclusion, octadecyl rhodamine B self-quenching as well as FRET were used to study the 
dissociation of lipoplexes by negatively charged liposomes in terms of membrane fusion with 
lipoplexes. It turned out that membrane fusion study using octadecyl rhodamine B de-quenching assay 
gave data which were comparable to data from the FRET assay.  
General observations in our experiments with DOTAP/pDNA lipoplexes were the following: (i) no 
correlation observed between dialysed lipoplexes pDNA release and lipid mixing with different 
negatively charged liposomes. This was indicated by virtual membrane fusion compared to mixed 
DOTAP/pDNA lipoplexes using both OD (R18) and FRET; (ii) the apparent high lipid mixing could 
be presumably due to probe dilution among the outer monolayers of the aggregated vesicles as 
indicated by the cryo-TEM studies and (iii) DOTAP/pDNA lipoplexes showed considerably low 
energy transfer efficiencies immediately upon mixing with anionic lipids the condition indicates lower 
lipoplexes stability and higher disassembly.   
DC-cholesterol/pDNA lipoplexes showed a well correlation between the membrane fusion with 
negatively charged liposomes and pDNA released as observed by both techniques. 
The differences between the PicoGreen® and the fusion assays may be related to the fact that the 
probe dilution fluorescence assays do not directly relate to pDNA release behaviour as shown in the 
pDNA release section.  
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CHAPTER 6 
 
Characterization of Polyethylenimine/pDNA 
Polyplexes Prepared by Detergent Dialysis 
Technique 
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  Abstract 
Complexes of plasmid DNA (pDNA) and the 25 kDa branched polycationic polymer 
polyethylenimine (PEI) are usually prepared by simple mixing of both components, leading to 
complex formation based on electrostatic interactions. In the present study, polyplexes were formed by 
an alternative technique complexing pDNA and PEI in the presence of the non-ionic detergent N-
octyl-beta-D-glucopyranosid (OGP) at different N/P ratios followed by dialysis. The mixed and 
dialysed polyplexes were characterized by laser light scattering to determine the influence of OGP on 
the hydrodynamic diameter and the zeta potential of the particles. Furthermore, using the PicoGreen® 
assay the status of pDNA condensation was determined. Gene expression of the polyplexes was 
characterized in HEK 293 cells using flow cytometry analysis. 
The preparation technique influenced the hydrodynamic diameter, zeta potential as well as de-
condensation of pDNA from the polyplexes dependent on the OGP concentration used. The 
preparation technique influenced physicochemical as well as biological results. With increasing OGP 
concentration zeta potential of the dialysed complexes decreased. This effect was correlated with an 
increase in polyplex size suggesting a tendency of the dialysed particles to aggregate. Dialysed 
polyplexes were characterized by a stronger condensation of pDNA compared to mixed PEI 
polyplexes. Corresponding to the physicochemical characteristics, the dialysed polyplexes showed 
lower expression of green fluorescent protein in HEK 293 cells compared to the mixed polyplexes.  
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6.1. Size and Zeta Potential of Polyplexes 
Hydrodynamic diameter and zeta potential of mixed and dialysed polyplexes were determined by 
photon correlation spectroscopy and laser Doppler anemometry, respectively. For these measurements, 
mixed polyplexes of 25 kDa branched polyethylenimine were prepared with plasmid DNA at different 
N/P ratios in 10 mM Tris buffer solution at pH 7.4 by simple mixing of both components leading to 
complex formation based on electrostatic interactions. Additionally, dialyzed polyplexes were formed 
by an alternative technique complexing pDNA and PEI in the presence of the non-ionic detergent 
OGP followed by dialysis. OGP concentrations were varied from 50 to 200 mM as detailed in the 
figures. All chosen concentrations were higher than the critical micellar concentration (CMC) of OGP. 
All polyplexes were freshly prepared before experiments at two different N/P ratios 5 and 10. These 
ratios were chosen based on previously published experiments with mixed polyplexes made of 25 kDa 
branched PEI (Fischer et al., 1999) leading to condensed, stable and highly effective polyplexes. For 
details of preparation see chapter 2 Materials and Methods section 2.2.3.  
Size and zeta potential of polyplexes were found to be dependent on (i) preparation technique of 
polyplexes, (ii) N/P ratio, and (iii) OGP concentration used for polyplex preparation. 
More specifically, the PEI/pDNA polyplexes formed by the mixing technique (0 mM OGP) 
showed comparable hydrodynamic diameters of 111 ± 7.3 nm and 161.7 ±12.7 nm at N/P 5 and 10, 
respectively (Figure 6.1). This is in accordance to the literature where sizes in the range of <200 nm 
were reported by several authors for PEI polyplexes produced under the same conditions (Kircheis et 
al., 2001; Kunath et al., 2003).  
Formation of polyplexes in the presence of 50 mM OGP resulted in a slight increase in size to 
about 203.67 ± 3.69 nm and 190.5 ± 22.29 nm at N/P 5 and 10, respectively, compared to mixed 
polyplexes without any major difference between N/P 5 and 10. Higher OGP concentrations yielded 
larger complexes with a small difference between 100 mM OGP (459 ± 58.57 nm) and 200 mM OGP 
(398 ± 27.01 nm) at N/P 5. At N/P 10 particles generated in 100 mM OGP showed sizes comparable 
to lower OGP concentrations (180.4 ± 26.12 nm), whereas at 200 mM OGP a significant increase up 
to 670 nm was observed.  
Additionally, the polydispersity indices (PDI) of the size measurements (Figure 6.1) were 
determined as a marker for particle size distribution. Mixed polyplexes showed a monomodal peak 
profile with narrow size distribution at N/P 5 and 10 demonstrating a homogeneous size distribution. 
At the same nitrogen/phosphate ratios dialysed polyplexes were characterized by a wider size 
distribution often with a bimodal peak profile suggesting aggregation of the particles. The 
polydispersity index increased with increasing OGP concentration. 
Interactions between PEI/pDNA polyplexes and negatively charged cell surfaces are based on 
electrostatic interactions and are therefore dependent on the particle surface charge (Boussif et al., 
1995). The results of the zeta potential analysis for PEI/pDNA polyplexes are depicted in Figure 6.2. 
Mixed polyplexes showed comparably high positive zeta potentials of 31.8 ± 0.64 mV and 34.3 ± 2.48 
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mV at N/P 5 and 10, respectively. The values of these data correspond well to previous publications 
(Boussif et al., 1995; Godbey et al., 1999) reporting zeta potentials in a comparable range of about 30 
mV. 
In contrast, at the same N/P ratios all dialysed polyplexes showed lower zeta potential values than 
the mixed polyplexes (Figure 6.2). Zeta potentials decreased with increasing concentration of OGP in 
the range from 50 mM to 200 mM. This effect was more pronounced for polyplexes prepared at N/P 5 
than at N/P 10. Lowest zeta potential values were observed for dialysed polyplexes prepared with 100 
mM (4.23 ± 0.71 mV) and 200 mM (7.77 ± 0.77 mV) OGP at N/P 5. For comparison, the zeta 
potential of free pDNA formulated only with OGP and without polymer was determined (Figure 3.8). 
Naked pDNA exhibited a negative charge of -51.4 ± 1.76 mV. Higher OGP concentrations decreased 
the zeta potential up to 
 -20.01 ± 3.31 mV for 200 mM OGP.  
Size and zeta potential of pDNA/polycation complexes are important parameters that should 
control not only hemocomatibility, the deposition and body distribution of polyplexes after their in 
vivo administration, but also their uptake by target cells. Sizes smaller than 150-200 nm and zeta 
potentials in the range from 30-40 mV were found to accomplish cellular interaction and uptake 
through endocytosis (Park et al., 2000). Furthermore, also the velocity of cytoplasmatic movement 
was found to be a function of particle size (Park et al., 2000). Mixed polyplexes of pDNA and 25 kDa 
PEI complexed at N/P 5 and 10 showed physicochemical properties in this desired range. The ability 
of the PEI polymer to sufficiently neutralize the negative charges of pDNA for the formation of an 
adequately compacted structure increased with higher N/P ratios (Erbacher et al., 1999). The influence 
of the N/P ratio on complex size has been described by others (Ogris et al., 1998). In our experiments, 
two different N/P ratios 5 and 10 were used which both were previously shown to produce condensed 
polyplexes with no significant difference in size. 
The detergent dialysis technique was shown to produce pDNA/lipid particles which were highly 
stable compared to those produced by mixing technique (Reimer et al., 1995; Zhang et al., 1997). 
Consequently, in the present study this technique was transferred from lipoplexes to polyplexes of 
pDNA and 25 kDa branched PEI. 
Concluding our laser light scattering experiments of dialysed polyplexes, the increase in 
hydrodynamic diameter correlated well with a decrease in zeta potential suggesting a tendency of the 
dialysed polyplexes to aggregate. This could be based on the lower cationic particle surface charge at 
higher OGP concentrations and therefore, a reduced electrostatic repulsion of the particles.  
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Figure 6.1: Influence of OGP concentration on the hydrodynamic diameter of 
polyplexes at different N/P ratios. The effect of different OGP concentrations (0-200 mM) 
on the hydrodynamic diameter and poly-dispersibility index (PDI) of polyplexes at N/P 5 
(striated bars) and N/P 10 (solid bars) was measured by photon correlation spectroscopy in 
three independent experiments. Results are given as mean +/- standard deviation. 
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Figure 6.2: Effect of OGP concentration (0-200 mM) on the zeta potential of 
polyplexes at different N/P ratios. The zeta potential of polyplexes at two different N/P 
ratios (N/P 5, striated bars and N/P 10, solid bars) was measured by laser Doppler 
anemometry in three independent experiments. Results are shown as mean +/- standard 
deviation. 
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6.2. pDNA Condensation 
The condensation of polyanionic pDNA by the cationic charges of PEI into small particles is an 
important prerequisite for gene delivery (Dunlap et al., 1997). The aim of the pDNA condensation 
experiments was to quantify the condensed or uncondensed status of pDNA in polyplexes prepared by 
detergent dialysis technique relative to polyplexes prepared by the mixing technique. Therefore, 
experiments were performed with 25 kDa branched PEI and plasmid DNA in the presence of the non-
ionic detergent OGP of concentrations in the range from 50-200 mM followed by dialysis at N/P ratios 
5 or 10. It was described that plasmid condensation by 25 kDa branched PEI was completed at N/P 
ratios well above 4 (Kunath et al., 2003; Choosakoonkriang et al., 2003; Kleemann et al., 2004).  
Experiments were performed at different pH (8 and 11.6). At alkaline pH, pDNA has been recently 
reported to be released from PEI polyplexes due to a reduced protonation of PEI compared to the 
physiological pH 7.4 (Moret et al., 2001). To quantify the amount of uncondensed pDNA, the 
fluorescent nucleic acid dye PicoGreen® was used. The fluorescence of PicoGreen® is enhanced upon 
intercalation into pDNA and quenched when displaced by higher affinity compounds. The 
fluorescence emitted upon addition of the dye to polyplexes was measured by fluorescence 
spectroscopy. Results were provided as relative fluorescence intensity where 1 is attributed to the 
fluorescence of PicoGreen® with naked pDNA at that pH. The recovered fluorescence was recorded as 
a function of the N/P ratio and OGP concentration at alkaline pH.  
The intercalation of PicoGreen® into polyplexed pDNA was measured at pH 8 and 11 (Figure 6.3).  
At pH 8, in all cases, fluorescence was lower compared to the values measured at pH 11.6. For 
mixed polyplexes at N/P 5, 18.3 ± 0.81 % fluorescence has been recovered, whereas at the same N/P 
ratio for OGP-based polyplexes the values were in the range from 3.75 ± 0.29 % (200 mM OGP) to 
5.1± 0.12 % (50 mM OGP). Additionally, N/P dependency could be observed since condensation of 
pDNA was more pronounced at N/P 10 than at N/P 5. Higher N/P ratios of 10 resulted in a higher 
reduction of the dye accessibility to plasmids compared to N/P 5 ratios (Figure 6.3 A). 
For mixed polyplexes at N/P 5 and 10 up to 80-85 % PicoGreen® fluorescence could be recovered 
at pH 11.6 (Fig. 6.3 B). This corresponds to results previously published by Moret et al. (2001). 
In contrast, all polyplexes which were formed in the presence of 50-200 mM OGP at N/P 5 and 10 
almost completely suppressed the fluorescence to levels lower than 30 %. The lowest recovered 
fluorescence (3.6 ± 0.5 %) and therefore highest inaccessibility of PicoGreen® to pDNA could be 
achieved using 200 mM OGP for the formation of polyplexes at N/P 10.  
The most prominent feature of PEI is its high cationic charge density. Every third atom of PEI is a 
possibly protonable nitrogen atom, which leads to a very high cationic charge density. Since PEI does 
not contain quaternary amines, cationic charges are generated by protonation of the amine groups by 
the biological environment, thus leading to a correlation between environmental pH and cationic 
charge density. PEI showed a level of protonation at pH 7.4 of 20 % compared to about 45 % at pH 5 
(Suh et al., 1994). The degree of protonation plays a critical role in polyplex formation, since 
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interactions with pDNA are based on electrostatic interactions. Also toxicity and endosomal release 
are a function of pH and buffer capacity. Increasing, in our experiments, the pH from physiological 
values (pH 7.4) where polyplexes were formed, to alkaline pH 8 and 11.6 reduced the protonation of 
PEI and therefore the electrostatic interaction with the negatively charged pDNA. Consequently, the 
pDNA was released from the polyplexes with higher pH and became accessible for the intercalating 
dye PicoGreen®. Since naked pDNA gave comparable results it was suggested that most of the 
plasmid has been released and de-condensed in the case of mixed polyplexes. In contrast, the low 
intercalation of PicoGreen® into pDNA in the presence of OGP suggested a highly condensed state of 
the pDNA in the polyplexes.  
The observed effects could be explained by two different theories: Firstly, as proposed previously 
that the ionic conditions of the surrounding media critically affect the interaction of multivalent 
cations with pDNA. Wilson and Bloomfield (1979) observed that the critical concentration of 
multivalent cations inducing pDNA condensation increases with increasing salt concentration.  
According to the counter-ion condensation theory (Manning, 1978; Taira et al., 2005), about 70 % 
of the negative charge of pDNA is neutralized owing to condensation of the counter-ions in solution. 
The formation of a condensed counter ion layer due to monovalent ions association is depicted in 
Figure 6.4. It is believed that the degree of counter-ion condensation is not sensitive to changes in the 
bulk concentrations of monovalent ions. Thus, a considerable amount of monovalent cations are 
condensed around pDNA.  
The strong compaction of PEI/pDNA in the presence of OGP could be explained as follows based 
on the literature. Detergents are well known destroyer of the water structures (Gregoriadis, 2007).The 
presence of non-ionic detergent OGP was suggested to interfere with the distribution of the rigid 
condensed counter ions around the pDNA as well as the hydration shell altering the spatial water 
structures. This leads to a higher electrostatic attraction of pDNA to the cationic PEI in aqueous 
solution than for mixed PEI/pDNA polyplexes where the presence condensed ions layer should be 
overcome.  
In absence of OGP, it would be according to counter-ion condensation that the wrapping of PEI 
polymer around pDNA may not necessarily neutralize all the pDNA charges but may cause local 
bending the pDNA required to facilitate condensation.  
In accordance with a previous study using fluorescence correlation spectroscopy (FCS) with two-
photon-excitation showing that polyplexes contained on average about 3.5 plasmid DNA and 30 PEI 
(25 kDa) molecules, while a high proportion of polymer (~86 %) remained in its free, unbound form 
(Clamme, 2003). 
The free polymer may play a significant part in cytotoxicity. Nevertheless, an excess of polycation 
is necessary, because the cationic surface charge of polyplexes mediates the interaction with the 
negatively charged cell membrane (Labat-Moleur et al., 1996) 
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According to our zeta potential measurements, the effect of OGP could also be observed on the 
zeta potential values of pDNA. The zeta potential measurements reflects that the decline of negative 
zeta potential values of pDNA in presence of OGP as consequence of electric layer disturbance 
(Figure 3.8). In addition, the effect on the zeta potential values was OGP concentration dependent. 
Secondly, the results can also be explained by residual OGP in the polyplexes possibly not fully 
removed during the dialysis step. The OGP concentration in the dialysis medium could not be 
measured due to the high dilution. Therefore, values were lower than the detection limit. Suggesting 
that residual OGP was attached to the pDNA, the lower zeta potential of the pDNA/OGP complex as 
measured in our experiments (Figure 3.8), limit the electrostatic interaction with PEI. Therefore, lower 
amounts of PEI could be interacted with the pDNA and conclusively, the zeta potential of the dialysed 
polyplex is reduced. Furthermore, an attachment of OGP not to the pDNA, but to the surface of the 
final polyplex will generate the same results. 
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Figure 6.3: Comparison of PicoGreen® fluorescence of polyplexes in dependency of 
OGP concentration and N/P ratio at pH 8 (A) and 11.6 (B). Polyplexes prepared in OGP 
containing solutions (0-200 mM) at N/P ratios 5 and 10 were incubated with PicoGreen® for 
5 min at pH 8 and 11.6. Fluorescence was measured by fluorescence spectroscopy at λex 485 
nm and λem 520 nm. Values are given as mean ± standard deviation (n=4). 
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Figure 6.4: Strategies in PEI/pDNA polyplex preparation. The polyplex is prepared by 
mixing technique (A) producing dispersed particles with highly positive zeta potential 
values. An alternative approach, illustrating the non-ionic N-octyl-beta-D-glucopyranosid 
(OGP) detergent dialysis technique. The pDNA is mixed with PEI polymer in the presence 
of (OGP) followed by dialysis (B). Here the cationic polymer PEI should efficiently 
condense DNA into polyplexes upon detergent substitution using dialysis technique. This 
forms aggregated polyplexes characterised by lower zeta potential values and large 
hydrodynamic diameters. 
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6.3. Transfection Efficiency  
The potential of mixed and dialysed polyplexes to introduce exogenous pDNA into eukaryotic cells 
was investigated in transfection experiments with regard to polyplex preparation technique, N/P ratio, 
transfection time and amount of plasmid DNA. HEK 293 cells were cultured in 6-well plates and were 
transfected in-vitro using a plasmid encoding the reporter gene green fluorescent protein (GFP). The 
transfection efficiency was measured by counting the percentage of GFP positive cells using flow 
cytometry. Transfection efficiency is given as percentage of cells expressing GFP. Mixed and dialysed 
polyplexes were applied for 5 h at N/P 5, 10, 15 and 20 using 2 µg and 3 µg pDNA per well. GFP 
expression was quantified after 24 h and 48 h. 
Figure 6.5 A, shows that naked pDNA was not able to transfect the HEK 293 cells effectively. Less 
than 0.05 % GFP positive cells were detected which was comparable to untreated cells. When HEK 
293 cells were treated with mixed polyplexes of different N/P ratios and pDNA amounts (Fig. 6.5 B), 
transfection levels increased up to 47.1 ± 1.8 % GFP positive cells at 3 µg pDNA and N/P 10. At 
higher N/P ratios (15 and 20) a significant decrease in transfection efficiency could be observed 
independent on the amount of pDNA added most likely due to cytotoxic effects of PEI. Phase contrast 
microscopy revealed changes in the cells morphology. This observation corresponds to the report of 
Fischer et al., (1999). A high cytotoxicity was observed caused by the high affinity of the polymer to 
bind the outer surface of the plasma membrane. This was detected using transmission electron 
microscope by huge clusters of the PEI polymer depending on the size, structure and molecular weight 
of the polymer. These cluster considered as the main cause of cell necrosis seen after 30 min 
incubation. 
Using dialysed polyplexes the transfection efficiency increased with higher N/P ratios and amount 
of pDNA as described before for the mixed polyplexes. Treatment of cells with dialysed polyplexes 
(Fig 6.5 A) demonstrated the highest number of GFP positive cells (3.2 ±0.07 % and 3.9 ± 0.38 %) at 
N/P 10 and N/P 20 respectively when 3 µg pDNA was applied. This effect needs further investigation. 
For all dialysed polyplexes the levels of GFP expression were significantly lower than for mixed 
polyplexes. But all values were higher than for naked pDNA. An increase in transfection time from 24 
h to 48 h did not change the transfection rate for N/P 5 polyplexes (Figure 6.6). However, longer 
transfection times resulted in higher transfection rates for polyplexes at N/P 10.  
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Figure 6.5: Green fluorescence protein (GFP) gene expression of HEK 293 cells 
after treatment with dialysed (100 mM OGP) (A) and mixed (B) polyplexes at 
different N/P ratios from 5 to 20. Cells were treated with polyplexes containing 2 and 
3 µg/well pDNA. The green fluorescence protein was quantified by flow cytometry 24 h 
after transfection. Values are shown as mean of six independent experiments. Error bars 
represent standard deviation. 
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Figure 6.6: Time-dependency of GFP gene expression of dialysed polyplexes. Dialysed 
polyplexes were prepared in 100 mM (B) OGP at N/P ratios of 5 and 10 followed by dialysis. 
The green fluorescence protein was assessed by flow cytometry 24 h (solid bars) and 48 h 
(striated bars) after transfection. The experiment was performed using HEK 293 cells which were 
treated with 2 and 3 µg pDNA/well. Values were calculated as mean of six independent 
experiments. Error bars represent standard deviation. 
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6.4. Conclusion 
In conclusion, transfection data correlated well with the physicochemical data of mixed and 
dialysed polyplexes. Mixed polyplexes were found to be very successful in transfecting cells due 
particles sizes smaller than 200 nm and high positive zeta potential which accomplish strong 
electrostatic interactions with and uptake into eukaryotic cells. For the significantly larger sized 
dialysed polyplexes with lower zeta potentials, transfection was found to be reduced presumably due 
to a lower interaction with the negatively charged cell membranes and consequently a lower uptake 
into the cells. An excess of cationic polymer and a positive surface charge of polyplexes is required to 
provoke endosomal membrane damage and release of polyplexes (Bieber et al., 2002; Boeckle et al., 
2004). Other studies showed that poly (ethylene) glycol derivatives masked the cationic surface charge 
of PEI/pDNA polyplexes and apparently interferred with the uptake mechanism (Fella et al., 2008). 
Additionally, the stronger condensation of pDNA and lower release of pDNA from the polyplexes as 
observed in the condensation experiments for dialysed complexes may also contribute to the low 
transfection efficiency.  
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7.1. Conclusive Summery 
 
The potential use of genes as therapeutic agents has attracted attention as a novel approach to the 
treatment of severe diseases. In the case of inherited disorders, the introduction of a normal copy of the 
affected gene can be effective, as in the well known case of gene therapy for severe combined immune 
deficiency due to adenosine deaminase (ADA) deficiency, in which the normal gene for ADA is used to 
treat the affected patient. For the treatment of acquired disorders, such as cancer and infectious diseases, 
effective potential strategies involve not only the introduction of a therapeutic gene, such as the gene for a 
cytokine or an antigen, but also the silencing of the expression of an abnormal gene, whose expression is 
enhanced in the tissue of the diseased part. Down-regulation of a gene can be achieved by the transfer of 
short antisense oligonucleotides (ODNs) into cells or by intracellular delivery of the more recently 
developed small interfering RNA (siRNA). In addition, a gene can be expressed by translocating plasmid 
DNA into cells containing the sequence for a gene of interest under the influence of a promotor. 
Non-viral vectors that comprise cationic lipids and cationic polymers have been found to be safer, easier 
to prepare and readily chemically modified than viral carriers. The efficiency of these vectors, however, is 
lower than that of viral vectors and has until now precluded their extensive use for in-vivo therapeutic 
applications. Therefore a better understanding of the parameters that govern transfection efficiency of 
non-viral vectors as well as the investigation of design and preparation technique of the non-viral carriers 
will be crucial for their development for in-vivo applications. 
Self-association between pDNA and complexing agents is accomplished in solution by direct mixing of 
both components. This approach relies on kinetic control to permit small particles that consist of cationic 
lipids or polymer and pDNA. In the direct mixing approach, kinetic control is achieved by adjusting the 
concentration, charge ratio, ionic strength of the solution and rate of mixing of both components. In more 
sophisticated method, the components are kept from aggregation using the non-ionic detergent N-octyl-
beta-D-glucopyranosid (OGP) to disrupt the bilayer structure and to form mixed micelles. This reduces or 
eliminates the multivalent interaction between the cationic lipid and the pDNA. The detergent is removed 
by dialysis and as the concentration of the detergent/solvent decreases the cationic lipid self-assembles 
with the pDNA into lipoplexes.  
The detergent dialysis method was initially used for preparing relatively stable cationic lipid/DNA 
lipoplexes by dissolving pDNA and cationic lipid mixture in a detergent solution, which is followed by a 
successive dialysis process to remove the detergent. The resulting particles did not show higher in-vitro 
transfection activity than the mixed lipoplexes, however, they have shown potency to fully protect pDNA 
following incubation with Escherichia coli DNase I (Wheeler et al., 1999; Monck et al., 2000; Tam et al., 
2000; Judge et al., 2006). However, so far the physicochemical characteristics of these non-viral carriers 
and the factors which influence the preparation by detergent octylglucoside dialysis are rarely addressed. 
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The present study describes the preparation and characterisation of gene carriers prepared by detergent N-
octyl-beta-D-glucopyranosid (OGP) dialysis technique compared to mixed carriers. For the evaluation of 
these non-viral carriers we performed different approaches:  
1. Study of physicochemical characteristics of lipid-based/pDNA complexes prepared by 
detergent OGP dialysis in terms of hydrodynamic diameter, zeta potential values compared to 
lipoplexes prepared by mixing technique (Chapter 3).  
2. In the second part of this chapter, we have estimated the condensation state of pDNA in 
dialysed lipoplexes by means of pDNA release using PicoGreen® assay as a marker for 
nucleic acid. Different anionic liposomes were applied to initiate pDNA release from dialysed 
lipoplexes compared to lipoplexes prepared by mixing technique (Chapter 3). The effect of 
acidic pH on the pDNA release from different lipoplexes by anionic lipids has been also 
estimated. 
3. The effect of detergent OGP dialysis on the morphological features of the dialysed 
DOTAP/pDNA lipoplexes was visualized using cryo-TEM. Mechanisms involved in the 
pDNA release from DOTAP/pDNA lipoplexes by DOPS/DOPE/DOPC (1:1:2) and 
OA/DOPE/DOPC (1:1:2) liposomes were visualized (Chapter 4).  
4. Lipid mixing estimation techniques were used to assess the disassembly of the lipoplexes by 
different negatively charged liposomes (Chapter 5). 
5. The detergent OGP dialysis technique was also utilized for preparation of polymer based-
pDNA complexes. Polyplexes consisting of branched 25 kDa polyethylenimine polymer 
(PEI) and pDNA (Chapter 6) were characterized regarding their physicochemical as well as 
biological activities.  
We exploit the principle of detergent dialysis approach to emphasize the importance of the structural 
properties of the pDNA complexes based on the physicochemical characteristics, the morphological 
features, and the differences compared to lipid mixing differences. The potential role of the non-ionic 
detergent OGP was discussed.  
In Chapter 3, the OGP-based dialysis technique was used as an alternative method to prepare pDNA 
lipoplexes. Instead of direct mixing of cationic lipid and pDNA, dialysed lipoplexes were formed in the 
presence of non-ionic detergent OGP followed by dialysis to substitute the detergent. Two types of 
cationic lipid were used to prepare the lipoplexes: DOTAP, a quaternary amine containing lipid and DC-
cholesterol, a tertiary amine containing lipid. The cationic lipid and pDNA were mixed in two different 
N/P ratios of 4 and 5 based on previous reports.  
Laser light scattering technique revealed that the preparation technique influenced the hydrodynamic 
diameter and the zeta potentials of the lipoplexes. For dialysed DOTAP/pDNA lipoplexes, the 
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hydrodynamic diameter was characterised by larger sizes presumably due to a tendency of aggregation 
compared to mixed lipoplexes independent from the N/P ratio. For DC-cholesterol/pDNA lipoplexes the 
size was not dependent on preparation technique and the N/P mixing ratios. The structural differences 
between amine head groups of DOTAP (quaternary amine group) and DC-cholesterol (tertiary amine 
group) may play a role in the assembly of lipoplexes. Nevertheless, the mean size of dialysed lipoplexes 
exceeded by far the size limit for successful endocytosis in most cells. 
Concomitantly with the size increase, the detergent dialysis technique produced lipoplexes showing a 
reduction in the zeta potential compared to mixed lipoplexes. This was observed for both DOTAP and 
DC-cholesterol based lipoplexes. Zeta potentials have a potential impact in stabilizing the colloidal 
properties of the lipid systems. In addition, it is well known that the endocytic uptake of lipoplexes into 
cells is based on the interaction of the positive charge of lipoplexes and the negatively charged cell 
membrane (Liang and Chou, 2009).  
Additionally, the effect of detergent dialysis technique on pDNA compaction in the lipoplexes was 
investigated. Disassembly of the lipoplexes must occur before mRNA transcription can proceed. 
According to that concept, pDNA release should be added to the list of barriers to non-viral gene delivery. 
DOPS, a major anionic component of endosomal membrane, and oleic acid, a minor cellular lipid, were 
used to initiate pDNA de-condensation from lipoplexes. Of all lipoplexes tested, only dialysed lipoplexes 
showed always considerably neglected pDNA release. The pDNA release was also dependent on the 
mixing N/P ratios used to prepare the lipoplexes. 
DOPS with different phospholipid compositions showed variable effect on the pDNA release from 
DOTAP/pDNA lipoplexes at N/P 4 and 5 ratios. The release of pDNA from mixed DOTAP/pDNA 
lipoplexes at N/P 5 was higher than N/P 4 when DOPS/DOPC liposomes were used. In contrast, the 
presence of DOPE showed a remarkable pDNA release from N/P 4 than at N/P 5.  
The pDNA de-condensation in terms of the pDNA release rate from mixed DOTAP/pDNA lipoplexes by 
OA/DOPE/DOPC liposomes was higher than that observed by DOPS/DOPE/DOPC liposomes. Similar 
release pattern of dialysed DC-cholesterol/pDNA lipoplexes was also observed.  
In order for nucleic acids to be delivered intact to cytoplasm or the nucleus of the cell there should be an 
escape mechanism from endo-/lysosomal pathway which is characterised by an acidic pH value. 
Therefore, the effect of acidic conditions on the pDNA release from lipoplexes was evaluated at pH 5.3. 
Mixed DOTAP/pDNA lipoplexes showed lower stability in acidic pH when DOPS containing liposomes 
were applied than that observed for DC-cholesterol/pDNA lipoplexes. A high increase in pDNA release 
compared to pH 7.4 was measured. This effect was not observed for dialysed lipoplexes. They exhibited 
similar pDNA release characteristics as observed at neutral pH.  
7. Conclusive Summery 
 126
From the obtained results, it can be concluded that the detergent induces cooperative interaction between 
cationic lipid and pDNA through hydrophobic interactions rather than only electrostatic forces as 
previously described for the mixing technique. This leads to lipoplexes characterized by lower zeta 
potential values and hence a higher tendency to aggregate. The pDNA compaction in the dialysed 
lipoplexes is considerably high. 
Chapter 4 illustrated the influence of detergent OGP on the morphological characteristics of 
DOTAP/pDNA lipoplexes. In addition, the lipid organisation of DOTAP with negatively charged 
liposomes formed during pDNA release was visualized by cryo-TEM.  
As also observed in PCS measurements the presence of non-ionic detergent OGP during cationic 
lipid/pDNA assembly produces lipoplexes shown by large aggregates in cryo-TEM. Both mixed and 
dialysed DOTAP/pDNA lipoplexes were arranged into lamellar forms. Dialysed DOTAP/pDNA 
lipoplexes showed dissimilar features than that visualized in case of mixed DOTAP/pDNA lipoplexes.  
As previously shown for mixed DOTAP/pDNA lipoplexes, typical “spike” like aggregates were 
visualised. In contrast, the detergent dialysis method resulted in compact large structures with high 
electron dense particles indicating pDNA compaction. The interaction between pDNA and DOTAP 
cationic lipid showed similar features to “spaghetti” like aggregates. This was not described for 
DOTAP/pDNA lipoplexes before. The size of dialysed DOTAP/pDNA lipoplexes measured by cyro-TEM 
correlated well to size measured by PCS. Cyro-TEM confirmed the heterogeneity of both systems. A 
better understanding of the molecular assembly of pDNA and cationic lipids should help to establish 
correlations with their biological activity. Indeed, the transfection efficiency of a given lipid-DNA 
complex highly depends on its structural and physicochemical properties as well (Chesnoy and Huang, 
2000). 
In another part of the study, after interaction of DOTAP/pDNA lipoplexes with DOPS/DOPE/DOPC 
liposomes pDNA was observed to be released by lamellar-lamellar contact rather than non-bilayer fusion 
intermediate formation. The presence of lamellar phase lipid organisation for both mixed and dialysed 
DOTAP/pDNA lipoplexes was characterised by cryo-TEM. After longer contact, lamellar lipoplexes and 
DOPS/DOPE/DOPC liposomes were progressively disintegrated in case of mixed lipoplexes. Mixed 
lipoplexes retained their lamellar arrangement up to complete disintegration by DOPS/DOPE/DOPC 
liposomes. Although dialysed lipoplexes showed similar mechanism of pDNA release, they did not show 
a marked disassembly by anionic lipid DOPS after longer incubation. 
A different mechanism of pDNA release from DOTAP/pDNA lipoplexes by oleic acid was visualized. 
OA/DOPE/DOPC liposomes formed an “inverted” non-bilayer phase transition with DOTAP lipid during 
pDNA release from DOTAP/pDNA lipoplexes. Although mixed and dialysed DOTAP/pDNA lipoplexes 
showed an “inverted” non-lamellar lipid phase separation, nevertheless, the size of the fusion 
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intermediates was more pronounced in mixed DOTAP/pDNA lipoplexes. This was indicated upon longer 
incubation time by an increase in size of fusion intermediates only in case of mixed DOTAP/pDNA 
lipoplexes. 
According the previous findings, lipoplexes with an excess of cationic lipid rapidly released their pDNA 
content upon addition of anionic lipid liposomes. In the case of the lipoplexes with excess pDNA, the 
release of pDNA was quite inefficient even after 1 h of incubation with the same anionic lipids (Koynova 
and MacDonald, 2007). 
We concluded that the presence of detergent during pDNA and cationic lipid assembly enhances the 
pDNA charge neutralization by the cationic lipids. After detergent dialysis, a considerable amount of 
cationic lipids is involved in the lipoplexes formation a condition where a condensation effect on pDNA 
might occur. This was clearly observed with the enlargement of fusion intermediate size during pDNA 
release which depends on the presence of free cationic lipids. In accordance, this was observed by a 
marked reduction in zeta potential and hence higher tendency for aggregation. These observations were 
accompanied by higher pDNA compaction in the lipoplexes and lower pDNA release. Additionally, the 
extent of pDNA release from DOTAP based lipoplexes by anionic lipids does not universally correlate 
with the propensity of the cationic/anionic lipid mixtures to adopt non-bilayer motifs. Only the rate of 
pDNA release could be enhanced. 
Next, in chapter 5, the stability by means of dissociation and disassembly of the DOTAP/pDNA and DC-
cholesterol/pDNA lipoplexes after incubation with DOPS and oleic acid lipids has been investigated. To 
assess lipoplexes disassembly, probe dilution assays of octadecyl-rhodamine OD (R18) and NBD-PE 
using fluorescence resonance energy transfer (FRET) were used.  
The lipoplexes disassembly was characterised by lipid mixing between lipoplexes and different negatively 
charged liposomes using OD (R18). However, the extent of lipid mixing of dialysed DOTAP/pDNA 
lipoplexes with DOPS/DOPE/DOPC liposomes was not correlated with their pDNA release shown in 
chapter 3. This lack of correlation has been attributed to the fact that apparent lipid mixing of dialysed 
DOTAP/pDNA lipoplexes with DOPS containing liposomes induced presumably by fluorophore dilution 
only in the outer-monolayers of the contacted membranes. As concluded, the lipid mixing is not 
necessarily resulted in the concomitant release of pDNA from the dialysed DOTAP/pDNA lipoplexes, a 
prerequisite for pDNA to become eventually transcriptionally active. A similar result was in line with 
FRET result for the same lipoplexes. The energy transfer efficiency (E) indicated that mixed and dialysed 
DOTAP/pDNA lipoplexes showed a massive aggregation with DOPS/DOPE/DOPC liposomes. This was 
indicated by complete energy transfer efficiency loss. OA/DOPE/DOPC liposomes showed similar effects 
as observed with DOPS containing liposomes with same phospholipids combination. Both techniques 
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showed that mixed DOTAP/pDNA lipoplexes were loosely bound to pDNA accompanied by concomitant 
pDNA release. 
The lipid mixing assays described in this chapter revealed that pDNA release from dialysed DC-
cholesterol/pDNA lipoplexes was correlated with pDNA release observed in chapter 3. Moreover, the 
FRET assay revealed higher stability of mixed DC-cholesterol/pDNA lipoplexes as well as dialysed 
lipoplexes when mixed with DOPS or oleic acid liposomes. This was indicated by initial high energy 
transfer efficiencies. 
Chapter 6 describes the use of the detergent dialysis approach to prepare polyplexes composed of pDNA 
and 25 kD polyethylenimine (PEI). Polyplexes were formed by an alternative technique complexing 
pDNA and PEI in the presence of the non-ionic detergent N-octyl-beta-D-glucopyranosid (OGP) at 
different N/P ratios followed by dialysis. Dynamic laser light scattering technique was applied to 
determine the influence of OGP on the hydrodynamic diameter and the zeta potential values of the 
polyplexes. Using the PicoGreen® assay, as a nucleic acid dye, the pDNA condensation state was 
estimated at alkaline pH values. By means of biological activity, gene expression efficiency of the 
polyplexes was characterized in kidney cell line (HEK 293) using flow cytometric analysis. 
We showed that PEI/pDNA polyplexes can be formulated in the presence of the detergent OGP to form 
condensed pDNA. Unlike regular polyplexes, dialysed polyplexes exhibited different physicochemical 
properties as well as biological activities. As previously observed for lipoplexes, the preparation technique 
influenced the hydrodynamic diameter, zeta potential as well as release of pDNA from the polyplexes. In 
addition, the effect was OGP (50-200 mM) concentration dependent.  
The hydrodynamic diameters of polyplexes at N/P 5 and 10 prepared by simple mixing were 111 and 
161.7 nm, respectively. Zeta potentials of both complexes ranged between 30 and 35 mV. In contrast, at 
the same N/P ratios all dialysed polyplexes showed reduced zeta potentials compared to the mixed 
complexes. The zeta potential further decreased with increasing concentration of OGP in the range 50-200 
mM used for polyplex preparation. This effect was more pronounced for polyplexes prepared at N/P 5 
than at N/P 10. The reduced zeta potentials correlated with an increase in size and a tendency of the 
dialysed polyplexes to aggregate. Plasmid DNA was condensed in mixed as well as in dialysed polyplexes 
at N/P ratios 5 and 10. However, at pH 11 mixed polyplexes released approximately 80% of the 
incorporated pDNA independent on N/P ratio. In contrast, all dialysed polyplexes formed very stable 
systems and showed a lower pDNA release (maximum: about 30%) compared to the mixed polyplexes 
with a reduction of release with increasing N/P ratios. Mixed polyplexes showed GFP expression up to 47 
% of cells with increasing amount of pDNA and a decrease in N/P ratio of polyplexes. At N/P ratios 
higher than 10, cytotoxic effects of the polyplexes were detectable. In comparison, transfection efficacies 
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of dialysed polyplexes were lower than for the mixed polyplexes with < 10% of all cells being positive for 
GFP. An increase in GFP expression was detectable with increasing amounts of pDNA and prolonged 
incubation time.  
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